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ABSTRACT 
The emergence of bovine spongiform encephalopathy (BSE) in the UK and in other 
countries and establishment of its link with new variant Creutzfeldt-Jakob disease 
(vCJD) has initiated a review of all practices in the meat industry that may have 
contributed to the emergence and transmission of these diseases. 
In these studies the potential contamination of cattle and sheep carcasses with brain 
tissues as a consequence of stunning has been investigated using a variety of applied 
techniques and analytic methods. These experiments demonstrated for the first time that 
entry of brain material into the venous circulation may occur following the use of all 
mechanical stunning methods currently in use or approved for use in the UK. The 
frequencies of brain tissue embolism observed ranged from 2 to 23 % depending upon 
the species and type of captive bolt gun used for stunning. Furthermore, in some cases 
such brain tissue emboli can be detected in the arterial blood as well as in the venous 
blood of stunned animals. In addition to determining the frequency of brain tissue 
contamination of blood, the study obtained the first experimental data on the quantity of 
brain tissue that enters the circulation after stunning. The extent and potential for 
contamination of visceral organs after stunning was investigated using detection 
methods based on microscopy, immunoassays and by the application of a real-time PCR 
assay. 
The application of established anatomical and radiographic techniques demonstrated the 
potential for alternative vascular dissemination routes for brain tissue emboli in the 
carcass that have not previously been investigated in regard to stunning and slaughter of 
livestock. 
A novel method of detecting brain tissue contamination in the venous blood using 
clotting time estimation in plasma was investigated in samples from cattle and sheep. 
In conclusion, these studies have obtained important new information upon the potential 
for current stunning methods to cause contamination of sheep and cattle carcasses with 
brain tissues and proteins. The findings in these studies underline the importance of 
developing innovations and or modifications to current stunning methods to reduce the 
possibility of transmission of prion diseases to humans through contaminated meat. 
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CHAPTER 1 INTRODUCTION AND REVIEW OF THE LITERATURE 
1.0 INTRODUCTION 
The epidemics of bovine spongiform encephalopathy (BSE) in cattle and of variant 
Creutzfeldt-Jakob disease (vCJD) in humans belong to the transmissible spongiform 
encephalopathy (TSE) group of diseases that were until twenty years ago relatively 
obscure. The acceptance that BSE is primarily a food borne disease has led to a revision 
of many areas within the meat industry. Although control measures introduced since the 
start of the BSE outbreak have largely been effective in controlling the disease, many 
uncertainties still exist including some that relate to routes of disease transmission to 
humans. The question of contamination of carcasses with potentially infected tissues at 
stunning and slaughter of livestock was first raised nearly ten years ago. Despite some 
limited work in this area, including studies involving examination of carcasses for brain 
tissue contamination following stunning and slaughter of livestock, the risk posed by the 
use of current stunning methods remains unknown. Any risk analysis is only as good as 
the data upon which it is based and it is important that accurate estimates are made at 
each critical control point of meat production. In this study the potential of various 
stunning methods to cause contamination of edible parts of the carcass with brain tissue 





1.1 TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES 
1.1.1 Historical perspective 
The first description of diseases which today are classified as Transmissible Spongiform 
Encephalopathies (TSEs) were made in the 18th Century in England, in reference to an 
unusual disease that was prevalent in the sheep flock and was adversely affecting the 
wool industry (Schwartz, 2003). In England, this disease was given the name Scrapie to 
describe the frequent observation that affected sheep would rub themselves against posts 
and fences as if to relieve an itch. In the 19th Century, scientific investigation of this 
disease demonstrated neuronal vacuolation in the brains of animals that had died of 
Scrapie and further studies in the 1930's demonstrated the transmissibility of the disease 
to previously healthy sheep (Cuille & Chelle, 1936). In 1935 Scrapie was found to have 
been transmitted in contaminated batches of Louping ill vaccine that not only confirmed 
the transmissible nature of the agent but also demonstrated its unusual resistance to the 
formaldehyde in which the vaccine had been prepared (Gordon, 1946). 
In the 1920's a rare disease, later to be known as Creutzfeldt-Jakob disease (CJD), was 
described in humans (Creutzfeldt, 1920; Jakob, 1921) and in the 1950's an apparently 
similar disease, locally called Kuru, was reported among a primitive people in what is 
now Papua New Guinea (Gajdusek & Zigas, 1957). 
A connection between these outwardly similar diseases of humans and of Scrapie 
disease in sheep was suggested by a veterinary surgeon (Hadlow, 1959) and resulted in a 
series of experiments that demonstrated the transmissible nature of these diseases and 
indicated a related infectious aetiology (Gajdusek, 1977). The causative agent of these 
diseases remained unknown until the application of advanced biochemical techniques in 
the early 1980's suggested a protein coded by the hosts own genome as the infectious 
cause (Prusiner, 1982). 
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1.1.2 Transmissible Spongiform Encephalopathy diseases 
This group of related neurodegenerative diseases are today recognised in a variety of 
mammalian species including humans and have been described throughout the world. 
Common clinical features of these diseases include a generally long incubation period, a 
chronic and progressive course and an inevitably fatal outcome after a variable period of 
illness (Taylor, 2002). More specific clinical signs are very variable and have led in the 
past, before the development of specific tests, to confusion in the correct diagnosis of 
cases. Histo-pathological examination of brain tissue from infected individuals 
demonstrates characteristic spongiform changes with neuronal death along with the 
frequent observation of insoluble amyloid-like deposits in the brain (Wells et al., 1987). 
Members of this group of diseases are now known to include, Bovine Spongiform 
Encephalopathy, Feline Spongiform Encephalopathy, Scrapie in sheep, Chronic Wasting 
Disease of cervids and elk, Transmissible Mink Encephalopathy of farmed mink and 
finally Kuru, Creutzfeldt-Jakob disease (CJD), Fatal Familial Insomnia (FFI), and 
Variant CJD of humans (Table 1.1). 
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Disease Known hosts Distribution 
BSE cattle See Table 1.3 
Scrapie sheep, goats World-wide except notably 
Australia, New Zealand 
Transmissible mink 
encephalopathy (TME) 
farmed mink North America 
Chronic wasting disease 
(CWD) 







Kuru humans Papua New Guinea 
vCJD humans UK, Ireland, Italy, France 
1.1.3 Infectious agent 
Transmissible spongiform encephalopathies are thought to be caused by small, 
proteinaceous particles which, although apparently infectious, appear to lack nucleic 
acids (Prusiner, 1982). Prion theory proposes that abnormal forms of naturally 
occurring prion proteins are responsible for disease (Prusiner, 1998). Normal prion 
proteins (PrP°) are naturally occurring glycosylated membrane proteins anchored in rafts 
through a glycosyl phosphatidyl inositol (GPI) chain (Baron et al., 2002). Nuclear 
magnetic resonance imaging of PrP°indicates a small globular protein of 253 amino 
acids in humans consisting of three 0-helical regions, an anti-parallel ß-pleated segment 
and a disordered N-terminus (Collins, Lawson & Masters, 2004). PrP° is found most 
abundantly in brain tissue in normal individuals but also occurs in smaller quantity in 
other tissues including those of the reticulo-endothelial system (Foster et al., 1993a). 
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The normal function of PrP° remains uncertain although it seems likely that it is a 
copper binding protein and is important in cell survival (Vassallo & Herms, 2003). 
The pathogenic form of prion protein (PrP) is deposited in the brain as an insoluble, 
relatively protease resistant iso-form of the normal prion protein. The pathogenic form 
of prion protein does not differ in primary amino acid sequence from normal prion 
protein but does have tertiary structural differences that include a higher B-sheet content 
(Prusiner, 1998) 
1.1.4 Pathogenesis of infection 
The pathogenesis of TSE disease is associated with the expression and accumulation of 
structurally aberrant conformers of the prion protein generically called PrPSO (Bolton, 
McKinley & Prusiner, 1982). Infection is believed to occur following the formation of 
dimers between PrPSC and PrP° that induce a conformational change of PrP° into PrPSc 
(Prusiner, 1982). This conversion produces a protein that is relatively resistant to 
Proteinase K digestion, a feature which is frequently exploited in diagnostic studies 
(Meyer et al., 1999). The `protein only' theory of prion disease has been supported by 
in-vitro studies demonstrating a structural change in the protein from a predominantly 
alpha-helical structure to one with higher beta-sheet conformation (Jackson et al., 1999). 
It is the progressive replacement of the normal prion protein for the abnormal PrPSO that 
is central to the pathogenesis of all prion diseases. Investigation of the role of 
chaperone proteins in transporting prion protein from the endoplasmic reticulum is 
providing new insights in to the mechanism of abnormal prion protein accumulation and 
deposition (Kimura et al., 2004). 
1.1.5 Species barrier 
All TSE diseases are thought to share the same pathogenesis in various species although 
transmission between species is known to be less efficient than that observed within a 
species. The basis of this so called `species barrier' may relate to amino acid differences 
between prion proteins from different species (Bosque, 2002). The species barrier is an 
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important concept in risk analyses of BSE transmission since it may have been an 
important and fortuitous factor in limiting transmission of cattle BSE to humans. 
1.2 BOVINE SPONGIFORM ENCEPHALOPATHY (BSE) 
1.2.1 The development of disease 
In the middle of the 1980's an unusual neurological disease was observed in cattle in the 
United Kingdom. The disease affected mainly dairy cows of 4-5 years of age. Clinical 
features were insidious in onset and included increased excitability and aggression and 
were often accompanied by abnormalities in gait (Wells et al, 1987). These signs were 
associated with generalised signs of disease including weight loss, reduction in milk 
yield and finally recumbency and death (Wilesmith et al., 1988). 
The incidence of the disease increased rapidly in the following years to reach epidemic 
proportions in the UK (Defra, 2004) (Table 2) and subsequently to be recognised in 
many European countries, Japan and most recently in North America (OlE, 2004) 
(Table 3). Histopathological examination of brain tissue from affected animals revealed 
vacuolations of the grey matter neuropil and neurones in the brain stem as well as the 
appearance of deposits known as scrapie associated fibrils. These characteristic changes 
identified the disease as a spongiform encephalopathy (Wells et al., 1987). 
The origin of BSE remains unknown, although it has been suggested that it originated as 
a sheep or bovine derived strain of abnormal prion in a single animal (Wilesmith, Ryan 
& Atkinson, 1991). The practice of re-cycling rendered tissues back to ruminant 
animals as meat and bone meal (MBM) containing the infectious agent is believed to 
have spread the disease to other animals (Wilesmith, Ryan & Atkinson, 1991). Much 
speculation has surrounded changes to the rendering process that were made in the late 
1970's in the UK that may have allowed the survival of a "rogue" prion protein and 
allowed transmission to other animals by way of the feed (Taylor & Woodgate, 2003). 
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Table 1.2 Reported annual cases of bovine spongiform encephalopathy (BSE) in Great 
Britain (Defra, 2004) 



















Total cases 180,600 
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1.2.2 Infectious dose 
It has been estimated that up to 750,000 BSE infected cattle entered the human food 
chain before controls were implemented in 1988 (Anderson et al., 1996). From these 
infected cattle millions of people in the UK were exposed to potentially BSE infected 
meat. The incubation period of vCJD in humans is still unknown although estimates 
indicate a period of 15 to 18 years in most individuals but it is likely to be prolonged 
beyond this time in at least a proportion of infected individuals (Ghani, 2002). The 
infectious dose of BSE in humans is also unknown although studies using laboratory 
animal models suggest that it might be very small (Cummins et al., 2001). Infectivity of 
prion protein is estimated by bioassay using either transgenic mice or other laboratory 
species. An LD50 of 10 9'3 per gram of brain by intra-peritoneal administration has been 
determined by experiments using the 4PBI BSE strain isolated in C57BL/6 mice and 
implies that a single LD50 infectious dose is equivalent to 0.5ng brain (Maignien et al., 
1999). It is estimated that between 105 and 109 times as much infectivity is required for 
the oral route of infection as by intra-cranial injection (Prusiner et al., 1985; Kimberlin 
& Walker, 1989). This quantity has been compared to a minimum infectious dose of 
50-µg to 500-mg of infected brain tissue (Love et at., 2000). More recent oral challenge 
studies with calves have demonstrated infection following ingestion of as little as 1-mg 
of infected bovine brain material (Konold et al., 2004). 
1.2.3 Infectivity in tissues 
The infectivity of tissues including brain and spinal cord is already well documented 
(Jeffrey et al., 2001), however, the potential for TSE infectivity to be present in edible 
parts of the carcass, including muscle, is still unclear. The infectivity of muscle tissue 
was not previously documented in animals or humans infected with TSE diseases 
(Wadsworth et al., 2001) until recently when PrPSO was detected in the muscle tissue of 
mice and hamsters experimentally infected with Scrapie (Bosque et al., 2002). In a 
separate study, PrP" has been detected in muscle and spleen from patients diagnosed 
with sporadic CJD (Glatzel et al., 2003). The potential for secondary contamination 
with PrPSc of muscle tissues of beef carcasses as a result of slaughter and butchery 
practice is also described (Bauer et al., 1996; Anil et al., 1999; Helps et al., 2002). 
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Contamination of muscles with potentially BSE infected brain tissue by way of the 
circulation following captive bolt gun stunning of cattle has been hypothesised (Anil et 
al., 1999; 2001; 2002), but to date has not been demonstrated. 
1.2.4 New strains and public health 
A variety of strain types of TSE agents are known to exist and are identified by 
differences in the molecular mass of the PrPSO fragments, by the degree of glycosylation 
of the prion protein and upon the characteristic biological properties on transmission of 
the agent to laboratory animals. Indeed, it was through strain typing that convincing 
evidence of a link between BSE and vCJD was first made (Hill et al., 1997). The 
existence of new strains of BSE might have substantial implications for public health. 
Although recent estimates of the size of the vCJD epidemic suggest that fewer people 
may be affected than had originally been feared, researchers in Switzerland have noted 
an alarming increase in cases of sporadic CJD, raising questions of the possibility of an 
infectious aetiology (Glatzel et al., 2003). 
As part of an active BSE surveillance program in Italy over a million cattle brain-stems 
were tested of which 103 were found positive by August 2003. In two of the cattle 
brains examined a new BSE strain was identified with very different molecular and 
neuropathological characteristics from typical BSE cases. Furthermore, the molecular 
signature of this so called bovine amyloidotic spongiform encephalopathy (BASE) 
showed similarities to a PrPs" type associated with the sporadic form of CJD observed in 
humans (Casalone et at., 2004). 
1.2.5 Creutzfeldt-Jakob disease 
Before the emergence of BSE in the UK, CJD and other related diseases of humans 
were well recorded but relatively obscure due to there rarity (Masters et al., 1979). 
Three variations of CJD have been recognised since its first description in the 1920's 
(Creutzfeldt, 1920; Jakob, 1921). These variants included a sporadic form, familial 
form and, more latterly, an iatrogenic form of the disease that was first highlighted by 
10 
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transmission of CJD through contaminated human growth hormone treatment (Brown, 
1988). 
The possibility that BSE might be capable of infecting humans was largely dismissed in 
the early years of the BSE epidemic, although the similarity with CJD in humans was 
recognised soon after the epidemic in cattle was first observed (Taylor, 1989). 
Nevertheless, in spite of the perceived small risk to humans a National CJD surveillance 
unit was set up in the UK in 1990 in order to monitor CJD as a precautionary measure 
against any increase in CJD cases (UK CJD surveillance Unit). Unfortunately these 
early fears were confirmed when a novel form of CJD was observed in 1995 in the UK 
(Will et al., 1996). This new disease that was later named new variant CJD (vCJD), 
while showing many of the features of sporadic CJD differed in certain key clinical 
features. The age range of victims was much younger than expected (median 28 years, 
range 14-74), ataxia and psychiatric symptoms were more prominent and the duration of 
illness until death was also longer than that associated with sporadic CJD. 
Electroencephalogram (EEG) studies of the brains of victims were unremarkable 
although more recently magnetic resonance scanning (MRI) has proved helpful in 
diagnosis of the disease (Collie et al., 2003). All victims of this disease to date have 
been homozygous for methionine at codon 129 in the prion gene, suggesting an 
increased susceptibility to infection by this fraction of the population. Some researchers 
have suggested that the present distribution of the homozygous genotype may suggest 
that strong balancing selection at this locus occurred during the evolution of modern 
humans as a result of past outbreaks of TSE disease (Mead et al., 2003). A case of pre- 
clinical vCJD was reported from a patient who received a blood transfusion from a 
donor who subsequently died of vCJD. The infection was detected by a combined 
Western-Blot method and immunohistochemical analysis of the spleen in an individual 
heterozygous at codon 129 of the prion protein gene (Peden et al., 2004). This finding 
has confirmed earlier predictions that other genotypes may also be susceptible. On 
microscopic examination of the brains of victims of vCJD spongiform changes were 
visible in the caudate nucleus and putamen and florid plaques were identified in the 
cerebral cortex and cerebellar cortex (Ironside, 2003). Others brain tissues 
demonstrated extensive loss of neurones. All these signs were typical of the kind of 
pathology observed in TSE diseases of humans and animals. 
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At the time of writing 148 people have died of vCJD in the UK and a further 5 people 
have been diagnosed with the condition (UK CJD surveillance Unit). There is now 
compelling evidence that infection occurred by ingestion of BSE contaminated beef or 
from beef products, including those derived from mechanically recovered meat (Bruce 
et al., 1997). Recent research has raised the worrying possibility that BSE may also 
account for some cases of a sporadic-like form of CJD in humans (Asante et al., 2002). 
The fording of two cases of vCJD in people who received blood transfusions from 
people who subsequently contracted vCJD has given credence to reports that the agent 
may be transmitted between individuals through blood and blood products (Peden et al., 
2004). Biopsies of tonsil and appendix have been demonstrated to offer ante mortem 
diagnosis of vCJD at early stages of disease before clinical signs become apparent. A 
recent survey of stored appendices found a single positive out of more than eight 
thousand tested, translating into an eventual estimate of 120 cases of vCJD per million 
in the UK population (Hilton et al., 2002). While great efforts are being made to 
prevent further infections in the population, the fear that many people may already be 
infected has prompted research into potential treatments. Currently several trial 
compounds have shown potential for slowing the formation of pathogenic prion proteins 




Table 1.4 Worldwide annual deaths from new variant Creutzfeldt-Jakob disease (vCJD) 
Year Deaths from vCJD in 
countries excluding the UK 
Deaths from 
vCJD in UK 
1995 3 




2000 1(France) 28 
2001 1 (France) 20 
2002 3 (France) 17 
2003 18 
2004 3 (France), I (Italy), 1 
(Ireland) 
9 
1.2.6 Butchery practice and variant Creutzfeldt-Jakob disease 
The use of traditional butchery practices in which brains from cattle were routinely 
removed and used in the preparation of food products is believed to be responsible for 
the cluster of vCJD cases that occurred in Queniborough in the UK (Adams, 2001a). 
Brain material may also have contaminated hands and knives with infectious prions that 
were then inadvertently transferred to meat-cuts that entered the human food chain. 
These cases under-line the importance of investigating all potential routes by which 
brain material might contaminate meat through slaughter and butchery practice however 
small the perceived risk. 
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1.2.7 Transmissible spongiform encephalopathy diseases of sheep 
It is known that sheep in the UK were exposed to the same BSE contaminated food as 
cattle during the 1980s albeit in smaller quantities (MacKensie, 2002). Experimental 
inoculation of several sheep genotypes with BSE infected tissues has demonstrated the 
susceptibility of the species to BSE (Foster et al., 1993). It has been suggested that 
Scrapie, which demonstrates similar clinical signs to experimentally induced BSE in 
sheep, may be masking the presence of BSE in a small proportion of animals (Baron & 
Biacabe, 2001). In addition, the distribution of infective tissues in sheep experimentally 
infected with BSE has been shown to be much greater than that in cattle (Jeffrey et al., 
2001) indicating that the entire carcass from a BSE infected sheep might be infectious. 
In contrast, in cattle the majority of BSE infectivity is confined to tissues of the CNS 
and other tissues currently designated as SRM (Defra, 2004). Despite extensive testing 
BSE has not been identified in the sheep population to date. Furthermore, monitoring of 
Scrapie incidence has shown no marked increase in recent years making it unlikely that 
a substantial BSE epidemic has occurred in sheep (Gravenor et al., 2000). Surveillance 
and testing of Scrapie cases from both recent and stored samples by sensitive tests for 
prion protein has revealed a small number of cases that do not fit the recognised criteria 
for Scrapie disease of sheep. At the same time these cases currently designated as 




Table 1.5 Reported annual cases of Scrapie disease in Great Britain since 1993 












2004 Not available 
1.2.8 Bovine spongiform encephalopathy disease in other species 
Several species including humans were presumed infected with BSE by the inclusion of 
BSE infected material in the diet before implementation of effective control measures. 
Pigs have been demonstrated to be susceptible to BSE infection by the parenteral route 
(Dawson et al., 1990) and it is likely that some British pigs were fed the same infected 
meat and bone rations that are thought to have spread the infectious prions to cattle. 
However, pigs are unusual among simple stomached animals in being resistant to BSE 
infection by the oral route, a fording that fortunately makes it unlikely that pigs were 
infected by way of BSE infected rations (Wells et al., 2003). 
TSE disease has been reported in zoo animals including nyala and greater kudu and 
several cheetahs, lions, pumas and tigers that were presumably infected by consuming 
BSE infected rations (Delia., 2004). 
Since 1990 approximately 89 cases of feline spongiform encephalopathy (FSE) have 
been identified in the UK plus additional isolated cases in three European countries. It 
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is thought that these cases were caused through the consumption of commercial cat food 
containing BSE infected tissues (Defra, 2004). A recent report describes on-going tests 
on the brain of a French goat that initial tests suggested had been naturally infected with 
BSE (Anon, 2004"). If confirmed, this would be the first recorded case of naturally 
acquired BSE in this species and must also raise further questions as to the existence of 
undetected BSE cases in sheep. 
1.2.9 Transmissible spongiform encephalopathy disease in other species 
Prion disease caused by agents other than that affiliated with BSE afflicts several 
species of animals including some that are consumed by humans. Scrapie is a neuro- 
degenerative disease first described in sheep (Schwartz, 2003) but also known to infect 
goats (Baylis & Goldman, 2004) and Moufflon (Wood et al., 1991). Scrapie is not 
thought to cause disease in humans although clusters of spongiform disease in countries 
in which sheep brains are consumed has resulted in investigations that have so far found 
no connection (Zilber, Kahana & Abraham, 1991). The epidemiology of Scrapie is 
linked to recognised polymorphisms on codons 136,154 and 171 of the ovine prion 
protein gene (Hunter et al., 2003) in common with other TSE diseases in other species 
that also demonstrate preferential susceptibility in different genotypes. 
Transmissible mink encephalopathy is a prion disease of farmed mink seen mainly in 
North America that is thought to be transmitted through prion infected rations (Marsh & 
Hadlow, 1992). In North America the epidemic ofchronic wasting disease (CWD) in 
wild deer species appears to be increasing (Bosque, 2002). Although no evidence of 
transmission to humans exists, cases of prion disease among hunters who were known to 
have consumed wild venison have raised questions over the possibility of a link with 
disease in humans (Belay et al., 2001). 
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1.3 CONTROL MEASURES 
1.3.1 Control of BSE in Animals 
A range of control measures have been implemented since 1986 in the UK to prevent 
further infection of livestock with the BSE agent. These measures have been successful 
in causing a significant yearly decrease in the number of infected cattle in the UK. 
1.3.1.1 Notification, slaughter and incineration 
In June of 1988, BSE was made a notifiable disease in the UK and in August of that 
year cattle suspected of having BSE were compulsorily slaughtered and destroyed by 
incineration with 100% compensation paid to farmers for confirmed cases of the 
disease. An offspring cull of all cattle confirmed to have BSE was made compulsory in 
1999 (MAFF, 1999). 
1.3.1.2 Records, tagging and passports 
Investigations and control measures instituted following the identification of BSE 
positive animals requires an accurate method of tracing and identifying all animals that 
may be infected or had contact with infected animals. Legal requirements of record 
keeping include maintaining a history of all animal movements between premises and 
records of calf births and ear tag numbers. Records must be kept for a period of at least 
ten years. In 1998 the cattle tracing system (CTS) was introduced to monitor the 
movement of all cattle born after 1996 by way of cattle passports (MAFF, 1999). 
17 
Chapter 1 
1.3.1.3 Meat and bone meal ban 
Rendering is the process by which waste products from the meat processing industry are 
converted by cooking at high temperature into tallow and meat and bone meal (MBM). 
The greater quantity of this MBM was fed to high producing dairy cattle as an 
ingredient of concentrate feed. In the late 1970's a new method of rendering was 
introduced which reduced the use of organic solvents in the process. It has been 
suggested that this change in practice may have triggered the BSE epidemic by allowing 
the survival of a sheep derived prion (Taylor, 1995). Epidemiological investigations of 
BSE indicated a point source origin for the disease of which the MBM feed was the 
most likely (Wilesmith et al., 1991). 
A ban was placed on feeding ruminant tissues back to ruminants in 1988 in the UK and, 
although not immediately effective, has largely been responsible for the observed steady 
decline of BSE cases. Experiments have demonstrated that cow to calf transmission 
may account for a small proportion of new cases born after this ban was imposed 
(Bradbury, 1996). The continued illegal use of old feed stocks after the ban has also 
been cited as an additional factor for cases of BSE in animals born after imposition of 
the feed ban. 
A further ban was placed on feeding ruminant derived Meat and Bone meal to all farm 
animals in 1996 along with other stringent measures aimed at eradicating BSE from the 
UK herd. Some European countries have been slow to implement strict control 
measures and in such countries the incidence of BSE continues to rise. 
1.3.2 Control of BSE transmission to humans 
Although transmission to humans was judged unlikely at the start of the BSE epidemic, 
some measures were taken to protect public health in the UK soon after BSE was 
recognised. The recognition of vCJD in 1996 (Will et al., 1996) resulted not only in the 
implementation of much more stringent measures to control BSE but also in an EU ban 
on UK beef exports, with devastating economic effects upon the UK beef industry. 
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1.3.2.1 Inactivation of TSE agents 
The agents of TSE disease are extremely resistant to physical and chemical procedures 
that inactivate other disease agents. Standard decontamination procedures such as 
exposure to ultraviolet and ionising radiation are not effective in deactivating the 
infectious form of prion protein. The use of chemical disinfection methods have 
included, 1M sodium hydroxide, sodium hypochlorite at concentrations of 2000 ppm 
and autoclaving in water at 134°C that reduced infectivity by > 5.6 log io lethal doses 
(Fichet et al., 2004). Finding effective and economic deactivating procedures is of 
considerable practical importance for cleaning of abattoir equipment such as the bolt of 
captive bolt guns, saw and knife blades and contaminated surfaces. Contamination of 
surgical instruments with potentially prion-infected tissues has created difficult 
dilemmas for surgeons. The safest option is thought to be the single use of all surgical 
instruments, however the cost of this option would be prohibitive. A trial introduction 
of single use plastic instruments was shown to have far more mortality associated with 
their use than the risk associated with contracting vCJD through surgery (Frosh, Joyce 
& Johnson, 2001). 
1.3.2.2 Specified risk materials (SRM) 
As a further measure to prevent exposure of humans to the BSE infectious agent, tissues 
believed to contain up to 99% of infectivity were banned from human use in the UK 
from 1989. These tissues originally designated Specified Bovine Offal (SBO), included 
brain, spinal cord, tonsil, thymus, spleen and intestine from all cattle over 6 months of 
age. In the following years this ban was broadened to include other bovine tissues as 
well as inclusion of sheep and goat heads, spleens and spinal cords and is now 
designated Specified Risk Material (SRM). In practice it is not possible to easily 
remove the spinal cord or brain, so in effect it is the head and spine that are removed 
from carcasses and incinerated. In a recent amendment to SRM regulations (EC 
regulation 149/2004) small bone chips from the spinous and transverse processes from 
specified areas of the bovine vertebral column removed with the meat during boning 
operations will no longer be classified as SRM (Anon, 2004a). All tissues designated as 
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SRM are removed from carcasses at slaughter and dyed and stored separately prior to 
destruction by incineration. 
Table 1.6 Tissues currently designated as specified risk material (SRM) in the UK 
(EC No 999/2001) (FSA, 2004) 
Species Age SRM 
Bovine >6 months Skull, brain, eyes (head 
excluding the tongue), tonsils, 
spleen, spinal cord 
Bovine Calves of any age Intestine (from duodenum to 
rectum), thymus, tonsils, 
mesentery, spleen 
Ovine/caprine Permanent incisor tooth Skull, tonsils, brain, spinal 
cord, eyes 
Ovine/caprine All Spleen, ileum 
1.3.2.3 Over thirty months scheme (OTMS) rule 
Nearly all clinical cases of BSE have been in animals over thirty months of age and no 
reported cases below this age limit have occurred in the UK since 1996 (Bradley, 2003). 
The long incubation period of BSE in cattle (mean 60 months) and experimental 
evidence that infectivity is restricted to the distal ileum in animals that are under 32 
months of age has re-enforced the belief that only a negligible risk exists to the 
consumer from animals less than 30 months old. All cattle older than thirty months are 
slaughtered at designated abattoirs and incinerated. Exceptions to this rule include some 
grass fed cattle in the Beef assurance scheme that are authorised for human consumption 
up to 42 months of age. In 2001 there were 8 OTMS designated abattoirs out of a total 
of 394 in Britain. At this time, fears were expressed over the possibility of transmission 
occurring at the abattoir since cattle for human consumption were also slaughtered at 
some of these facilities although on different days (Adams, 2001). The resistance of 
the prion protein to normal disinfection procedures would seem to make these concerns 
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justified in light of the known potential for wide dissemination of neural tissues within 
the abattoir environment (Helps et al., 2004; Prendergast et al., 2004). 
The decline of BSE cases in the UK combined with the development of sensitive post- 
mortem tests has initiated a revision of the OTMS rule. It has been proposed that all 
cattle slaughtered over 30 months of age will be tested for BSE by an accredited assay 
before entry into the food chain in line with current EU legislation (EC No. 999/2001). 
It is estimated that the replacement of the OTMS could save up to £300m a year in the 
UK. To date the scheme has cost around £3bn. a year to implement since its inception 
(FSA, 2004). 
1.3.2.4 Changes in stunning and slaughter practice 
Based on evidence that demonstrated a risk of contamination of the carcass with brain 
tissue after stunning (Garland, Bauer & Bailey, 1996; Anil et al., 1999) the practice of 
pithing after stunning was banned in 2001 and air-injection pneumatically-activated 
captive bolt guns are no longer recommended for use in the UK. Pithing involves the 
introduction of a flexible rod into the bolt-hole created by the penetrating CBG and then 
directed through the foramen magnum into the spinal canal to maximise destruction of 
the brain and spinal cord. The practice has benefits both for animal welfare and for 
worker safety but may result in an increased risk of carcass contamination with brain 
tissues (Anil et al., 1999). In addition the Scientific Steering Committee (EC, 2002) 
suggested that more investigation should be conducted into the prevalence of neural 
embolism after stunning with captive bolt gun devices currently used in the UK. 
1.3.2.5 Ban on the use of mechanically recovered meat (MRM) 
Mechanically recovered meat refers to meat removed from the skeleton, including the 
spinal column, after the application of conventional carcass de-boning techniques. This 
practice is associated with a potential risk of removing SRM tissues including the dorsal 




MRM was traditionally used in the production of burgers, sausages and other meat 
products prior to the introduction of a ban in the UK in 1995. This ban was extended 
within the EU in 2001 to include MRM from bovine, ovine and caprine skeletons. 
Epidemiological investigations of MRM suggest that the production of beef MRM in the 
UK peaked at 5000 tonnes in 1987 and was around 2000 tonnes at the time of the ban in 
1995 (Cooper & Bird, 2002). A study of the effectiveness of the SBO ban on reducing 
BSE transmission by MRM found that the SBO legislation in 1989 contributed only a 
6% reduction in infectivity from beef MRM at that time. Remaining infectivity in 
MRM, even after the SBO ban, arose from inclusion of small quantities of spinal cord 
material and from the dorsal root ganglia that may have been removed with the meat 
(Cooper & Bird, 2002). A recent study has investigated the use of ultra-high pressure to 
inactivate experimental prion infectivity in processed meats with significant reductions 
in BSE infectivity in samples as compared controls (Brown et al., 2003). The 
development of methods of prion inactivation applicable to the food industry could 
increase the safety of processed meat products. 
1.3.2.6 Active surveillance and post-mortem testing for BSE 
In the EU, all cattle over thirty months of age that are intended for human consumption 
must be tested by an authorised rapid post-mortem test. Any carcass that is found 
positive is incinerated along with the carcass in the line before and the two in the line 
after (Bradley, 2003). The basis for this decision stems from research indicating that 
99.95% of cattle demonstrating clinical sings of BSE are over thirty months of age. 
Below thirty-two months of age only the distal ileum contains detectable infectivity 
(Bradley, 2003). In the UK all OTMS cattle are currently disposed of according to UK 
OTMS regulations, however it is expected that the OTMS rule will be phased out in 
2005 in favour of post-mortem testing. Post-mortem tests are based on sensitive 
immunoassays (Bird, 2003). Tests that are currently authorised by the EU commission 
include: 
" The Prionics blotting system 
" Enfer ELISA (Abbott) 
" CEA ELISA systems (BioRad, Marnes-la-Coquette, France) 
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All three of these tests are believed to approach 100% in terms of sensitivity and 
specificity (Dealler, 2004). 
1.3.2.7 Ante-mortem testing for BSE 
Due to the current practice of testing only a proportion of animals entering the food 
chain it is possible that sub-clinically infected animals under thirty months of age may 
enter the food chain undetected. Although such animals are likely to be less infective at 
earlier stages of the disease these animals might still pose a risk for the consumer. 
Extensive research has been invested in the development of effective ante-mortem tests 
that can detect BSE before characteristic clinical signs appear. Serum from BSE 
infected cattle and from healthy controls was analysed by a combination of infrared 
spectroscopy and multivariate pattern recognition analysis with a reported sensitivity 
and specificity for BSE diagnosis of 96 and 92% (Lasch et al., 2003). In a separate 
study, antibodies to Acinebacter bacteria and bovine brain peptides have been compared 
in BSE infected and in healthy control animals in a study to develop an ante-mortem test 
(Wilson et al., 2003). Other researchers have attempted to record a perturbation of heart 
rate among sub-clinically BSE infected cattle since pathological changes in the brain 
stem of infected animals may modulate heart rate variability (Promfrett et al., 2004). A 
recent report describes gait changes in BSE infected cattle that may be used as a useful 
indicator for BSE suspects (Braun et al., 2004). Despite promising results from these 
and other studies a reliable ante-mortem test for BSE has not yet been developed. 
1.4 PRE-SLAUGHTER STUNNING 
1.4.1 Stunning of cattle and sheep in the UK 
Stunning animals before slaughter aims to induce a state of unconsciousness so that 
slaughter may be carried out without pain and suffering for the animal. In the UK, 
legislation protects the welfare of animals to be slaughtered by requiring the use of an 
approved method of stunning, exceptions include those animals slaughtered by religious 
methods for such as Muslim (Halal) and Jewish (Shechita) markets (Defra, 1995). 
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Stunning methods of sheep and cattle in the UK include electrical stunning and the use 
of mechanically operated devices. 
1.4.2 Stunning methods 
1.4.2.1 Electrical stunning 
Electrical stunning is used by approximately 70% of sheep slaughter plants but is not 
widely utilised for cattle stunning in the UK. Currently six plants in the UK use this 
system as a stunning method for cattle and its popularity may increase in future. 
Stunning of cattle is performed by the application of three electrical cycles comprising a 
head-only stun followed by a cardiac cycle and finally a spinal discharge cycle (Wotton 
et al., 2000) except for Halal slaughter for which head only stunning is applied. While 
electrical stunning is used routinely and effectively in New Zealand, where the system 
for cattle was developed, cost and welfare problems have so far limited its widespread 
implementation in the UK although it is commonly used in other European countries 
including Germany. 
1.4.2.2 Gas stunning and slaughter 
The use of carbon dioxide and inert gases is used effectively in the stunning and 
slaughter of pigs and chickens (Gregory, Moss & Leeson, 1987; Raj, 1998). However, 
the method has not proven adaptable for use in cattle because of the large size of the 
animals and in sheep because of the potential for gas absorbency of the fleece. 
1.4.2.3 Captive bolt stunning 
When used correctly, captive bolt guns induce an instantaneous stunned state by the 
application of percussive forces to the skull. Stunning by captive bolt involves the 
transfer of the kinetic energy of the bolt to the animal's head, which causes severe 
disruption of normal electrical brain activity and at the same time produces extensive 
tissue damage and haemorrhage (Blackmore, 1979). If operated optimally the use of 
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CBGs for sheep and cattle provide a cheap, efficient and welfare friendly method of 
stunning prior to slaughter. The emergence of BSE and vCJD and the possibility that 
CBGs may sometimes cause contamination of the carcass with infectious prions have 
called into question the safety of mechanical stunning methods for livestock (Anil et al., 
1999; 2002). In the UK, captive bolt gun equipment is no longer subject to firearms 
legislation and consequently is readily available to those involved in the routine culling 
of livestock (DEFRA, 1995). The banning of captive bolt gun use would have serious 
welfare implications for the slaughter of livestock since no similarly efficient and 
available method of stunning currently exists. 
1.4.2.3.1 Captive Bolt Guns used for stunning of cattle and sheep 
Captive bolt guns employed for stunning cattle comprise both penetrating and non- 
penetrating devices. Both types of device comprise a steel bolt retained within the 
barrel of the gun by a flange and is buffered by special sleeves which absorb the impact 
on firing and ensure that the bolt returns to its original position. When the gun is fired 
the expansion of gases produced by the detonation of a cartridge drives the bolt out of 
the barrel at speeds of 40 to 50 m/s for a distance of approximately 80-mm (HSA, 1998). 
Penetrating guns are designed to drive the bolt of the gun through the skull and into the 
brain (Figure 1.1). Non-penetrating devices are equipped with a mushroom shaped bolt 
end, which impacts the animal's head (Figure 1.2). These non-penetrating CBG devices 
are not designed to enter the animal's brain but nevertheless have been shown to be as 
effective as penetrating devices in inducing a stunned state (Daly & Whittington, 1989). 
Sheep are stunned using only captive bolt guns of the penetrating type in the UK. Both 
cartridge-activated and pneumatically-activated guns are used. 
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1.4.2.3.2 Trauma induced by penetrating and non penetrating captive boll 
devices 
The magnitude of the brain damage induced by percussive stunning is determined by the 
quantity of kinetic energy transferred to the brain (Finnie, 1997). Penetrating CBGs 
initially fracture the skull producing a round discrete hole with either no attendant 
fractures or with fine fracture lines of limited extent radiating from the bony deficit in 
the skull (Finnie, 2000). The inner table of the skull is also fractured and bone 
fragments are driven into the brain tissue. The bolt then penetrates the dural membranes 
surrounding the brain and creates a permanent haemorrhagic wound track in the brain 
tissue. Considerable laceration and crushing of tissue is caused by the passage of the 
bolt in addition to rupture of the vessels of the venous sinuses. Severe damage also 
occurs in areas remote from the passage of the bolt including severe damage to the 
cerebellum and brainstem and considerable sub-arachnoid and intraventricular 
haemorrhage (Finnie, 1993; Farag, 2002) 
The impact of a non-penetrating CBG on the skull of cattle produces a 3-cm depressed 
fracture of the skull with radiating fracture lines (Finnie, 1995). In most cases both the 
inner and outer tables of the skull are fractured and multiple fragments of skull are 
driven deep into the brain. Contusions and laceration of tissue are evident much of 
which is caused by the bone fragments driven into the tissue. Extensive sub-arachnoid 
haemorrhage is, present both dorsally and around the base of the brain. The dural 
membrane may remain intact in some cases although there is often sub-arachnoid 
haemorrhage around the midbrain and cerebellum. Examination of cattle brains after 
stunning with both types of CBG suggests that comparable trauma to tissues and blood 
vessels are produced (Farag, 2002). The results of this recent study are in contrast to the 
findings of an earlier study, which found sub-arachnoid haemorrhage but no brain 
contusions after use of a non-penetrating CBG on cattle (Finnie, 1995). 
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Figure 1.3 A bovine skull and brain following non-penetrating captive bolt gun 
stunning demonstrating tissue trauma and haemorrhage 
Figure 1.4 A bovine skull and brain following penetrating captive bolt gun stunning 
demonstrating tissue trauma and haemorrhage 
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1.5 CNS TISSUE CONTAMINATION AT STUNNING AND SLAUGHTER 
1.5.1 Potential for carcass contamination at stunning and slaughter in sheep and 
cattle 
The stunning and slaughter of livestock provides the opportunity for contamination of 
the carcass with a variety of potentially infectious agents (Anil et at., 1999; Buncic et al., 
2002). Infectious agents including bacteria present on hides and hooves, in body fluids 
or in the tissues themselves may contaminate the carcass by the use of invasive 
procedures at stunning and slaughter. 
1.5.1.1 Bacterial contamination 
All operations at stunning and slaughter of livestock in which the skin and tissues are 
penetrated have the potential to introduce bacteria onto edible parts of the carcass. The 
practice of sticking, in which a knife is used to severe major blood vessels in the neck or 
chest, has previously been shown to allow bacteria to enter the circulation (Mackey & 
Derrick, 1979). In addition, the use of penetrating captive bolt stunning has been 
demonstrated to cause extensive contamination of muscles and peripheral organs with a 
marker bacteria placed on the bolt of a penetrating captive bolt gun or directly into the 
bolt-hole after stunning (Buncic et al., 2002) 
The use of penetrating CBGs is known to cause spread of pathogenic bacteria from the 
hide, coat and tissues into the blood circulation. Furthermore, the use of a marker 
bacterium introduced by way of the CBG has demonstrated not only extensive 
contamination of the carcass but also of the abattoir environment (Daly et al., 2002). 
Some studies have attempted to draw inferences upon the potential of brain tissue 
fragments to be disseminated in the carcass from experiments using marker bacteria to 
model the movement of the brain tissue in the blood (Prendergast et al., 2004). 
However the innate differences between the morphology of bacteria and that of brain 




1.5.1.2 CNS tissue contamination 
Carcass splitting has been identified as an important contributor of carcass 
contamination with CNS tissue (Helps et al., 2004). Further contamination may occur 
by carriage of brain tissue fragments in the circulation as a result of mechanical stunning 
methods 
1.5.1.2.1 Carcass splitting 
All areas of abattoir practice have been examined to identify areas in which such 
contamination might occur. Carcass splitting has been demonstrated to cause 
contamination of the cut surfaces of the carcass with CNS material (Helps et al., 2002) 
prompting research into other methods of carcass dressing to avoid damaging the spinal 
cord. Proposals have included the use of a hot boning method already used in some 
countries in which the meat is removed from the carcass without prior chilling and 
without the need for carcass splitting. An oval saw has recently been developed that 
allows removal of the intact spinal cord and surrounding vertebrae. This saw design is 
currently undergoing trials to evaluate commercial viability (Mr. Andy Knight, Silsoe 
Institute, UK, personal communication). 
1.5.1.2.2 Captive bolt gun stunning 
The use of air-injection pneumatically-activated CBGs was stopped in the UK after 
research suggested an increased risk of carcass contamination by brain tissue fragments 
(Anil et al., 1999). It is thought that such tissue fragments are forced into the venous 
circulation by the high intra-cranial pressures created by injecting air into the cranium 
(Garland, Bauer & Bailey, 1996; Anil et aL, 1999). Before this risk became apparent 
air-injection pneumatically-operated CBGs were used in the UK from 1980 and in the 
USA since 1982 (Roth, 2001). The contamination of edible parts of the carcass 
following the use of CBGs without air-injection facility has not been documented in 
cattle despite a previous trial on small numbers of cattle (Anil et al., 1999). It has been 
surmised that if brain tissue fragments were to enter the circulation such fragments 
would be voided in the blood at exsanguination or would become trapped in the heart or 
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lungs (Bradley, 2003). In either event, contamination of other parts of the carcass with 
brain tissue would be unlikely. However, this hypothesis has not been demonstrated by 
experiment or proven by observation. Although it is true that the majority of reports of 
brain tissue emboli describe fragments of brain tissue in the heart or vessels of the lungs 
the potential of small microscopic fragments to penetrate the lungs is unknown. 
1.5.1.2.2.1 Environmental CNS tissue contamination 
CNS tissue may also contaminate the abattoir environment, equipment as well as the 
workers themselves. In a study in which a selected bacterial species was used as a 
marker for CNS tissue, the marker bacterium was detected on the captive bolt, around 
the bolt hole on the animals head and also on the hands and aprons of operatives after 
stunning (Prendergast et al., 2004). While such contamination may appear unavoidable, 
the risk involved if a BSE infected animal were to be processed might be unacceptable. 
Head contamination with brain tissue leaking from the bolt-hole may be reduced by the 
use of a rubber bung in the bolt-hole after stunning (Daly et al., 2002). In a recent study 
an average 0.6-g of brain tissue was recovered from the area around the bolt-hole after 
penetrating CBG stunning of cattle (Magill, 2004). 
1.6 HEAD TRAUMA AND ENTRY OF BRAIN TISSUE FRAGMENTS AND PROTEINS INTO 
THE VENOUS CIRCULATION 
1.6.1 Leakage of brain proteins into the circulation after head trauma 
Measurement of serum levels of myelin basic protein, a CNS specific protein, has 
previously been investigated as an aid for assessment of patients after head trauma. 
Results suggested that following severe head trauma the blood brain barrier is breached 
allowing entry of some brain proteins into the circulation (Thomas, Palfreyman & 
Ratciffe, 1978). A variety of CNS proteins have been investigated in similar studies 
including S-l00ß (Raabe et al., 1998). Recent studies have demonstrated that even 
relatively mild head trauma, such as sustained by soccer players, can cause elevation of 
31 
Chapter 1 
S-1000 protein in the venous blood (Mussak et al., 2003). In a recent study of CBG 
stunning in cattle elevated levels of the pre-synaptic protein Syntaxin 1B were detected 
in some samples within the first thirty seconds of stunning. In this same study good 
correlation was obtained between the Syntaxin assay and the results of analysis of the 
same samples by microscopy and immunohistochemistry in which fragments of brain 
tissue were actually visualised (Anil et al., 2002). The results of these studies would 
suggest that elevation of some brain protein markers in the blood may be associated with 
fragments of brain tissue dislodged by severe head trauma. 
Figure 1.5 Graph demonstrating the variation in concentration of a brain specific 
protein in jugular blood samples taken following the application of two stunning 
treatments (Anil et al., 2002) 
Venous blood syntaxinl-B levels in cattle 
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1.6.2 Brain tissue emboli in the circulation following severe head trauma 
Pulmonary embolism following head trauma consisting of fat, marrow, skin, foreign 
bodies and brain are an uncommon finding on post-mortem examination (Torry, 1987). 
Brain tissue pulmonary embolism is an even rarer event, although cases are described in 
the literature following traumatic forceps delivery of neonates (Tan & Hwang, 1976) 
and from a variety of other severe head injuries. An early study of 213 cases of severe 
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head injury in humans gave an incidence of brain tissue embolism of 2% (McMillan, 
1956). A more recent retrospective and prospective study of cerebral tissue pulmonary 
embolism after head trauma estimated an incidence of 10% (Collins & Davis, 1994). A 
case study of a single victim of head trauma who died some 32 hours after falling from a 
ladder found significant pulmonary embolism of brain tissue that showed significant 
tissue reaction and haemorrhage upon histopathologic examination (Torry, 1987). This 
unusual fording of vital brain tissue indicated that the embolism occurred some time 
after the initial trauma and has interesting implications for the timing and mechanism by 
which entry of brain tissue into the circulation might occur following severe head 
injuries. 
1.6.3 Reported prevalence of brain tissue embolism after captive bolt stunning 
Garland, Bauer and Bailey (1996) described an estimated incidence of 2.5-5% of neural 
emboli in the lungs of cattle in an unspecified number of cattle following the use of an 
air-injection pneumatically-activated penetrating type CBG. Others have shown that 7 
of 220 animals had macroscopically visible brain tissue fragments in the pulmonary 
arteries, which were confirmed as neural in origin by histology (Bauer, Garland & 
Edwards, 1996). Although useful in identifying the existence of a problem with captive 
bolt stunning these studies based on post-mortem examination of carcasses are likely to 
have been inaccurate measures of prevalence of neural embolism since many carcasses 
with microscopic brain tissue emboli may have been over-looked at post-mortem 
examination. 
These initial findings were made in the USA and workers there were quick to suggest 
that their findings might indicate a risk factor for contamination of meat at stunning with 
PrP' in the UK (Garland, Bauer & Bailey, 1996). This suggestion was at first denied 
(Taylor, 1996) and initial studies in the UK conducted on ten cattle stunned with a 
conventional captive bolt gun demonstrated no embolism of cerebral tissue, a 
subsequent study of 210 cattle also found no evidence of neural embolism (Munro, 
1997). In a related study, the hearts of several thousand cattle were examined for 
evidence of neural embolism after stunning and slaughter, with only 2 of 1050 
confirmed as containing brain tissue emboli after the use of the air-injection 
pneumatically-activated CBG (Schmidt et al., 1999'). 
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In a novel approach, workers at Bristol University examined jugular venous blood 
collected immediately following stunning in cattle using a variety of stunning devices. 
The results of this study indicated that 4 of 15 cattle stunned with an air-injection 
pneumatically-activated device showed neural emboli in the blood collected, a single 
animal stunned by conventional captive bolt followed by pithing was also found to have 
brain tissue in jugular samples (Anil et al., 1999). The identification of the tissue 
detected in these later studies was confirmed by two analytic methods. The first 
involved the use of a capture ELISA for a brain specific protein and the second 
employed validated microscopic and immunocytochemical methods for staining and 
visualising the neural emboli with antigen-specific antibody stains (Love et al., 2000). 
In a similar experiment to investigate neural embolism after stunning in sheep, brain 
tissue was detected in two of fifteen sheep stunned with cartridge or pneumatically- 
activated penetrating CBGs respectively. No evidence of brain tissue emboli was 
detected in the small volumes of aortic blood examined in this experiment (Anil et al., 
2001). Based on the available data, the Scientific Steering Committee (SSC) of the EC 
ranked various stunning methods. The order of the perceived risk of causing brain tissue 
to enter the circulation after use of mechanical stunning methods (EC, 2002) is given 
below: 
" Pneumatic stunner that injects air 
" Pneumatic stunner that does not inject air 
" Captive bolt stunner with pithing 
" Captive bolt stunner without pithing 
" Non-penetrating stunner or electronarcosis (Absent or negligible risk) 
It was also suggested that further research was needed to investigate stunning and brain 
tissue contamination of the carcass. 
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1.6.4 Mechanism of entry of tissue into the circulation 
Collins and Davis (1994), in post-mortem studies found that the dura mata was intact in 
70% of cases of cerebral tissue embolism suggesting that rupture of the dura and or 
large venous sinuses is not always necessary for entry of brain tissue fragments into the 
circulation. In a separate study post-mortem examination of two head trauma victims 
demonstrated a large cerebral venous defect in each case as the probable site of entry of 
brain tissue into the systemic circulation (Ogilvy et al., 1988). Although the mechanism 
of entry of brain tissue into the circulation has not been investigated in reference to CBG 
stunning of livestock, observations have been made of extensive rupture of dural 
membranes and cerebral venous sinuses following the application of both penetrating 
and non-penetrating CBG stunning of cattle (Finnie, 1993; 1995, Farag, 2002). In 
addition, extensive laceration of brain tissue suggests that brain tissue trauma and blood 
vessel rupture are contributing factors for embolism of brain tissue. 
1.6.5 Size and quantity of brain tissue fragments that may enter the circulation at 
stunning 
The quantity of brain material that may enter the venous return at stunning is a critical 
factor in any risk analysis of captive bolt gun stunning of livestock and contamination of 
the carcass with potentially infected tissues. Brain tissue fragments ranging from a few 
millimetres up to a maximum of 14-cm have been found in the pulmonary arteries of 
cattle after use of an air-injection pneumatically-activated CBG (Garland, Bauer & 
Bailey, 1996). In a separate report, segments of spinal cord as large as 10 to 13-cm 
were observed in the right ventricle of a single carcass after use of a similar type of 
CBG (Schmidt et al., 1999). Fragments of brain tissue as large as 3-cm have been 
observed in the liver, kidney and right ventricle of the heart of a single cow after the use 
of an air-injection pneumatically-activated CBG in a post-mortem study of carcasses 
(Roth L., 2001). An examination of jugular blood samples taken from four cattle after 
the use of an air-injection pneumatic CBG and in a single cow after use a penetrating 
cartridge-activated CBG followed by pithing revealed fragments of brain tissue up to 
50-µm in diameter (Anil et al., 1999). In a related study fragments as small as 5-µm 
were observed in jugular blood samples from sheep after use of penetrating CBGs (Anil 
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et al., 2001). All descriptions of brain tissue emboli in blood or in organs to date have 
relied on either sampling of small quantities of blood (Anil et al., 1999; 2001) or upon 
post-mortem observations (Garland, Bauer, Bailey, 1996; Schmidt et al., 1999b). Neither 
method has been able to quantify the total amount of brain tissue that can enter the 
circulation after stunning. 
Figure 1.6 Fragments of brain tissue in bovine venous blood detected by microscopy 
and stained by immunocytochemical methods (Anil et at., 1999) 
1.7 CNS TISSUE DETECTION METHODS 
1.7.1 Macroscopic examination 
Brain tissue fragments have previously been identified in the pulmonary arteries at post- 
mortem following severe head injuries (Ogilvy et al., 1988). Macroscopically visible 
pieces of brain tissue have been observed the pulmonary arteries of cattle after stunning 
(Bauer, Garland & Edwards, 1996) and in a related study segments of spinal cord up to 





Histopathological examination of emboli found in the pulmonary arteries of human 
subjects has been used to identify tissue suspected to be neural in origin (Collins & 
Davis, 1994). The use of routine stains including haemotoxylin and eosin may assist 
identification however identification of tissues by histopathology alone maybe 
unreliable (Davis et al., 1991). 
1.7.3 Cholesterol measurement 
Cholesterol is found in high concentration in tissues of the CNS and analysis of 
cholesterol content has previously been suggested as a means of identifying CNS 
contamination of meat products (Ltlcker et al., 1999). The presence of cholesterol in 
high concentrations in other tissues including liver and yolk makes confirmation by this 
method difficult. 
1.7.4 Immunoassays 
More accurate and sensitive techniques of CNS tissue confirmation have involved the 
development of specific antibodies raised against CNS specific proteins. A solid phase 
radioimmunoassay has reliably identified antibodies raised against a panel of proteins 
including myelin, myelin basic protein and glial fibrillary acidic protein (GFAP) 
(Linthicum et al., 1981). The use of ELISA based on CNS specific antigens is well 
documented to be reliable means of CNS tissue identification (Schmidt et al., 2002; 
Love et al., 2000). Numerous brain tissue antigens have been used to stain sections 
suspected to be CNS tissue. In recent studies, Syntaxin 1B (Anil et al., 1999; Love et al., 
2000) and GFAP (Helps et al., 2002) have been used to positively identify CNS tissue 
contamination of carcasses. 
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1.7.4.1 Syntaxin 10 
Syntaxin 1 ß, a 35KD strongly membrane bound protein of CNS cells has been used as 
the antigen in an ELISA test designed to detect neural tissue emboli in blood (Anil et al., 
1999; Love et al., 2000). 
1.7.4.2 Glial fibrillary acidic protein (GFAP) 
GFAP is already well documented as a marker for acute astrocyte injury (Van Geel et 
al., 2002; Missler et al., 1999). It is a non-soluble, acidic, cytoskeletal monomeric 
protein molecule with a molecular mass of 40 to 53DA and an iso-electric point between 
5.7 and 5.8 (Rueger et al., 1981). GFAP has previously been measured in CSF and in 
blood as an indicator of CNS pathology (Missler et al., 1999). GFAP belongs to the 
class-111 intermediate filament proteins and consists of 432 amino-acids (Reeves et al., 
1989). Intermediate filaments are filamentous developmentally regulated structures 10- 
nm in diameter that forms part of the cytoskeleton of most mammalian cells (Kelley et 
al., 2000). Cytoskeletal GFAP is packed into polymers (Petzold et al., 2004), after 
break-up of the GFAP polymer following injury a soluble fragment of GFAP of 
approximately 41kDA is released into adjacent fluid compartments (Eng & Ghirnikar, 
1994; Petzold et al., 2004). GFAP is present in both white and grey brain CNS tissues 
and is strongly upregulated during astrogliosis (van Geel et al., 2002). Interestingly 
much stronger staining for GFAP was detected in BSE positive cow brains as compared 
in negative controls (Miyashita, Stierstorfer & Schmahl, 2004). GFAP has previously 
been used as a sensitive marker for the presence of CNS tissue in meat products (Kelley 
et al., 2000; Schmidt et al., 1999) and in carcass swab samples (Helps et al., 2002). 
Although previously described as specific for CNS tissue (Eng, Ghirnikar & Lee, 2000), 
other peripheral tissues are known to demonstrate immunoreactivity to GFAP (Kelley et 
al., 2000; Schmidt et al., 1999a). Nevertheless, the comparatively weak 
immunoreactivity in these peripheral tissues allows differentiation with tissues of CNS 
origin (Schmidt et al., 1999a). 
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1.7.5 Combined microscopy and immunocytochemistry 
Although helpful in identifying suspected brain tissue emboli the use of microscopy 
alone often produces inconclusive results, further staining of such specimens by the use 
of immunohistochemical methods has been used to confirm the CNS origin of tissue 
sections (Davis et al., 1991; Love et al., 2000). Love et al., (2000) demonstrated that in 
prepared agarose blocks of plasma, buffy coat and red blood cell fractions, the brain 
tissue fragments in the samples were exclusively found in the buffy coat fractions of the 
blood samples. In addition it was found that the Cytoblock preparations provided 
greater concentration of the buffy coat fraction than did the agarose blocks. Larger 
fragments of brain tissue were visible by conventional microscopic examination even in 
those samples containing only 50-mg of brain tissue per 100-m1. Trial immuno-staining 
with antibodies to NSE, MAP-2, neurofilament proteins, synaptophysin, S-l00ß and 
GFAP showed labelling of brain tissue and no reaction to bone marrow, skin or muscle. 
The strongest and most consistent staining of both grey and white matter was achieved 
with the use of anti- S-l00ß antibody staining. (Love et al, 2000). 
1.7.6 Brain tissue emboli and coagulation abnormalities 
Severe head trauma and pulmonary embolism of brain tissue is known to be associated 
with changes in coagulation parameters, including that of prothrombin time (PT) 
(Ogilvy et al., 1988; Anil, Krailadsiri & Seghatchian, 2002). In previous studies 
between 3 and 64% of traumatic head injury patients were reported to develop a 
coagulopathy soon after admission to hospital (Kuo, Chou, & Chio, 2004). The 
mechanism is believed to involve release of tissue factor (thromboplastin) from 
damaged tissue, which initiates activation of the clotting cascade via the extrinsic 
pathway. When any tissue is damaged, tissue factor is released from vascular 
compartments and is also synthesised by some cells including monocytes in response to 
inflammatory changes, which follow an injury (Utter et al., 2002). Brain parenchyma 
and meninges contain high levels of thromboplastin and other systemic coagulation 
components and it is suggested that brain tissue emboli may result in the release of high 
concentrations of tissue factor into the circulation, which may trigger the coagulation 
cascade (Simpson, Speed & Blumbergs, 1991). Reports in the medical literature support 
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a correlation between coagulation abnormalities and brain tissue destruction in contrast 
to brain compression alone, and suggest that measurement of coagulation parameters 
may be diagnostic and prognostic for some cases of head injury (van der Sande et al., 
1978). Prothrombin time (PT) has previously been investigated in plasma from cattle in 
which brain tissue embolism had occurred after stunning, with inconclusive results 
(Anil, Krailadsiri & Seghatchian, 2002). An experimental study using rabbits 
investigated the response to injection of brain tissue thromboplastin and found an 
immediate effect of prolonged PT time due to activation of the clotting cascade by 
thromboplastin (Tvedskov et al., 1996). The release of brain tissue thromboplastin in 
cattle and sheep after stunning and in the presence or absence of brain tissue emboli may 
be a useful marker test for detection of carcasses in which brain tissue contamination 
has occurred. 
1.7.7 Use of the polymerase chain reaction for the detection of CNS tissue 
fragments in the carcass 
1.7.7.1 Conventional PCR 
The development of the polymerase chain reaction along with the availability of Taq 
DNA polymerases (Saiki et al., 1985) has made it possible to amplify selected regions of 
the genome many fold to levels at which detection becomes possible. The application of 
PCR provides the potential for accurate and sensitive techniques for the detection of 
CNS tissues in both meat and meat products and in ruminant feeds that has not 
previously been attainable by other methods (Schmidt et al., 1999a; Love at al., 2000). 
An immuno-quantitative PCR has been described for the detection of CNS tissues using 
an ELISA for the immuno-detection of bovine brain PrP in combination with real-time 
PCR to amplify the biotinylated reporter DNA (Gofflot et al., UNPUBLISHED). In a 
separate study, a PCR assay has been developed based on the amplification of a 
fragment of 16S rRNA gene of mitochondrial DNA that has allowed the detection of 
vertebrate tissues in feedstuffs down to a detection limit of 0.0625% (Bottero et al., 
2003). A PCR assay has been developed to detect glial fibrillary acidic protein (GFAP) 
mRNA of bovine CNS tissue in meat and meat products. Although GFAP mRNA is 
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present in small amounts in peripheral tissues the study reports a technique of heat 
inactivation of non-CNS signals prior to RNA extraction (Seyboldt et al., 2002). 
1.7.7.2 Real-time PCR 
Conventional PCR methods can be used to detect a DNA template in a sample, but for 
the accurate quantification of the amount of template DNA present, real-time PCR must 
be used. The use of probes linked to fluorescent makers allows detection of the 
amplified DNA as it forms (Bustin, 2000). Fluorescence values are automatically 
recorded during every amplification cycle and represent the amount of product DNA 
formed. Larger amounts of starting template DNA will require fewer amplification 
cycles to reach a statistically significant quantity above that of background levels. This 
point is called the threshold cycle (Ct-cycle) and occurs during the exponential phase of 
amplification (Bustin, 2000). The Ct value can be translated into a quantitative result by 
comparison with a standard curve. 
A real time quantitative PCR assay based on the amplification of the sex-determining 
region of the bovine Y chromosome (SRY) along with normalisation for bovine 28S 
rDNA has previously been used to quantify the contamination of carcasses as a result of 
the practice of carcass splitting (Helps et al., 2004). 
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1.8 POTENTIAL ROUTES OF DRAINAGE OF BRAIN TISSUE FRAGMENTS FROM THE 
HEAD 
1.8.1 Venous Drainage of the head 
The cranial system of venous sinuses is responsible for drainage of blood from the brain. 
All venous sinuses are external to the dura mater and in the head lie between the dura 
mater and the periosteum, in the spine these sinuses are found in the epidural space. 
At the foramen magnum there is continuity of the cranial sinuses with the longitudinal 
sinuses of the spine. The venous sinuses are devoid of valves both in the brain and also 
throughout the length of the spine. This feature may allow bacteria or tumour cells to 
migrate from abdominal organs directly to the brain (Batson, 1940). It is possible that 
emboli may also travel from the brain to other areas of the body by this route. 
The cerebral sinuses are grouped into dorsal and basilar (ventral) systems. The smooth 
walled dorsal sagittal sinus lies in the base of the falx cerebri in the median plane. It 
divides into the paired transverse sinus which itself gives off rostral and caudal 
branches. The rostral branch becomes the temporal sinus and forms the basilar system 
of venous sinuses. The caudal branch forms the condylar sinus and makes a smooth 
transition along with the basilar sinus into the internal vertebral plexus of the spine. 
This system consists of two pairs of longitudinal vessels lying within the epidural space 
and continuing along the length of the canal. Segmental anastomoses between these 
vessels give a ladder-like appearance in which the spaces are taken up by the 
intervertebral discs, which bulge into the canal (Batson, 1957). The venous drainage of 
the vertebral column of the ox was well described by Smuts (1977) and in the sheep by 
Rauhut (1962) and demonstrates that although both are essentially similar some 
anatomical differences exist. In contrast to the ox, there are no dilatations of the venous 




1.8.2 Haemodynamics of venous drainage 
The main drainage vessels of the head are undeniably the jugular veins. However, since 
the blood flow in the vertebral veins was first investigated (Batson, 1940), it was 
discovered that posture may influence which venous system carries the larger quantity of 
blood. The anatomy of the human internal vertebral plexus has been well described 
(Groen et al., 1997), and a postural dependency of cerebral outflow has been 
demonstrated (Valdueza et aL, 2000). These studies demonstrated that in the upright 
position there was collapse of the jugular veins and an increase in the venous outflow by 
the vertebral system of veins. The vertebral system of veins are protected from the 
effects of gravity by the bony casing of the vertebrae which provide a non-collapsible 
conduit for venous return that is capable of supporting a gravitational pressure gradient 
parallel to that of the arteries (Zippel, Lillywhite & Mladinich, 2001). The result of this 
arrangement is that in a prone position the jugular veins are the principal drainage 
vessels of the head, in an upright posture however, the jugular veins undergo complete 
or partial collapse and the vertebral veins become the major drainage vessels of the 
head. In the head down position the system is believed to function in reverse, with 
blood from the posterior extremities being shunted first into the plexus and then into the 
anterior vena cava prior to return to the heart. The distended dural sac at the dependant 
end occludes the plexus so that only one end of the plexus is to be functional at any 
given time (Dilenge & Perey, 1973). The effect of a head down position on blood flow 
has been investigated in snakes using fluoroscopic methods. In these studies conducted 
on one snake no venous return was observed in the vertebral plexus while at the same 
time the jugular veins became engorged (Zippel, Lillywhite & Mladinich, 2001). A 
similar posture dependant division of blood flow was observed in monkeys (Epstein et 
al., 1970). 
The effect of posture on blood flow from the head is important in stunning and slaughter 
of sheep and cattle as the effects of hoisting the carcass after stunning for sticking and 
exsanguination may affect the drainage of blood from the head. If such a change in 
venous drainage were to occur, the dissemination of neural emboli in the circulation 
might also be affected. 
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1.8.3 Lymphatic drainage of the head 
Following the use of captive bolt guns extensive haemorrhage and tissue damage are 
evident on examination of the brain. The dural membrane is invariably ruptured 
especially after the use of a penetrative CBG. In a recent study of cattle brains after 
CBG stunning extensive subarachnoid haemorrhage was observed in nearly all cases 
(Farag, 2002). 
The dura mater is the thick outer membrane of the brain and is fused with the inner 
periosteum of the skull. The cranial venous sinuses are enclosed within the thickness of 
the dura mater. The dura forms many folds, one of which extends into the division 
between the cerebral hemispheres and is referred to as the falx cerebri. Below the dura 
mater is the more delicate arachnoid mater. The space below the arachnoid mater is 
called the subarachnoid space and is composed of numerous trabeculae and filaments. It 
is within this space that the cerebrospinal fluid (CSF) is found. 
The CSF is largely produced by the lining of the ventricular system within the brain. 
This fluid is drained from the subarachnoid space partly through the arachnoid villi or 
granulations that project through the arachnoid mater into the dorsal sagittal sinus of the 
brain. In this manner some of the CSF is returned to the venous circulation. 
A portion of the CSF is drained to the lymphatics of the olfactory region through the 
cribiform plate. This lymphatic fluid is drained by ducts to the system of cervical lymph 
nodes before returning to the blood via the anterior vena cava. The lymphatic system is 
well suited for the transport of particles such as microorganisms and emboli. Studies of 
lymphatic drainage of the brain of rats using Indian ink have demonstrated drainage to 
cervical lymph nodes within 30 minutes (Kida, Pantazis & Weller, 1993). Similar 
findings have been observed in rabbits and cats (Bradbury & Cole, 1980). Such 
particles become trapped in the nodes and are removed from the lymph fluid. Studies 
have demonstrated increased drainage of CSF via the lymphatic system following raised 
intra-cranial pressure (Caversaccio, Peschel & Arnold, 1996) such as might occur 
immediately following the use of captive bolt gun stunning. 
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After CBG stunning fragments of brain and blood from ruptured vessels will be mixed 
with CSF in the sub-arachnoid space. It is likely that some of this material will be 
drained into the dorsal sagittal sinus by passage through the arachnoid villi. Such 
material on entering the venous system might be drained from the head via the jugular 
veins or perhaps by the internal vertebral plexus of the spine. 
It is possible that like the CSF a portion of this material might enter the lymphatic 
system and be drained to the lymph nodes of the neck. The deep cervical lymph nodes 
are located within the muscles of the neck and are not classified as SRM. If neural 
emboli were to be trapped by such nodes it is possible that contamination of edible 
tissues with neural tissue might occur. It is likely that the lymphatic system plays a 
secondary role to that of the venous system in transport of neural emboli but might still 
carry a significant risk to the consumer of meat. 
1.9 REDUCTION OF CNS TISSUE CONTAMINATION OF THE CARCASS 
The recognition that current stunning and slaughter practices can result in contamination 
of carcasses with material classified as SRM, has given rise to suggestions for 
preventive measures. Abandoning the use of stunning would have severe welfare 
consequences and is not in-line with UK legislation concerning the slaughter of animals. 
Alternative stunning methods for cattle have been suggested including modifications to 
current methods, however no commercially viable method is presently available. 
Suggestions for preventing contamination as a result of carcass splitting include the use 
of hot-boning in which the carcasses are butchered while still warm. This method 
already used in some countries affords the advantage of avoiding carcass splitting and 
the consequent risk of CNS tissue contamination. In the UK the recent development of 
an oval saw that removes the vertebral column in its entirety including the dorsal root 
ganglia has offered an alternative solution to the problem of carcass splitting. This saw 
is currently under-going trials to assess its commercial viability (Remcolm project, 
Silsoe Research Institute, Bedford, UK). 
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1.10 AIMS OF THE STUDY 
By the use of a variety of applied methods, the experiments described in this thesis have 
investigated the potential of current stunning methods used on cattle and sheep to cause 
introduction of brain tissues into the venous circulation. Furthermore, the risk of such 
brain tissue emboli contaminating edible parts of the carcass with tissues of potentially 
high BSE infectivity has been explored. 
The specific questions this study has attempted to answer are given below: 
1. Which stunning methods currently in use/or available in the UK carry a risk of 
brain tissue embolism? 
2. What is the frequency of brain tissue entry into the venous circulation after 
stunning by captive bolt gun in cattle and sheep? 
3. Can brain tissue fragments and proteins disrupted by captive bolt gun stunning 
of cattle and sheep penetrate the pulmonary capillary filter and enter the arterial 
circulation within the time-frame of commercial stunning and slaughter? 
4. How much brain material enters the venous blood of sheep after captive bolt gun 
stunning? 
5. What are the potential venous drainage routes of emboli from the head following 
the use of captive bolt gun stunning? 




CHAPTER 2 MATERIALS AND METHODS 
2.0 INTRODUCTION 
The general methodologies employed in the experiments in this thesis are described in 
this chapter. More specific descriptions are included with the results and discussion of 
each experiment. Experiments were carried out in cattle at a local abattoir reserved for 
slaughter of cattle over thirty months of age (Jarrett's and Sons Abattoir, Oldland 
Common, Bristol, UK). All experiments conducted in sheep took place at the Langford 
site of the Bristol School of Veterinary Science. 
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2.1 DETECTION OF BRAIN TISSUE CONTAMINATION IN BLOOD AND OTHER TISSUES 
USING ELISA AND A COMBINATION OF MICROSCOPY AND IMMUNOCYTOCHEMISTRY 
2.1.1 Aims 
" To determine the frequency of brain tissue embolism after captive bolt gun stunning 
in cattle and sheep. 
" To investigate the potential for brain tissue fragments to penetrate the lungs and 
enter the aortic circulation. 
" To investigate the potential of electrical stunning to cause entry of brain tissue 
fragments into the venous circulation. 
" To investigate the potential for organ contamination with brain tissue fragments. 
2.1.2 Principles 
Immunoassays are based on the specificity of the reaction possible between antibodies 
and antigens. The high level of sensitivity achievable with these assays allows the 
accurate detection and quantification of the analyte of interest. 
2.1.3 Experimental design 
The sample size of 100 animals in each test group was chosen based upon the estimated 
design sensitivity that would be required to detect and establish the frequency of brain 
tissue embolism following the use of each captive bolt gun. These estimates were made 
based upon the results of similar investigations of brain tissue embolism after stunning 
previously conducted on small groups of animals (Anil et al., 1999; 2001). The number 
of sample animals chosen in these studies was also constrained by logistical and cost 
considerations of sampling from large numbers of cattle and sheep. 
2.1.4 Anaesthetic methods 
Anaesthetic drugs and regimens were employed in many of this series of experiments in 
both cattle and sheep. Standard veterinary methods of anaesthetic monitoring were 
used. The regimen used in both species is given below. 
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2.1.4.1 Induction mixture 
2% xylazine (0.4mg/kg) (Bayer, Bury St. Edmunds, UK) and 10% ketamine (12mg/kg) 
(Fort Dodge, Southampton, UK) were administered together in the same syringe. 
2.1.4.2 Maintenance mixture 
A mixture of guaiphenesin, ketamine and xylazine (100: 6: 3) was prepared by addition 
of 30-m1 of ketamine and 15-m1 of xylazine to a 500-m1 bottle of guaiphenesin (10% 
guaiphenesin (Chassot Ltd, Preswick, UK), 10% ketamine and 2% xylazine). This 
mixture forms a precipitate within 2 to 3 days of preparation so warming and agitation 
was necessary to re-dissolve all constituents before use. 
2.1.4.3 Euthanasia drugs 
In some instances euthanasia was performed by intravenous administration of 
barbiturate solution (Euthatal (200mg/ml), Bayer, UK). 
2.1.4.4 Administration of anaesthetic to cattle 
All anaesthetic preparations were injected intravenously through a pre-placed catheter 
inserted into a jugular vein. 
2.1.4.5 Administration of anaesthetic to sheep 
The anaesthetic induction mixture was administered by an intra-muscular injection into 
the caudal thigh area of each animal. The maintenance mixture was given by intra- 
venous injection via a pre-placed catheter inserted into the jugular vein. 
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2.1.4.6 Monitoring of anaesthetic depth 
Conventional methods of checking anaesthetic depth in all animal subjects were used 
including respiratory rate and depth, heart rate, palpebral and corneal reflexes and 
withdrawal reflexes. More anaesthetic mixture was administered as necessary. 
2.1.5 Surgical procedures 
2.1.5.1 Implantation of jugular catheters in cattle for administration of anaesthetic 
It was necessary to implant indwelling catheters into the jugular veins to allow 
administration of anaesthetic to the cattle without undue interruption to the normal 
running of the abattoir. Animals were first restrained in a crush in the lairage area of the 
abattoir and a twelve gauge 52-mm intravenous angiocatheter (Intraflon, Vycon Ltd, 
Ecouen, France) was introduced in a caudal direction into the jugular vein. A steady 
and strong flow of blood from the end of the catheter indicated correct placement within 
the lumen of the vessel. A bevelled polyvinyl catheter (1.5-mm diameter lumen, Klarer 
PVC, UK) was then threaded into the jugular vein using the pre-placed angio-catheter to 
allow access to the lumen of the jugular vein. When at least 12-cm of PVC catheter was 
advanced into the vessel the guiding catheter was removed and the catheter was secured 
in place using both tape and super-glue (RS Ltd. UK). The PVC catheter was 
immediately flushed with 5% heparinised saline (Multiparin 5000 iu/ml, UK) solution 
to prevent clotting within the tubing and then capped to prevent leakage of blood. The 
catheter was further protected by more adhesive tape placed around the neck of the 
animal. The cattle were then moved through one at a time to the stunning box where 
the injection port of the jugular catheter was retrieved and the anaesthetic induction 
mixture was administered as a bolus injection of 15-ml of 10% ketamine and 6-ml of 
2% xylazine. Immediately as anaesthesia was induced the animal was released on to the 
killing floor of the abattoir by release of the gate of the stunning box. At this point a 




2.1.5.2 Implantation of jugular catheters in sheep for administration of anaesthetic 
The anaesthetic induction mixture was administered by an intra-muscular injection into 
the caudal thigh area of each animal (12mg/ml ketamine and 0.4mg/kg xylazine). 
Allowing at least five minutes for induction of anaesthesia each sheep was transferred to 
the procedure laboratory and placed in a hammock lying on the sternum. To allow 
further administration of anaesthetic a 22-g, 1-inch intravenous catheter (Angiocath, 
Becton Dickinson Infusion Therapy Systems Inc., Utah, USA) was introduced into the 
jugular vein. The jugular catheter was secured in place by way of tape and flushed with 
heparinised saline to prevent blockage with clots. Anaesthetic depth in each animal was 
maintained by administration of between 5 and 20-m1 of anaesthetic maintenance 
mixture. 
2.1.5.3 Implantation of jugular collection catheters 
When a. satisfactory level of anaesthesia was achieved and the animal was lying on the 
right flank and employing a `cut-down' method, a 14-g Foley balloon catheter (Benkat 
instruments, UK) in cattle and 2-mm polyvinyl catheters (Klarer PVC, UK) in sheep 
was advanced in a cranial direction into the jugular vein lumen and secured in place 
with string ligatures. The balloon cuff of the Foley catheter implanted in cattle was also 
maximally inflated to prevent any leakage of blood flow around the catheter. A similar 
procedure was performed on the contra-lateral jugular vein after turning the animal onto 
the left flank. When both jugular veins were cannulated a plastic Y-piece was attached 
to each catheter joining to a single length of plastic tubing to allow collection from a 
single catheter end. 
2.1.5.4 Implantation of aortic collection catheters 
Arterial catheters were used in both cattle and sheep to allow sampling of aortic blood. 
Anaesthesia was induced and maintained and the animals were placed on the left side. 
An incision was made over the jugular groove to expose the jugular vein. Using blunt 
dissection the under-lying carotid artery was located and identified by palpation of a 
strong pulse. The artery was then partially freed from the connective tissues and two 
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string ligatures were placed around the vessel. Using these ligatures to limit blood loss 
a small V-shaped incision was made in the vessel. A bevelled polyvinyl catheter of up 
to 1-cm diameter in cattle (Klarer PVC, UK) and 2-mm in sheep was introduced into the 
carotid artery and advanced into the proximal aorta, as determined by measurement of 
the entry point of the catheter to the estimated position of the heart on the skin surface. 
An average length of approximately 30 and 90-cm of catheter was inserted into the 
carotid arteries of sheep and cattle respectively. The catheter was then secured in 
placed with the string ligatures and the end plugged with a cap. 
2.1.6 Preparation and administration of brain tissue suspensions 
2.1.6.1 Brain tissue suspensions 
The procedure used to prepare suspensions was designed to mimic the nature of brain 
tissue fragments dislodged during normal captive bolt stunning and that might enter the 
circulation. Loose brain tissue created by previous stunning of an animal with a 
penetrating captive bolt gun during the slaughter process was carefully removed by 
flushing with normal saline followed by aspiration with a 10-m1 syringe through the bolt 
hole of a fresh carcass. The tissue was suspended by vigorous agitation in normal saline 
in a ratio of 1-g of tissue to 9-ml of saline. A 10-m1 sample of suspension therefore 
contained approximately 1-g of brain tissue. Previous studies suggest that this is a 
conservative estimate of the amount of brain tissue that may be dislodged from the 
cranial cavity during stunning with a captive bolt gun (Anil et al., 2002). The aim in 
obtaining and suspending the brain tissue in the manner described was to achieve a 
comparable total volume and range of particle sizes to the embolic showers produced as 
a consequence of stunning with a captive bolt gun. 
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2.1.6.2 Administration routes of brain tissue suspensions 
2.1.6.2.1 Jugular vein injection 
Brain tissue suspensions were administered as bolus injections in the jugular veins by 
way of pre-placed catheters in most cases. In some experiments injections were made 
directly into the jugular vein lumen by way of a syringe and needle. 
2.1.6.2.2 Angularis oculi vein injection 
The area ventral and rostral to the medial canthus of the eyes was clipped and cleaned. 
Using digital pressure, the angularis oculi vein was raised to facilitate catheterisation. A 
cut-down technique was used in combination with digitally applied tension on the vein 
to allow a 22-g, 1-inch angiocatheter to be introduced to the lumen of the vein. 
Withdrawal of blood confirmed correct placement of the catheter within the vein. A 1- 
ml quantity of saline and heparin solution was used to flush the catheter to prevent 
clotting within the lumen. The catheter was secured with tape. Brain suspensions were 
injected into each vein using the pre-placed catheters and a 10-ml syringe. 
2.1.62.3 Intra-cranial injection 
Injections into the cranium were achieved by way of a pre-drilled hole in the midline of 
the skull or by way of a bolt-hole created by prior stunning using a penetrating captive 
bolt gun. A 10-m1 syringe with a 2-inch 16-g needle was used to inject the brain 
suspension into the cranial cavity. 
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2.1.7 Pre-slaughter stunning 
2.1.7.1 Placement of animals for stunning 
2.1.7.1.1 Cattle 
Cattle were stunned on the killing floor of the abattoir while anaesthetised and in left 
lateral recumbency. 
2.1.7.1.2 Sheep 
Sheep were stunned while anaesthetised and in lateral recumbency on a table with the 
head of the animal extended over the table edge. 
2.1.7.2 Captive bolt guns 
2.1.7.2.1 Penetrating cartridge activated captive bolt gun (cattle) 
Cowpuncher Cash 8000 Model Stunner (Accles & Shelvoke, Birmingham, UK) 
A 3-grain cartridge was routinely used throughout the project. 
2.1.7.2.2 Non penetrating cartridge-activated captive bolt gun (cattle) 
Cash Magnum Knocker Concussion Stunner (Accles & Shelvoke, Birmingham, UK) 
A six- grain cartridge was routinely used throughout the project. 
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Figure 2.1 Photograph of the penetrating captive bolt gun (Cash Magnum Knocker, 
Accles & Shelvoke, Birmingham, UK) (right) and the non-penetrating captive bolt gun 
(Cowpuncher Cash 8000 Model Stunner, Accles and Shelvoke, Birmingham, UK) (left) 
ii 4/ 4 
2.1.7.2.3 Penetrating cartridge activated captive bolt gun (sheep) 
A Temple Cox Mark 10 humane stunner (Accles & Shelvoke, Birmingham, UK) with 
1.25-grain cartridges was used to stun sheep through out the project. 
2.1.7.2.4 Penetrating pneumatically activated captive bolt gun (sheep) 
A Cash Ramrod pneumatic stunner (Accles & Shelvoke, Birmingham, UK) without air- 
injection facility was used to stun sheep. A cylinder of compressed air at 100 psi was 
used to activate the device. 
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Figure 2.2 Photograph of the penetrating pneumatically-activated captive bolt gun 
(Cash Ramrod pneumatic stunner, Accies & Shelvoke, Birmingham, UK) (left) and the 
cartridge-activated penetrating captive bolt gun (Temple Cox MK. 10 humane stunner, 
Accies & Shelvoke, Birmingham, UK) (right) 
2.1.7.3 Stunning position 
2.1.7.3.1 Cattle 
2.1.7.3.1.1 Penetrating captive bolt gun 
The muzzle of the CBG was placed at right angles to the skull at the intersection of two 
imaginary lines drawn from the eyes to the base of the contra-lateral horn 
2.1.7.3.1.2 Non penetrating captive bolt gun 
The muzzle was placed approximately 20-mm above the point indicated for use with a 
penetrating captive bolt gun before activation for stunning. 
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Figure 2.3 Ideal stunning position with non-penetrating (blue dot) and penetrating 
(red dot) captive bolt guns for use on cattle 
2.1.7.3.2 Sheep 
All sheep were stunned by an experienced slaughter-man using standard commercial 
techniques. Briefly, the muzzle of the CBG was placed on the highest point of the head, 
on the midline of the skull aiming straight down before activation of the gun 
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Figure 2.4 Ideal stunning position with a penetrating captive bolt gun for use on 
polled sheep 
2.1.7.4 Re-stunning 
Animals that were judged to be inadequately stunned by the initial shot were 
immediately re-stunned by a second stun placed close to but away from the immediate 
area of the original stunning position. Conventional methods of estimating recovery 
after stunning including observation of rhythmic breathing and return of eye reflexes 
were used to detect animals that were poorly stunned after the initial shot. 
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2.1.8 Sample collection 
2.1.8.1 Blood 
2.1.8.1.1 Jugular samples 
A 10-m1 pre-stun sample was collected into a test-tube containing citrate anti-coagulant 
(3.8% citrate, pH 5.2) and gently agitated. Animals were then stunned and blood 
collection was carried out over one minute with samples collected every ten seconds 
into a 250-m1 plastic bottle containing 25-m1 of citrate anti-coagulant. 
2.1.8.1.2 Aortic samples 
2.1.8.1.2.1 Sheep 
A 10-m1 pre-stun sample was collected into a test-tube containing citrate anti-coagulant 
(3.8% citrate, pH 5.2) and gently agitated. Animals were then stunned and blood 
collection was carried out over the entire duration of blood flow with samples collected 
every minute into a 250-m1 plastic bottle containing 25-m1 of citrate anti-coagulant. 
2.1.8.1.2.2 Cattle 
A 10-m1 pre-stun sample was collected into a test-tube containing citrate anti-coagulant 
(3.8% citrate, pH 5.2) and gently agitated. Animals were then stunned and blood 
collection was carried over two minutes with samples collected every ten seconds into a 
250-m1 plastic bottle containing 25-m1 of citrate anti-coagulant. 
2.1.8.1.3 Exsanguinated blood 
Approximately five hundred millilitres of exsanguinated blood was collected as rapidly 
as possible following electrical stunning and sticking by holding a 500-m1 plastic 




Organ samples including the spleen, liver and kidneys were taken at post-mortem via a 
mid-line abdominal incision. Organs were removed in their entirety and placed in 
sterile, labelled bags. 
2.1.9 Slaughter 
After sample collection, animals were exsanguinated in the normal commercial manner 
by severing the main vessels of the neck. In some cases animals were killed by intra- 
venous administration of barbiturate. 
2.1.10 Macroscopic brain examination 
At a commercial abattoir (St. Merryn Meat Ltd, Merthyr Tydfil, Wales) in which a fully 
automated electrical stunning device (Jarvis, New Zealand) is used, fifteen fresh cattle 
heads were removed from the line immediately following slaughter, exsanguination and 
subsequent decapitation. 
The dorsal cranium was removed by the use of a saw to expose the dorsal surface of the 
brain in each case. The dura was reflected and the surface of the brain cortex was 
examined for macroscopic evidence of trauma or haemorrhage. The specimens were 
labelled and photographs taken in every case. The brain was then carefully removed 
from the cranium and the ventral surface examined and photographed. Each brain was 
also weighed to give an average weight of brains examined in the study. Sagittal and 
coronal sections were made of each brain and the internal structures examined. 
2.1.11 Laboratory processing of samples 
Samples of blood and tissues were taken from both sheep and cattle for processing and 
analysis by the methods described below. These experiments formed part of the larger 
study of contamination of the carcass after stunning. Samples were examined for the 
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presence of brain tissue fragments by microscopy and immunocytochemistry and for the 
presence of elevated levels of GFAP by ELISA. 
2.1.11.1 Separation of blood sample fractions 
Two 1-ml aliquots of the whole blood samples were removed from each sample and 
rapid frozen in liquid nitrogen before transfer to a freezer at 30°C for storage. The 
remaining blood in the collection bottles were placed in a pre-chilled centrifuge (MSE, 
UK) (5°C) and spun for thirty minutes at 800 x g. From each fractionated sample two, 
1-ml aliquots of the plasma supernatant were drawn off by pipette and stored at -30°C. 
The remaining plasma overlying the buffy coat layer as well as the greater quantity of 
the under-lying erythrocyte fraction was suctioned off using a peristaltic pump (603u, 
Watson-Marlow Ltd, Falmouth, England). The remaining buffy coat was then divided 
into two samples. One of these samples was combined with an equal volume of twenty 
percent formalin in a Universal plastic tube and sent for immunocytochemical testing. 
The remaining buffy coat was placed in three 1-ml sample tubes and rapid frozen in 
liquid Nitrogen. Any remaining buffy coat was retained. All samples to be stored were 
placed in labelled plastic bags and transferred to a freezer at -30°C. 
2.1.11.2 Samples sent for analysis 
Samples of buffy coat were analysed by ELISA and by microscopy and 
immunocytochemistry. All samples collected including those taken immediately prior to 
stunning were analysed by GFAP ELISA. Due to financial and time constraints only a 
proportion of samples were analysed by microscopy and immunocytochemistry. 
Initially these samples included only those taken between ten and thirty seconds after 
stunning as previous work had indicated that the majority of positive samples were 
taken during this period. Later in the project the number of samples from each animal 
analysed by this technique was increased to include samples taken between zero and 
forty seconds. In addition, samples that appeared to be clotted during processing were 
sent as additional samples for processing by this technique. 
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2.1.11.3.1 Cattle jugular samples 
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All storage bottles for the various fractions to be removed from the samples were 
previously labelled with a capital C for cattle and secondly with the individual sample 
number that remained consistent throughout all stages of . sampling and processing. 
The 
one millilitre sample bottles were capped with transparent caps to allow easy 
identification of cattle samples. 
2.1.11.3.2 Cattle aortic samples 
These samples were labelled with a capital C for cattle followed by a letter indicating 
the animal designation finally all samples were consecutively numbered. 
2.1.11.3.3 Sheep jugular samples 
Sheep samples were labelled 'SH' followed by the sample number. Green caps were 
used to cap sample tubes that were placed in labelled bags and stored in a freezer 
designated for sheep samples. 
2.1.11.3.5 Sheep aortic samples 
These samples were labelled with a capital S for sheep followed by a letter indicating 
the animal designation finally all samples were consecutively numbered. 
2.1.11.3.6 Sheep organ samples 
Organ samples were labelled with a capital S for sheep followed by a letter designating 
the experiment that included V for the investigation of drainage to organs by way of the 




2.1.12 Analytic methods 
2.1.12.1 Enzyme Linked Immunosorbent Assay (ELISA) 
2.1.12.1.1 Principles 
All immunoassays involve the use of antibodies as reagents. Enzyme immunoassays 
use enzymes linked to an antibody in the assay to allow quantification of an unknown 
reactant by way of a colour change. The ELISA used in this experiment is classified as 
an indirect sandwich ELISA. In these assays, antibodies are passively attached to a 
solid phase (ELISA plate) and specific antigens in the sample are captured. An 
additional detecting antibody is then added followed by the addition of an anti-species 
enzyme conjugate. A substrate is then added to produce the colour change that is 
quantified against a dilution curve of a standard in a spectrophotometer. 
2.1.12.1.2 Reactants 
" Polyclonal Rabbit Anti-Glial fibrillary acidic protein (DakoCyomation, 
Glostrup, Denmark) 
" Bovine GFAP Standard (American Research Products, USA) reconstituted with 
200µl of distilled water to give Img/ml solution. Then 5µl aliquots were placed 
into siliconised eppendorfs and stored at -70°C. 
" Monoclonal Mouse anti-GFAP (Chemicon International, California, USA). 
Alkaline phosphotase conjugated donkey anti-mouse IgG (Jackson 
Immunoresearch Laboratories, Inc., USA) Reconstituted with 0.5-m1 distilled 
water and stored at -30°C. The diluted conjugate was used on the same day and 
any remaining reagent was discarded. 





" Carbonate buffer (Sigma-Aldrich, St. Louis, USA) 
" Phosphate buffered saline lOx PBS 




" Polyoxyethylene Sorbitan Monolaurate (Tween 20, Sigma, St. Louis, 
USA) 
" PBS-Tween-milk (0.5m1 Tween in 1L PBS) 
" Milk Marval dried low fat milk 
" PBS-Triton (0.5%) 5m1/L 
2.1.12.1.4 Consumables 
" ELISA plates (Greiner bio-one, Glouscester, UK) 
" Universal tubes (Bibby-Sterilin, Ltd, Staffordshire, UK) 
2.1.12.1.5 Capture ELISA for GFAP 
ELISA plates were coated with polyclonal Rabbit anti-GFAP (DAKO Z0334) and 
incubated for one hour at 37°C in a humidity chamber. The antibody was prepared by 
diluting at one part to five hundred in carbonate buffer (Sigma C-3041) and 50 pl was 
added to each well. The antibody was discarded and the plates were washed for four 
rinse cycles at 200 µl of PBS- tween20 (0.05%) per well in an automated plate washer. 
(Labsystems, UK). To prevent non-specific binding of protein, 200µ1 of PBS-Tween 
20/5% non-fat dried skimmed milk was added to each well and incubated for one hour 
at room temperature. The plates were then washed as previously described. Bovine 
GFAP (American research products 03-62007) was used as the standard and was 
prepared by taking lmg/ml of stock solution and diluting at 1: 500 with PBS-Triton-X- 
100 (0.5%). These samples were aliquoted into 150µl samples in silicone coated 
eppendorfs and stored at -70° C. For each ELISA plate used the GFAP standard was 
serially diluted over the range of concentrations from 2000ng/ml to 0.244 ng/ml. On a 
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separate plate 75 µl of each buffy coat sample was added neat to each well and then 
75µ1 of 0.5%PBS-triton was added to all wells. Using the previously prepared plate 
with the GFAP standard 50µl of each sample was added in duplicate to a well and the 
plate incubated at room temperature for ninety minutes. After a further rinse a blocking 
solution of monoclonal anti-GFAP antibody (Chemicon MAB 3402) diluted 1: 10,000 in 
PBS-tween20/milk is added at 50µl to each well and incubated at room temperature for 
one hour. The plates were then rinsed. A 50µ1 volume of alkaline phosphatase 
conjugated goat anti-mouse IgG antibody (Stratech 715-055-150) was then added to 
each well after diluting at 1: 1000 in PBS/tween20 milk. The plates were incubated at 
room temperature for one hour. The plates were again rinsed and then S01L1 of 
phosphatase substrate (Sigma 104-105) was added to each well at a concentration of 
1 mg/ml diluted in carbonate buffer. The plates were then incubated overnight at 4°C to 
allow development. The following morning the plates were read at a dual wavelength 
of 405/492nm. The purpose of reading at a dual wavelength was to remove background 
readings due to properties of the plate which were detected at the higher wavelength of 
492nm. A standard curve was generated from the serially diluted standard that allowed 
quantification of the sample results. Due to the dilution of the samples in PBS-triton a 
2x multiplication of the calculated concentration was necessary to obtain the true 
concentration of the unknowns. At the end of the assay waste wash collected was 
treated with 1M Sodium Hydroxide and left overnight before being disposal. 
2.1.12.1.6 Controls 
2.1.12.1.6.1 Negative controls 
Pre-stun samples were included on every plate run by ELISA, in addition to the final 
well in the GFAP standard dilution series in which all reactants were added except for 
the standard. 
2.1.12.1.6.2 Positive controls 
A known positive sample was added to each ELISA plate in addition to the dilution 
series of the GFAP standard. 
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2.1.12.1.7 Repeatability of the assay 
The intra and inter-plate variability was calculated using ten replicates of a dilution of 
the GFAP standard on separate occasions. The coefficients of variation of the replicate 
samples from the mean were then calculated. 
2.1.12.1.8 Analysis of samples prepared for validation study 
Samples were processed and sent for analysis by GFAP ELISA and by microscopy and 
immunocytochemistry. Technicians blinded to the identity of samples performed the 
assays. All samples for GFAP ELISA were repeated in duplicate on the same plate and 
all positives were repeated on at least one other occasion. The plates were read at 405- 
nm to obtain the optical density of each well. 
2.1.12.1.9 Selection of the positive/negotive threshold (cutoff) 
A conservative estimate was used to define a positive sample. It was decided to 
determine the cut-off value for a positive sample as five times the standard deviation 
plus the background level. The background was calculated from the mean value of a 
random selection of thirty pre-stun sample values (assuming a normal distribution of the 
background OD values obtained by ELISA). [eg. for cattle samples, mean pre-stun 
OD=0.086 where n=30, SD=0.03, cut off=0.236 (0.086+ 5*0.03)]. 
2.1.12.1.10 Parallelism 
Equivalent activity between the GFAP standard and the brain tissue in blood 
suspensions was achieved by plotting the dilution curves for the GFAP standard and for 
the brain in blood suspensions from the OD values obtained in the assay and from the 




The sensitivity of the ELISA was assessed by an end-point dilution analysis of prepared 
brain tissue in blood suspension prepared using both cattle and sheep tissues. 
2.1.12.1,11.1 Preparation of brain in blood suspensions 
A small quantity of brain tissue was removed from fresh bovine and ovine carcasses and 
gently macerated with a mortar and pestle. Then 0.5-g of this tissue was weighed and 
transferred to a bottle containing 50-m1 of fresh anti-coagulated bovine blood. This 
sample was then mixed by use of a vortex. Five similar brain tissues in blood 
suspensions were prepared using both bovine and ovine brain tissue and blood. 
2.1.12.1.11.2 Dilutions 
Two fold serial dilutions of these preparations were made using an automatic pipette 
with a sterile tip for each dilution. The final dilution was 0.6pg/ml after 14 further 
dilutions. 
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All samples were analysed in duplicate on at least two separate occasions. 
2.1.12.1.11.4 Statistical analysis 
A Mann-Whitney 2 sample rank test was performed on the GFAP concentrations 
detected by ELISA for the positive cattle and sheep samples 
A retrospective analysis of the power and sample size based upon the detected 
difference in frequency was performed for the chosen sample size of 100 and also for 
larger sample sizes using Minitab version 14. 
2.1.12.2 Microscopy and immunocytochemistry 
2.1.12.2.1 Principles 
The use of microscopy in the analysis of blood and tissue samples relies upon the 
experience and judgement of the neuropathologist to correctly identify the prepared 
tissue sections. Further immunohistochemical staining methods allow confirmation of 
the identity of tissues initially observed under a light microscope. In this technique 
antibodies are used to link tissue antigens specifically to a stain that can then be readily 
identified under a light microscope. The method involves four stages: 
" Fixation- Tissues are preserved without disrupting the original structure 
" Antigen retrieval- Increase's the reactivity of the antigens that will bind 
to the detector antibodies. 
" Section preparation- Tissue is embedded in paraffin wax and thin 
sections are made. 
" Detection- An enzyme linked antibody is used to produce a colour 
change following addition of the appropriate substrate. 
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2.1.12.2.2 Microscopy and immunocytochemistry 
The method for sample processing and analysis has been previously described (Love et 
al., 2000). In brief, this was as follows. Samples of bully coat were fixed in formalin, 
pelleted and embedded in paraffin wax Cytoblocks. 5-µm-thick sections were then cut 
at multiple levels through the block. Adjacent sections were stained with haematoxylin 
and eosin or immunostained by a standard streptavidin-biotin-peroxidase method for 
neurofilament protein (Dako, Ely, UK) or S l00ß protein (Dako, Ely, UK). Samples 
were regarded as positive if the Cytoblock sections included fragments of tissue that 
were immunopositive for both neurofilament protein and S 1000 protein. 
2.1.12.2.3 Controls 
Negative controls comprised of sections immunostained with an irrelevant antibody or 
immunostained according to the protocol with the omission of the primary antibody. 
Other controls included paraffin sections of skin, muscle, bone marrow and brain from 
slaughtered animals. 
2.1.12.2.4 Validation 
The sensitivity of the analytical method was assessed by an end-point dilution analysis 
of the same prepared brain tissue in blood suspensions prepared for the estimation of the 
detection limit of the ELISA. 
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2.2 ANATOMICAL INVETSIGATION OF VENOUS CEREBRAL DRAINAGE 
2.2.1 Aims 
" To investigate all venous drainage routes from the head that may contribute 
towards carriage of brain tissue emboli following the use of captive bolt gun 
stunning in sheep and cattle. 
2.2.2 Vascular casting 
2.2.2.1 Principles 
Injection with a liquid resin that dries and hardens to assume the conformation of the 
internal lumen of the vessels in to which it is introduced offers an effective method of 
demonstrating structures that would otherwise be difficult to identify and separate from 
surrounding soft tissue. The use of concentrated alkaline solutions to macerate all 
tissues including bone enables the vessel casts to be observed without overlying tissues 
and reduces the risk of damaging the delicate casts by manual removal of surrounding 
tissues. 
2.2.2.2 Specimen preparation 
The animals were anaesthetised by induction with an intra-muscular injection of 10% 
ketamine (12mg/ml) and 2% xylazine (0.4mg/kg) and were given further doses of 
pentobarbital (200mg/ml) to ensure deep anaesthesia before being killed by 
exsanguination by severing the vessels of the lower neck. Prior to exsanguination each 
animal was injected intravenously with 10,000 IU of heparin to reduce clotting and 
blockage of small veins. Captive bolt stunning was not used on these animals to limit 
damage to blood vessels within the head. The heads were removed from carcasses by 
disarticulation of the fifth and sixth cervical vertebrae. 
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2.2.2.3 Resin preparation 
Methyl Methacrylate resin (Tensol 70, Evode Speciality Adhesives, UK) in 
combination with hardener (Tensol 70, Evode Speciality Products Ltd, UK) was used to 
prepare the casts. This resin was chosen due to availability, ease of injection due to low 
viscosity of the resin and the solidity of the cast produced (Mr. S. Gaze, Department of 
Anatomy, University of Bristol, UK- personal communication). A mixture was used of 
1-ml of resin per three drops of hardener along with 1-ml of coloured pigment 
(Educational and Scientific Products Ltd, UK) for each 10-m1 syringe of mixture 
prepared. 
2.2.2.4 Injection with methyl methacrylate resin 
The external jugular veins of each specimen was identified and partially exposed to 
reveal the cut ends. Ten millilitres of methyl methacrylate resin (Tensol 70, Evode 
Speciality Adhesives, UK) was drawn up in a 10-m1 syringe and a pigment (red, yellow 
or blue) (Educational and Scientific Products Ltd, UK) and hardening agent (Tensol 70, 
Evode Speciality Products Ltd, UK) was added. This resin mixture was then manually 
injected into both external jugular veins under pressure employing string ligatures 
around the vessel and syringe tip to prevent leakage. All specimens were left overnight 
at room temperature to allow hardening of the resin. The following day the heads were 
skinned and the mandible of each head was removed. 
2.2.2.5 Maceration of tissues 
A IM (40mg/ml) solution of sodium hydroxide (Prolabo pellets, VWR International, 
Foutenay sous Bois, France) was prepared and poured into a plastic bucket in which the 
specimen had been placed such that sufficient solution was added to cover the 
specimen. The caustic solution at room temperature was refreshed at weekly intervals 
by the addition of further quantities of sodium hydroxide pellets. The maceration of the 
specimen was monitored and photographs were taken to document the process and also 
observe the relationship between the vessels and the surrounding tissue structures. 
During the process of tissue maceration the casts became increasingly delicate requiring 
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extreme care in moving the casts. After six weeks (sheep and calf heads) to twenty 
weeks (adult cow head) the specimens were thoroughly rinsed in tap water to remove 
debris and chemical residues. 
2.2.2.6 Assessment and analysis 
The vessels demonstrated were then described, drawn and measured to obtain the 
internal diameter of the veins. Photographs were taken of the finished casts. 
2.2.2.7 Precautions 
The injection of the casts with resin was performed in a well-ventilated room and 
protective clothing including masks, overalls and gloves were worn when handling 
dangerous chemicals. The solutions of macerated tissue were bagged and sent for 
incineration. 
2.2.3 Anatomical study by dissection 
2.2.3.1 Principles 
Dissection of formalin preserved specimens allows detailed investigation of anatomical 
structures using specialist instruments and techniques. 
2.2.3.2 Specimens 
A fresh adult sheep cadaver was obtained from the Langford site abattoir (University of 
Bristol, UK) following the use of electrical stunning and slaughter by exsanguination. 





The specimen was submerged in a bath of twenty-percent formalin and left for one 
week. It was then thoroughly rinsed in running water before dissection was attempted. 
2.2.3.4 Dissection 
Removal of overlying soft tissues was accomplished using scalpels, dissecting scissors 
and forceps. Bony structures were removed by using bone rongeurs. 
2.2.3.5 Precautions 
Dissection was performed in a well-ventilated room and protective clothing was worn. 
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2.3 RADIOGRAPIUC STUDY OF VENOUS CEREBRAL DRAINAGE 
2.3.1 Aims 
" To investigate the effects of animal orientation at stunning and slaughter upon 
uptake and transport of brain tissue emboli by the venous circulation after 
application of captive bolt gun stunning in sheep. 
2.3.2 Principles 
Administration of a radiographic contrast media into the venous circulation of 
anaesthetised animals allows the demonstration of cerebral venous outflow by way of 
radiography. 
233 Anaesthesia 
The animals were anaesthetised with an intra-muscular induction mixture (ketamine 
12mg/ml, xylazine 0.4mg/ml). The animals were then entubated and maintained on a 
mixture of 1-2% halothane, with 2-4 litres of oxygen and nitrous oxide per minute using 
a closed breathing system. 
2.3.4 Animal positioning 
Radiographs were taken of anaesthetised sheep in a prone position on the sternum, and 
after they were transferred to a specially constructed brace that allowed elevation of the 
animals into various degrees of a "head down" perpendicular position without the 
necessity for shackling. In addition the brace allowed correct positioning of the 
radiographic plate under the animals head. 
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2.3.5 Contrast media 
A low osmolar, non-ionic, iodinated contrast agent administered by intravenous or intra- 
cerebral injection was used to demonstrate the venous sinuses and veins draining the 
head (Omnipaque (iohexol), Nycomed UK Ltd). 
2.3.5.1 Administration of contrast media 
2.3.5.1.1 Angularis oculi vein injection 
A small incision was made over the vein to allow placement of a 1-inch 22g 
angiocatheter (Otiva, Johnson and Johnson) in the vein. The catheter was secured in 
place by means of tape and a small quantity of superglue. A bolus of 10-m1 of contrast 
media was given into each vein. A tape ligature was briefly placed around the animal's 
neck during injection of contrast media with animal in both positions. 
2.3.5.1.2 Dorsal sagittal sinus injection 
A 22-gauge catheter was introduced to the sagittal sinus by way of a burr-hole drilled in 
the midline of the skull. Reflux of blood from the catheter port suggested correct 
placement of the catheter in the vein lumen. A bolus injection of 10-m1 of contrast 
media was injected. 
2.3.5.1.3 Infra-cranial injection 
The skin over-lying the highest point of the head was incised and reflected to expose the 
under-lying bone. A small hole of approximately 3mm diameter was then drilled 
through the skull on the midline and on the highest point of the skull by the use of an 
electric bur. Penetration of the skull was confirmed by observation of cerebrospinal 




Two radiographs were taken in rapid succession of both views for each animal. All 
radiographs were obtained with a focal-film distance of 100-cm. An automatic film 
processor and drier were used to develop all films. 
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2.4 SEPARATION AND QUANTIFICATION OF BRAIN TISSUE EMBOLI BY FILTRATION 
2.4.1 Aims 
" To investigate the use of a leukocyte filtration system for separation from blood 
of brain tissue emboli created by the application of captive bolt gun stunning in 
sheep. 
" To quantify the amount of brain tissue emboli released into the venous 
circulation after captive bolt gun stunning. 
2.4.2 Principles 
Filtration using leukocyte filters may provide a method for removing tissue fragments 
of similar and larger size than leukocytes from blood samples. In addition, since the 
entire blood volume collected after stunning can be passed through a filter the method 
may allow the quantification of the brain tissue emboli present in the venous blood 
returning from the head. The use of the pre-filter component of the leukocyte filtration 
system should allow separation of the larger fragments of brain tissue and enable rapid 
estimation of the weight of captured tissue in the filter. 
2.4.3 Anaesthesia 
All animals were anaesthetised by intramuscular injection of an induction mixture of 
ketamine (12mg/kg) and xylazine (0.4mg/kg) and were then maintained by intravenous 
injection of a guaiphenesin anaesthetic mixture (100: 6: 3 mixture of 10% guaiphenesin, 
10% ketamine and 2% xylazine). 
2.4.4 Animal preparation 




2.4.5 Stunning position 
Sheep were stunned while in lateral recumbency. 
2.4.6 Captive bolt guns 
Seven of the sheep were stunned by a cartridge-activated penetrating captive bolt gun 
(Temple Cox, Mark V, Accles and Shelvoke) using a 1.25-grain cartridge and the 
remaining eight animals were stunned by use of a pneumatically-activated penetrating 
captive bolt gun (Cash Ramrod, Accles and Shelvoke, UK) using 100 pounds per square 
inch (psi) air pressure to activate the gun. 
2.4.7 Collection of blood 
A pre-stun sample blood sample was taken from the jugular cannulas and the animals 
were immediately stunned by either a pneumatically-activated CBG (Cash ramrod, 
Accles and Shelvoke, UK) or by a cartridge-activated CBG (Temple Cox, Accles and 
Shelvoke, UK) and blood collection initiated through the jugular catheters. Sample 
collection continued over a one minute period into six 250-m1 containers in which 25m1 
of citrate anti-coagulant had been placed. 
2.4.8 Filters 
Standard leukocyte filters (Leucolab (KSV0001XQ, Maco Pharma Laboratories 
Pharmaceutiques, Tourcoing, France) for use with human blood were used to filter the 
collected blood samples. 
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Figure 2.5 Photograph of the pre-filter used to separate the brain tissue emboli (left) 
and a schematic diagram of the complete filtration system (right) (Leucolab, 
Macopharma, Tourcoing, France) 
2.4.8.1 Filtration 
The collected blood was then passed through the pre-filter container which had 
previously been removed from the outer casing and suspended over an empty collection 
bottle. 
2.4.9 Weighing collected tissue 
Each filter was weighed and labelled and the weight was recorded. The collected 
jugular blood was then passed through the filter and the filtrate was collected. The filter 
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was then flushed with saline to remove any remaining blood cells and then filter was 
then re-weighed. 
2.4.10 Analysis of collected tissue 
The filters were then suspended in 20% formalin and sent for analysis by the combined 
techniques of microscopy and immunocytochemistry. 
2.4.11 Analysis of filtrate 
The filtrate was stored at -30° C and kept for analysis by ELISA. 
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2.5 POLYMERASE CHAIN REACTION FOR DETECTION OF BRAIN TISSUE 
CONTAMINATION 
2.5.1 Aims 
" To validate a real-time PCR assay previously developed for use with bovine 
DNA using ovine DNA. 
" To use the assay to investigate contamination of the ovine carcass with brain 
tissue emboli following the application of captive bolt gun stunning. 
2.5.2 Principles 
The polymerase chain reaction (PCR) allows amplification of the number of copies of a 
specific region of DNA (deoxyribonucleic acid), in order to produce enough DNA to be 
adequately tested. A gene is composed of a precise sequence of four different 
deoxyribonucleotides within a stretch of DNA. The nucleotides are distinguished by the 
presence of one of four different nucleotide bases namely Adenine, Thymidine, 
Cytosine and Guanine. The first step necessary for the PCR is to synthesize "primers" 
of about 20 nucleotides long using each of the 4 bases, which replicate lengths of DNA 
on either side of the length to be replicated. 
The actual amplification process involves three temperature changes that are repeated 
over 30-40 cycles to produce a large number of copies of the DNA strand. The first 
stage involves denaturation of the DNA at 94°C in which the double helix un-winds, 
this is followed by an annealing step at 54°C in which the primers attach to the DNA 
template on both sides of the open helix. The polymerase enzyme attaches at this point 
and begins to replicate the template. The temperature is then raised to 72°C to allow 
optimal extension of the template from the 5' to 3' direction by the polymerase enzyme. 
The detection of product DNA may be done using a method of gel electrophoresis or 
alternatively may use fluorescently labelled probes that attach to the newly synthesised 




Blood and tissues were obtained from the Langford site abattoir. Dr. C. R. Helps, 
(Department of Clinical Veterinary Science, University of Bristol, UK) donated samples 
of bovine brain material for use in initial trials of the assay 
2.5.4 Reagents 
" Platinum Q PCR Supermix (Invitrogen, Groningen, The Netherlands) 
" Bovine Y primer (Cruachem Ltd, Glasgow, Scotland) 
" 28s rDNA primer (Cruachem Ltd, ) 
" 28s rDNA FQ probe (Cruachem Ltd, ) 
" SRY FQ probe (Cruachem Ltd, ) 
" Platinum Taq (Invitrogen) 




DNA was extracted from tissue samples using QlAamp DNA minikit (Qiagen, Crawley, 
UK). The protocol described in the Qiagen Dneasy tissue kit handbook for DNA 
extraction from animal tissues was followed except that only a single elution into 10011l 
of buffer AE was done. 
2.5.6 Primers and Probes 
Primers to amplify bovine Y-chromosome and bovine 28S DNA sequences were 
previously designed for investigation of CNS contamination during carcass splitting 
(Helps et al., 2004). Primers and probes were designed from Genbank sequences 




Table 2.2 Base sequences of primers and probes designed for the real-time PCR assay 
Primer/Probe Primer/Probe 5' to 3' sequence 
Bovine 28S rDNA forward GGCGAAAGACTAATCGAACCAT 
Bovine 28S rDNA reverse CGAGAGCGCCAGCTATCCT 
Bovine 28S rDNA FQ probe Tex Red- 
TAGTAGCTGGTTCCCTCCGAAGTTTC 
CCT-BHQ2 
Bovine SRY forward GTGAACGAAGACGAAAGGTGG 
Bovine SRY reverse AGAATGGGCGCTTTTTCAGC 
Bovine SRY FQ probe Fam- 
TCAGCAAGCAGCTGGGATATGAGTG 
GAA-BHQ1 
2.5.7 Real-time PCR 
An iCylcer IQ system (Bio-Rad Laboratories Ltd, Hemel Hempstead, UK) was used to 
amplify the product DNA. The reaction mixture followed that of a previous experiment 
(Helps et al., 2004). This included 12.5µl of Platinum Q PCR Supermix-UDG, 200nM 
bovine SRY primers, 200nM bovine 28S rDNA primers, IOOnM SRY FQ probe, 
200nM 28S rDNA FQ probe, 1.25 units Platinum Taq, 3mM MgClz, 5 tl DNA and water 
to 25µl. The mixture was first incubated at 95°C to activate the Platinum Taq then 45 
cycles at 95°C for 10 seconds and 60°Cfor 30 cycles. Fluorescence was detected at 
530nm and at 630nm at each annealing step. Threshold cycles were calculated using 
Bio-Rad software. 
2.5.8 Efficiency of amplification 
Ten-fold dilutions of DNA extracted from male sheep brain were prepared in AE buffer 
to yield dilutions ranging from 10'1 to 10-6. These samples including the undiluted male 
sheep DNA and a negative control were assayed by real-time PCR to produce a standard 
curve using the Bio-Rad software. A graph of threshold cycle (Ct) vs. loglo copy 
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number of the sample dilution series was produced. The slope of this graph gave the 
reaction efficiency. 
The detection limit of the PCR was calculated using the starting quantity of brain tissue 
from which the male DNA was extracted and the dilution factor of the final sample in 
which the SRY DNA was amplified. 
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2.6 INVESTIGATION OF PROTIROMBIN TIME ESTIMATION OF PLASMA AS AN 
INDIRECT TEST FOR BRAIN TISSUE EMBOLI IN BLOOD 
2.6.1 Aims 
" To investigate the use of prothrombin time estimation as a tool for identifying 
samples from sheep and cattle in which embolism of brain tissue into the blood 
occurred following stunning by captive bolt gun. 
2.6.2 Principles 
Screening tests for coagulation involve in-vitro activation of the clotting cascade and 
measurement of the time until a clot is formed. Prothrombin time (Pt time) is used to 
evaluate the extrinsic clotting pathway and measures the activity of the coagulation 
factors, II, V, VII and X. The addition of calcium thromboplastin to citrated plasma 
starts the cascade of reactions that ends in the formation of a fibrin clot. 
The sample plasma is placed in a well along with a ball bearing that sits on two curved 
rail tracks. An electro-magnetic field generated by two independent coils is applied 
alternately to each end of the well to produce a constant swinging pendulum movement 
of the ball. The oscillation of the ball is recorded through an inductive displacement 
sensor (Figure 2.6). Clotting measurement is based upon the decreased amplitude of the 
ball oscillations as the viscosity of the sample increases with clotting. An algorithm is 
used to calculate the clotting time. 
86 
Chapter 2 
Figure 2.6 Diagram indicating the determination of clotting measurement by 
recording ball oscillations through an inductive displacement sensor (ST art 4, 







To minimise instrumental and reagent differences in the evaluation of prothrombin time 
the World Health Organisation has introduced a method of standardisation known as the 
International Normalised Ratio (INR) to express PT time when human plasma samples 
are analysed. 
In this study PT times are not standardised since comparison of the results with other 
assay systems was not required and a similar method of standardisation does not exist 
for animal plasma samples. 
2.6.3 Reagents 
" Rabbit brain thromboplastin (Neoplastine Cl plus, Diagnostica Stago, Asineres, 
France) 
" Owens Veronal buffer (Diagnostica Stago) 
" STA Unicalibrator (Diagnostica Stago) 




Cattle and sheep plasma was obtained from animals during the sampling for brain tissue 
embolism after CBG stunning in which blood samples were collected into citrated 
collection bottles. The samples for the coagulopathy study were chosen from the stored 
plasma samples and included samples that were previously found to have been taken 
from animals positive for brain tissue embolism by either or by both of the analytic 
methods used. A selection of samples designated as negative for brain tissue embolism 
were also included. All seven samples from each sample animal including the pre- 
stunning samples were included in the samples analysed except in cases in which 
plasma samples were missing. 
2.6.4.1 Storage 
Plasma was rapid frozen in liquid nitrogen before being transferred to freezers at -30°C. 
Samples were stored for up to 18 months before assay for PT time. 
2.6.5 Controls 
The STA Unicalibrator supplied with the kit was assayed in duplicate as the positive 
control sample and duplicate samples of distilled water provided negative control 
samples before each use of the machine to check the accuracy and reproducibility of 
results. 
2.6.6 Clotting time determination 
Plasma samples were thawed at room temperature and then centrifuged at 800x g before 
use in the assay. Samples were run in duplicate on a coagulation analyser (ST art 4, 
Diagnostica Stago, Asnieres, France). 
The activating reagent was first warmed to thirty seven degrees and was mixed by 
magnetic stirrer after which 50-µl of sample plasma in citrate was then added in 
duplicate to the cuvettes in which a ball bearing had previously been placed. The 
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cuvette was then warmed for a period of at least fifty seconds to reach a temperature of 
37°C. After the required temperature was reached, the cuvette was moved to the test 
area and 100-µl of Neoplastin Plus reagent was added. Simultaneously the magnetic 
field was activated causing oscillation of a ball bearing previously placed in the well. 
The movement of this ball bearing on curved rail tracks on the base of the cuvette well 
was monitored by an inductive displacement sensor built into the machine. As the 
viscosity of the sample increases as the clotting cascade is activated the ball bearings 
rate of oscillation is slowed and the PT time calculated and recorded. 
2.6.7 Performance 
Within assay and inter-assay coefficients of variation were calculated by analysis of 20 
aliquots of the unicalibrator on the same day and on three separate days respectively. 
2.6.8 Statistical analysis 




CHAPTER 3 EXPERIMENTAL 
3.1 DETECTION OF BRAIN TISUE CONTAMINATION IN BLOOD AND OTHER 
TISSUES USING AN ELISA AND A COMBINATION OF MICROSCOPY AND 
IMMUNOCYTOCHEMISTRY 
3.1.1 Introduction 
In this study the potential for brain tissue fragments to be disseminated in the carcasses 
of cattle and sheep after use of stunning methods currently in use or that are authorised 
for use in the UK was examined. 
Brain tissue contamination was detected in blood and other tissues using an ELISA 
developed for detection of the CNS specific protein glial fibrillary acidic protein 
(GFAP). In addition, a proportion of samples from each animal was also analysed for 
the presence of brain tissue using a combined technique of microscopy and 
immunocytochemistry. In this technique, the central nervous system (CNS) tissue 
specific proteins S-l00ß and neurofilament protein were used as antigen markers for the 
presence of brain tissue. 
As part of validation exercises of both analytic methods used in this group of 
experiments, a series of dilutions of macerated brain tissue in blood was prepared and 
subsequently analysed by ELISA and also by the technique of microscopy and 
immunocytochemistry. 
3.1.2 Aims 
" To determine the frequency of brain tissue embolism after captive bolt gun stunning 
in cattle and sheep. 
" To investigate the potential for brain tissue fragments to penetrate the lungs and 
enter the aortic circulation. 
" To investigate the potential of electrical stunning to cause entry of brain tissue 
fragments into the venous circulation. 




3.1.3.1 Jugular vein blood sampling following stunning 
For details of the method refer to 2.1 
3.1.3.1.1 Captive bolt gun stunning 
3.1.3.1.1.1 Cattle 
Jugular venous samples were taken from two hundred cattle of which one hundred were 
stunned with a penetrating captive bolt gun and the remaining one hundred by a non- 
penetrating captive bolt gun. All samples were taken from cattle at an over thirty 
months scheme (OTMS) designated abattoir (Jarrett's abattoir, Keynsham, Bristol, UK) 
approved for this purpose by the UK Home Office. Between six and twelve cattle were 
sampled on each visit and included a variety of breeds and a range of ages above thirty 
months. All animals sampled were female and the majority were of the Holstein- 
Friesian breed. 
3.1.3.1.1.2 Sheep 
Jugular venous samples were taken from two hundred adult sheep, one hundred after 
stunning with a cartridge-activated penetrating CBG and one hundred after the use of a 
pneumatically-activated penetrating CBG without air-injection facility. All sheep used 
in the experiment were animals previously selected for culling due to a variety of causes 
including barrenness, 'poor doers' and disease. A variety of common breeds were 
obtained from a farm close to the Langford site (University of Bristol, UK). No attempts 
were made to restrict the age of animals included in the study although a size restriction 
of between twenty and sixty kilograms was imposed. The weight and gender of animals 
was noted. Sampling of sheep was conducted from February 2002 to March 2003. 
Between six and fifteen animals were sampled on any given occasion. 
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3.1.3.1.2 Electrical stunning 
At a commercial abattoir (St. Merryn Meat Ltd, Merthyr Tydfil, Wales)in which a fully 
automated electrical stunning device (Jarvis, New Zealand) is used, twenty cattle heads 
were removed from the line immediately following slaughter, exsanguination and 
subsequent decapitation and then examined for brain tissue and vessel trauma. 
At the same abattoir on a separate occasion approximately five hundred millilitres of 
exsanguinated blood was collected as rapidly as possible following electrical stunning 
and sticking from twenty animals randomly selected from the line. Practical restrictions 
at the abattoir prevented a pre-stun sample from being taken. 
3.1.3.2 Aortic blood sampling following injection of brain suspension and 
simultaneous stunning 
For details of the method refer to 2.1 
3.1.3.2.1 Cattle 
Prepared suspensions of brain tissue were injected into the jugular vein blood of ten 
cattle that were then each stunned by a penetrating captive bolt gun. Sampling of aortic 
blood began immediately and continued for two minutes. 
3.1.3.2.2 Sheep 
3.1.3.2.2.1 Jugular vein injection 
Prepared suspensions of brain tissue were injected into the jugular vein blood of eleven 
adult sheep that were then each stunned by a penetrating captive bolt gun. Sampling of 
aortic blood began immediately and continued for the full duration of blood flow. 
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3.1.3.2.2.2 Intra-cranial injection with occluded jugular drainage 
Three adult sheep of 30 to 40-kg were used in this study. Prepared suspensions of brain 
tissue were injected into the bolt-hole of a single sheep and into the angularis oculi 
veins of two further sheep following stunning by a penetrating captive bolt gun. Both 
jugular veins of all sheep had previously been exposed and tied off in order for the 
vertebral venous system to act as the sole drainage portal from the brain. Sampling of 
aortic blood began immediately and continued for the full duration of blood flow. 
3.1.3.3 Organ sampling following injection of brain tissue suspension and stunning 
Five adult sheep were used in this study in which brain tissue suspensions were injected 
into the cerebral sinuses by way of the angularis oculi veins. The animals were then 
stunned and slaughtered by exsanguination. Samples of exsanguinated blood were 
taken and at post-mortem samples of cervical lymph nodes, spleen, liver and kidney 
were taken from each carcass. 
3.1.3.4 Validation 
As part of validation exercises performed on both analytic methods used in this group of 
experiments a series of dilutions of macerated brain tissue in blood was prepared and 
analysed by ELISA and also by the technique of microscopy and immunocytochemistry. 
In addition, brain tissue suspensions of known concentration were injected into lymph 
node specimens previously harvested from bovine carcasses that were then also 




3.1.4.1 Jugular-vein blood sampling of cattle following captive bolt gun stunning 
3.1.4.1.1 Penetrating CBG group 
3.1.4.1.1.1 ELISA 
Two animals (2/100) were found to have raised levels of GFAP of which one animal 
(65) demonstrated increased levels of GFAP from twenty seconds to forty seconds of 
sampling time with a peak during twenty to thirty seconds of sampling time (Fig 3.1). 
The second positive animal (67) demonstrated increased GFAP levels in the sample 
taken at twenty to thirty seconds after stunning. 
Figure 3.1 Graph demonstrating the concentrations of GFAP detected by ELISA in 
samples taken after captive bolt gun stunning from a single cow (65) 
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Table 3.1 Positive bovine samples taken after the use of a penetrating captive bolt gun 
and detected by ELISA 
Cattle 
number 
Sample number Positive by 
GFAP ELISA (ng/ml) 
Timed aliquot 
*(1-7) 
65 451 1.37 3 
452 4.98 4 
453 1.63 5 
67 466 2.13 4 
*Aliquot 1= pre-stun sample 
3.1.4.1.1.2 Microscopy and immunocytochemistry 
Three (3/100) animals were found positive by the complementary methods of 
microscopy and immunocytochemistry of which one was also positive by ELISA (cow 
number 65). Animal 65 produced positive samples in aliquots taken at twenty to forty 
seconds and also in the final sample taken at fifty to sixty seconds. This final sample 
was observed to be clotted at the time of processing of samples and consequently was 
sent as an additional sample. Animal 129 was found positive in samples taken between 
ten and thirty seconds while the third positive animal 133 was positive in the aliquot 
taken at thirty to forty seconds only. 
Table 3.2 Positive bovine samples taken after the use of a penetrating captive bolt gun 
and detected by microscopy and immunocytochemistry 
Cattle number Sample number Timed aliquot* 
(1-7) 
65 452 4 
453 5 
455 7 
129 899 3 
900 4 
133 929 5 
quot 1= pre-stun sample 
95 
Chapter 3 
3.1.4.1.2 Non penetrating CBG group 
3.1.4.1.2.1 ELISA 
No animals (0/100) were found to be positive by ELISA of blood samples. 
All samples analysed by GFAP ELISA were found to have levels of GFAP consistent 
with background concentrations. 
3.1.4.1.2.2 Microscopy and immunocytochemistry 
Two (2/100) animals were found positive by the complementary methods of microscopy 
and immunocytochemistry. Brain tissue fragments were observed in Cytoblock sections 
prepared from blood samples obtained from animals 88 and 137 respectively. A single 
sample taken between thirty to forty seconds of sampling time was found to contain 
fragments of meninges from animal 88 while a single aliquot taken between ten and 
twenty seconds of sampling time was found to be positive for brain tissue fragments 
from animal 137. 
Table 3.3 Positive bovine samples taken after the use of a non-penetrating captive bolt 
gun and detected by microscopy and immunocytochemistry 
Cattle number Sample number Timed aliquot* 
88 614 (identified as meninges 
by microscopy) 
5 
137 955 3 
*Aliquot 1= pre-stun sample 
3.1.4.1.3 Combined results 
Four (4/100) animals were identified as having embolism of brain tissue fragments after 




Two (2/100) animals were identified as having embolism of brain tissue fragments after 
the use of the non-penetrating CBG [Frequency of 0.02,95% confidence interval of 
0.006-0.07]. 
There was found to be no significant difference between the frequencies of brain tissue 
embolism observed with use of each captive bolt gun (Fishers exact test, p= 0.683). 
Table 3.4 Calculations of power based on actual and larger cattle sample sizes 
Proportion Sample size Power 
0.02 100 0.131236 
0.02 500 0.457704 
0.02 1000 0.746269 
0.02 2000 0.959990 
Figure 3.2 Individual samples in which brain tissue emboli were detected by ELISA 
(2), microscopy and immunocytochemistry (1) or by both analytic methods (3) 






1=IC, 2=ELISA, 3=IC and ELISA 
  P-CBC 
  NP-CBG 
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3.1.4.2 Jugular-vein blood sampling of sheep following captive bolt gun stunning 
3.1.4.2.1 Pneumatically-activated CBG group 
3.1.4.2.1.1 ELISA 
Seventeen samples from ten (10/100) different animals demonstrated significantly 
elevated levels of GFAP above background levels. 
Table 3.5 Positive ovine samples taken after the use of a pneumatically-activated 









86 599 1.9 4 
118 821 50.6 2 
822 5.11 3 
121 842 3.21 2 
137 955 1.21 3 
143 997 14 3 
998 2.01 4 
160 1119 3.2 6 
174 1213 4.5 2 
1214 9.3 3 
1215 2.9 4 
178 1241 5.47 2 
1242 1.28 3 
1243 1.44 4 
198 1383 1.52 3 
203 1416 1.93 2 
1417 2.42 3 
iquot 1= pre-stun sample 
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Figure 3.3 Percentage frequencies of positive samples in each timed aliquot 
















3.1.4.2.1.2 Microscopy and immunocytochemistry 
Twenty-one samples from thirteen (13/100) different animals were found to contain 
visible fragments of brain tissue. 
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Table 3.6 Positive ovine samples taken after use of a pneumatically-activated 







86 599 4 
600 5 
115 800 2 
801 3 
118 821 2 
121 842 2 
843 3 
129 900 4 
137 954 2 
143 997 3 
998 4 
999 5 
163 1137 3 
174 1214 3 
178 1241 2 
1242 3 
184 1283 2 
198 1383 3 
203 1416 2 
1417 3 
1418 4 
* Aliquot 1= pre-stun sample 
100 
3.1.4.2.2 Cartridge-activated CBG group 
3.1.4.2.2.1 ELISA 
Twenty-five samples from fourteen (14/100) different animals demonstrated 
significantly elevated levels of GFAP above background levels. 
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Table 3.7 Positive ovine samples taken after use of a cartridge-activated penetrating 









71 492 24.32 2 
74 513 1.78 2 
514 1.124 2 
75 520 9.82 2 
521 2.19 3 
80 555 18.84 2 
556 9.74 3 
557 1.814 4 
82 569 4.66 2 
570 23.78 3 
83 576 29.84 2 
577 2.175 3 
90 627 2.284 4 
92 640 1.65 3 
96 667 1.17 2 
668 1.55 3 
99 688 244.5 2 
689 13.2 3 
104 723 3.716 2 
111 772 23.97 2 
773 2.96 3 
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130 905 25.4 2 
906 12.59 3 
907 26.2 4 
161 1124 4.5 4 
* Aliquot I= pre-stun sample 
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Figure 3.4 Percentage frequencies of positive samples in each timed aliquot 












  Positive 
123456 
Blood Aliquots 
3.1.4.2.2.1 Microscopy and immunocytochemistry 
Twenty-eight samples from eighteen (18/100) different animals were found to contain 
visible fragments of brain tissue. 
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Table 3.8 Positive samples taken after use of a cartridge-activated penetrating captive 







70 487 4 
488 5 
75 522 4 
81 564 4 
82 571 4 
83 578 4 
90 627 4 
92 640 3 
94 656 5 
99 689 3 
690 4 
691 5 
111 773 3 
774 4 
114 794 3 
130 905 2 
906 3 
908 5 
132 919 2 
920 3 
155 1080 2 
921 4 
161 1124 4 
169 1178 2 
1179 3 
1180 4 
183 1276 2 
200 1396 3 
* Aliquot 1= pre-stun sample 
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3.1.4.2.3 Combined results 
A total of fourteen (14/100) animals were found positive for brain tissue embolism after 
the use of the pneumatically-activated CBG [Prevalence of 0.14 with 95% confidence 
interval of 0.085 to 0.22]. 9 animals (64%) were confirmed positive by both assays. 
A total of twenty-three (23/100) animals were found positive for brain tissue embolism 
after use of the cartridge-activated CBG [Prevalence of 0.23 with 95% confidence 
interval 0.16to 0.32]. 9 animals (39%) were confirmed positive by both assays. 
Figure 3.5 Individual samples in which brain tissue emboli were detected by 
microscopy and immunocytochemistry (1), ELISA (2), or by both analytic methods (3) 
following use of the cartridge-activated (C-A) CBG or pneumatically-activated (P-A) 
CBG 
I 
  C-A CBG 
  P-A CBG 
123 
1=IC; 2=ELISA; 3=IC & ELISA 
There was found to be no significant difference between the frequencies of brain tissue 
embolism observed with use of each captive bolt gun (Fishers exact test, p= 0.099) 
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Table 3.9 Calculations of power based on actual and larger sheep sample sizes 
Proportion Sample size Power 
0.14 100 0.373416 
0.14 500 0.956954 
0.14 1000 0.999412 
Table 3.10 Concentrations of GFAP detected by ELISA in ovine blood samples taken 
after stunning by captive bolt gun 
Sample designation Cartridge-activated 




activated captive bolt 
gun [Concentration of 
GFAP (ng/ml)] 
1 24.32 1.9 
2 1.78 50.6 
3 1.124 5.11 
4 9.82 3.21 
5 2.19 1.21 
6 18.84 14 
7 9.74 2.01 
8 1.814 3.2 
9 4.66 4.5 
10 23.78 9.3 
11 29.84 2.9 
12 2.175 5.47 
13 2.284 1.28 
14 2.175 1.44 
15 2.284 1.52 
16 1.65 1.93 












Figure 3.6 Concentrations of GFAP detected by ELISA in ovine blood samples 















A Mann-Whitney 2 sample rank test was performed on the GFAP concentrations 
detected from each CBG group of positive samples. No significant difference was found 
between the medians (p=0.197). 
3.1.4.3 Blood sampling of cattle following electrical stunning and sticking 
Raised levels of GFAP were detected in a blood sample collected from a single animal 
(1/20). All other samples had levels of GFAP consistent with the background level. 
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OD value by 
GFAP ELISA 
Positive by GFAP 
ELISA (ng/ml) 
18 C(e)36 0.63 2.5 
3.1.4.4 Examination of cattle brains following electrical stunning and slaughter 
Superficial focal sub-arachnoid haemorrhages on the surface of the cortex were 
observed in eleven (11/15) specimens. Although four (4/15) specimens had no 
macroscopic evidence of trauma or haemorrhage small blood vessels on the surface of 
the cortex appeared dilated and congested. In six (6/15) specimens the brain tissue 
displayed a denatured appearance possibly as a result of heat generated by the electrical 
current within the skull during the stunning process. All venous sinuses appeared intact 
in every specimen (15/15). 
Figure3.7 Photograph demonstrating superficial haemorrhages on the surface of the 
cortex of a bovine brain following application of electrical stunning 
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Figure 3.8 Photograph demonstrating congested and dilated appearance of small 
arterioles on the surface of the cortex of a cattle brain following application of electrical 
stunning 
3.1.4.5 Aortic blood sampling of cattle following injection of brain suspensions and 
stunning 
3.1.4.5.1 ELISA 
Moderately raised levels of GFAP were detected in samples from three of ten (3/10) 
animals tested, namely (C(c) 30, C (i) 107, C (j) 120, C (j) 121 &C (j) 122). All other 
samples including all pre-stun samples were negative. 
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c 30 5 3 
i 107 1.68 2 
j 120 2.3 2 
121 1.1 3 
122 1.48 4 
- aampie i refers to me pre-stun sample 
3.1.4.5.2 Microscopy and immunocytochemishy 
All Cytoblocks examined were negative for brain tissue fragments from all ten cattle 
sampled (0/10). 
3.1.4.6 Aortic blood sampling of sheep following injection of brain suspensions and 
stunning 
3.1.4.6.1 ELISA 
Central nervous system protein was detected in blood samples from six of eleven (6/11) 
animals tested namely, IS (a), S (b), S (d), S (f), S (h) and S (k). In five animals, S (a), S 
(b), S (d), S (f) and S (h), GFAP was detected within the first minute following injection 
of brain suspension. The GFAP concentrations of the positive control sample S (g) 




Table 3.13 Concentration of GFAP (ng/ml) in positive blood samples taken following 
stunning for the maximum duration of blood flow from each animal and later analysed 
by ELISA and by a combination of microscopy and immunocytochemistry 
Time in successive 
minutes of each sample 
Sheep designation 
a b d f h* k P g 
1 153.2 58.02 0.603 1.004 1.516 nd nd 15.96 
2 228.8 64.58 2.87 1.084 2.491 nd nd 33.90 
3 149.4 46.24 4.56 1.03 2.117 0.806 nd 51.60 
4 4.76 1.033 1.573 nd 270.50 
5 2.87 0.84 2.06 nd 278.50 
6 3.16 0.93 nd 285.90 
7 2.79 nd 
8 1.14 nd 
9 5.13 nd 
10 2.71 nd 
11 5.89 nd 
12 3.98 nd 
nd- Not detectable 
" Positive on immunocytochemistry 
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Figure 3.9 Concentrations of GFAP detected by ELISA in sequential aliquots of 








r 0 1 , 
123456789 10 11 12 
Sampling time after brain suspension injection and 
stunning (minutes) 
Figure 3.10 Concentrations of GFAP detected by ELISA in positive control samples 
[S (g)] prepared by the addition of known amounts of brain tissue to citrated blood 
samples 




3.1.4.6.2 Microscopy and immunocytochemistry 
Blood samples from two (2/11) animals S (h) and S (k) yielded Cytoblock sections that 
contained material immunopositive for both Si OOP and neurofilament protein. None of 
the other blood samples were positive for either antigen on microscopy and 
immunocytochemistry. 
Figure 3.11 Brain tissue fragments (black) in Cytoblocks prepared from aortic ovine 
blood samples stained with neurofilament and S-l00ß proteins 
Bai=20µm 
3.1.4.7 Intra-cranial injection with occluded jugular drainage 
3.1.4.7.1 ELISA 
All aortic samples analysed were negative for GFAP when assayed by ELISA. 
3.1.4.7.2 Microscopy and immunocytochemistry 
All aortic samples analysed were negative for brain tissue fragments. 
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3.1.4.8 Organ sampling following injection of brain tissue suspension and stunning 
3.1.4.8.1 ELISA 
3.1.4.8.1.1 Organs 
All samples analysed by ELISA gave OD levels similar to background readings 
however unusually high background levels of GFAP were obtained from all samples 
making identification of any possible positives difficult 
3.1.4.8.1.2 Blood 
Analysis of post-stun samples indicated elevated levels of GFAP in the jugular return of 
all samples 
Table 3.14 Concentrations of GFAP (ng/ml) detected by ELISA in jugular blood 
samples from sheep after stunning and injection of brain tissue suspension 
Sample time (s) Sheep 1 Sheep 2 Sheep 3 Sheep 4 Sheep 5 
Pre-stun sample nd nd nd nd nd 
10 92.4 5.6 7.9 75.1 24.0 
20 147.9 5.3 10.1 12.3 58.3 
30 5.7 5.2 11.5 nd 2.4 
40 nd 5.4 9.9 nd 70.9 
50 nd nd 3.7 nd 1.9 
60 nd nd 8.4 nd 30.3 
Nd=not detectable by ELISA 
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3.1.4.8.2 Microscopy and immunocytochemistry 





The ELISA readings obtained from the assay of the two-fold serial dilution of brain 
tissue in blood generated a curve that was parallel to that of the recombinant GFAP 
standard (Roche) (Figure 3.12). This indicates that CNS tissue can be detected and 
quantified when diluted in blood using the described methods. 
.ý 
The minimum detection limit of brain tissue in blood was found to be between 39µg/ml- 
156µg /ml (wet weight brain per ml blood). The minimum detection limit of GFAP was 
0.5ng/ml. The actual cut-off point used to define a positive sample was higher at 
Ing/ml or 0.05ng/well which correlates well with previous detection limits of GFAP as 
quoted in other studies (Helps et al., 2002). 
The inter-assay co-efficient of variation between ten positive samples repeated (in 
duplicate) on two separate occasions was - 17%. 
The intra-assay co-efficient of variation between eight identical dilutions of the GFAP 
standard was - 13% 
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Figure 3.12 Graph showing standard curve for the GFAP ELISA and a parallel 










-+-dose response curve 
-. -GFAP Standard curve 
Cut Off (5SD) 
0.00'r POP- i, 
0.1 1 10 100 1000 10000 
ug of brain per ml of blood / ng GFAP per ml 
3.1.4.9.1.2 Microscopy and immunocytochemistry 
The limit of detection of the analysis varies from 312µg/ml to 9.8pg/ml. All five 
dilutions were detectable down to a dilution of 312pg/ml, in four series dilutions to 
39pg/ml and in a single dilution down to a minimum detectable dilution of 9.8pg/ml. 
The negative control samples were all correctly identified as negative. 
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Table 3.15 Positive bovine samples detected by microscopy and immunocytochemistry 





1-15 16-30 31-45 
(-)control 
46-60 61-75 76-90 
10.00 + + - + + + 
5.00 + + - + + + 
2.500 + + - + + + 
1.250 + + - + + + 
0.6250 + + - + + + 
0.3125 + + - + + + 
0.1560 + + - nd nd + 
0.0780 nd + - nd nd + 
0.0390 + + - nd + + 
0.0195 nd nd - + nd nd 
0.0098 nd nd - nd nd + 
0.0049 nd nd - nd nd nd 
0.0024 nd nd - nd nd nd 
0.0012 nd nd - nd nd nd 
0.0006 Td nd - nd nd nd 
+= Samples positive by microscopy and immunocytochemistry 
Nd = not detectable 
-= negative samples 
3.1.4.9.2 Sheep 
3.1.4.9.2.1 ELISA (blood) 
The ELISA readings obtained from the assay of the two fold serial dilution of brain 
tissue in blood generated a curve that was parallel to that of the recombinant GFAP 
standard. This indicates that CNS tissue can be detected and accurately quantified when 
diluted in blood by this method. The lower detection limit of GFAP was approximately 
0.5ng/ml although samples with a concentration below Ing/ml were considered 
negative. The lower detection limit of brain tissue in blood was found to be between 
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39pgml -156µg /ml (brain wet weight/ml blood). The inter-assay co-efficient of 
variation between ten positive samples repeated (in duplicate) on two separate occasions 
was = 17%. The intra-assay co-efficient of variation was = 13% 
The cut-off value for a positive sample was defined as five times the standard deviation 
plus the background level. The background was calculated from a random selection of 
pre-stun samples assuming a normal distribution of the OD values obtained by 
spectrophotometric reading of the ELISA plates [mean pre-stun OD= 0.0736 where 
n=11, SD=0.0174, cut-off= 0.16 (0.074+5*0.0174) 
GFAP was consistently detected in all samples above the limit of detection and was 
absent in all negative control samples. 
Figure 3.13 Graph showing standard curve for the GFAP ELISA and a parallel 










-"-Dose response curve 
-*-GFAP Standard curve 
-Cut Off (5SD) 
pg of wet weight of brain per ml of blood ! ng GFAP per ml 
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3.1.4.9.2.2 ELISA (Tissues) 
GFAP was detected in all three samples but was absent from the negative control 
samples. 
Table 3.16 Concentration of GFAP detected by ELISA in bovine lymph nodes 
previously injected with suspensions of brain tissue 




0.00 (negative control) nd 
0.00 (negative control) nd 
0.00 (negative control) nd 
-no[ ae[ectauie 
3.1.4.9.2.3 Microscopy and immunocytochemistry 
The limit of detection of the analysis varies from 312gg/ml to 9.8µg/ml. All five 
dilutions were detectable down to a dilution of 312µg/ml in two series dilutions to 
39µg/ml and in a single dilution down to a minimum detectable dilution of 9.8gg/ml. 
The negative control samples were all correctly identified as negative. 
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Table 3.17 Positive ovine samples detected by microscopy and immunocytochemistry 








16-30 31-45 46-60 61-75 76-90 
10.00 - + + + + + 
5.00 - + + + + + 
2.500 - + + + + + 
1.250 - + + nd + + 
0.6250 - + + + nd + 
0.3125 - + + + + + 
0.1560 - + nd nd + nd 
0.0780 - nd nd nd nd nd 
0.0390 - + nd nd + nd 
0.0195 - nd nd nd nd nd 
0.0098 - nd nd nd nd + 
0.0049 - nd nd nd nd nd 
0.0024 - nd nd nd nd nd 
0.0012 - nd nd rid nd rid 
0.0006 - nd nd nd rid nd 
nd - Not detectable by the ayhný -c metho 
+- brain tissue was detected 
no brain tissue present 
3.1.5 Discussion 
The frequency with which brain tissue fragments enter the venous circulation of 
livestock following the use of mechanical stunning methods is of considerable 
importance in assessing the safety of these techniques. Since the emergence of BSE in 
cattle and of vCJD in humans, control measures have been implemented to restrict all 
potential routes by which transmission of BSE to humans could occur. The use of 
captive bolt guns for stunning livestock prior to slaughter has been suggested as a risk 
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factor for the contamination of carcasses with tissues of potentially high BSE infectivity 
(Garland, Bauer & Bailey, 1996; Anil et al., 1999; 2001). The findings of these 
preliminary observations and experiments highlighted the need for an in-depth 
investigation of the use of captive bolt guns and the frequency and extent of 
contamination of carcasses with brain tissue. In addition, this work suggested the need 
for a review of stunning methods currently in use in the UK. 
In the experiments described in this thesis, the risks associated with the use of stunning 
methods currently in use or that are authorised for use in the UK, were comprehensively 
investigated using a variety of applied techniques. The results of analyses of blood 
samples collected from cattle and sheep after stunning indicate that all four of the 
captive bolt guns examined (See 2.1.4), can cause entry of brain tissue fragments into 
the venous circulation. The range of frequencies of brain tissue embolism determined 
compares with figures reported in a study of brain tissue embolism after severe head 
trauma in humans (Collins & Davis, 1994). The similarity in the frequency ranges 
reported in this and other related studies (Garland, Bauer & Bailey, 1996), despite 
differences in the type and causes of head trauma, suggests that the occurrence of brain 
tissue embolism may need to be considered after use of any stunning method that causes 
severe skull and brain trauma. 
Extrapolation of the frequency of brain tissue embolism determined in this experiment 
(2 to 4%) to the total number of cattle slaughtered annually in the UK (GLIPHA, 2001) 
suggests that between forty and eighty thousand carcasses may risk contamination after 
captive bolt gun stunning. Furthermore, consideration of historical data on the numbers 
of cattle slaughtered after the emergence of BSE suggests that a significant number of 
carcasses may have been contaminated by this route between 1985 and 1995, before 
effective control measures for BSE were instituted. 
The comparatively high frequencies of brain tissue embolism detected in the sheep 
study must strengthen arguments for the blanket use of alternative stunning methods in 
this species. Experimentally induced BSE in sheep is known to result in widespread 
infectivity in the carcass in comparison to cattle in which nearly all infectivity is 
restricted to tissues currently designated as SRM (Jeffrey et at., 2001). In view of this 
finding, additional BSE contamination through brain tissue dissemination in an already 
BSE infected carcass might significantly increase the risk to the consumer of ingesting 
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an infective dose. The high frequencies of brain tissue emboli detected in sheep as 
compared to cattle samples may indicate a fundamentally greater risk of brain tissue 
embolisation in sheep after CBG stunning. The smaller sheep brain might be expected 
to suffer proportionately greater trauma and be subjected to greater intra-cranial 
pressures after stunning than the larger cattle brain, resulting in higher frequencies of 
brain tissue emboli. Alternatively, this finding may relate to differences in the method 
of sample collection and processing. The smaller body weight of sheep along with the 
commensurate smaller blood volumes collected during sampling may have resulted in 
an overall higher detection rate of brain tissue emboli in sheep samples. 
Statistical comparison of the frequency of brain tissue emboli detected in each species 
indicated no significant difference between each CBG group examined. However, the 
small numbers of positive samples detected in the study does not allow reliable 
comparisons of each gun in cattle. A retrospective analysis of the data and calculation 
of the power of the test obtained from the cattle studies indicated only a 13% chance of 
detecting a difference between each sample group. Increasing each sample group size 
to 500,1000 or 2000 animals would have increased the chances of detecting a 
difference between uses of each CBG to 46%, 75% and 96% respectively. Clearly, 
further studies examining greater numbers of cattle might reveal significant difference 
in risk between the use of the non-penetrating and penetrating guns. In the parallel 
sheep study, calculation of the power of the chosen sample size indicated a 37% chance 
of detecting a difference between stunning with each CBG. If the sample group size 
had comprised 500 or 1000 animals the chances of detecting a difference would have 
increased to 96% or 99.9% respectively. In light of the calculated powers of each 
experiment and irrespective of cost and logistical implications a group size of at least 
2000 cattle and 500 sheep would have best increased the chances of detecting a 
difference between the use of each CBG in the respective species. 
Non-penetrating captive bolt guns were previously thought unlikely to carry a risk of 
brain tissue embolisation (EC, 2001), although investigations of brain trauma after 
stunning indicated comparable or greater levels of brain tissue damage to that observed 
after penetrating CBG stunning (Farag, 2001). The finding in this study, of brain tissue 
fragments in samples from two cattle after the use of a non-penetrating CBG was 
unexpected and has cast doubt upon the use of these guns as a safer alternative to 
penetrating CBG stunning. 
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Brain tissue emboli were detected within a minute of blood collection, and in most cases 
were found in samples taken within thirty seconds of stunning. Given this time-frame 
in the real abattoir environment, the majority of emboli would have sufficient time to 
pass through the jugular veins and heart to challenge the pulmonary capillary filter 
before the jugular veins were severed and the circulation halted by cardiac arrest as a 
result of exsanguination. Stunning to sticking intervals vary among abattoirs but will 
generally lie in the range of thirty to ninety seconds. 
The methods of isolating and detecting brain tissue emboli employed in these 
investigations were developed in preliminary studies that examined the occurrence of 
brain tissue emboli after CBG stunning in a small number of cattle and sheep (Anil et 
al., 1999; 2001; 2002). Prior to the development of these novel techniques, brain tissue 
emboli had been reported as an unexpected finding at post-mortem examination of cattle 
carcasses (Garland, Bauer & Bailey, 1996). The unreliability of investigations based 
solely upon post-mortem examination, was highlighted by a later investigation of neural 
embolism after stunning that failed to detect any brain tissue emboli in over two 
hundred cattle carcasses examined (Munro, 1997). 
By capturing all the jugular venous blood draining from the head within the first minute 
of stunning, the methods utilised and described in this study should minimise the risk of 
overlooking brain tissue fragments disrupted by captive bolt gun stunning. 
Furthermore, this technique allows detection of brain tissue emboli in aortic blood 
samples. These small fragments and proteins would have already passed though the 
lungs and would not be detectable by post-mortem examination of the heart and lungs of 
carcasses. 
The use of two analytic methods increased the chances of detecting emboli although 
examination of the results obtained revealed a level of discrepancy between samples 
identified as positive by each assay. This apparent disparity between the ELISA and 
analysis by microscopy and immunocytochemistry was not entirely unexpected in view 
of the findings from a previous related study that also found some disagreement in 
results of two analyses (Anil et al., 2002). Sampling variance of the isolated buffy coat 
fraction during processing may have resulted in an uneven distribution of brain tissue 
fragments between samples sent for analysis. Furthermore, each analytic method 
examined less than one percent of the blood collected and consequently carried a risk of 
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over-looking some positive samples. It is also possible that elevated levels of GFAP 
may have been present in some samples without the presence of identifiable fragments 
of brain tissue. The negative findings by ELISA from samples in which brain tissue 
fragments were observed by microscopy may relate to enzymatic degradation of GFAP 
in some positive samples during storage (Missler et al., 1999). 
The experiments conducted to establish the performance of the two analytic methods 
using prepared brain in blood suspensions, suggested that both will correctly identify 
samples containing brain tissue material. Prepared tissue samples indicated that the 
ELISA could also detect brain tissue contamination in peripheral organs. However, 
samples obtained from a sheep after stunning and injection of brain tissue suspension 
indicated a high background level of GFAP that interfered with detection of brain tissue 
contamination. These findings indicated the need for development of an alternative 
method of detecting brain tissue contamination of organs. 
In a study of head trauma in humans, some brain proteins including GFAP were found 
to be consistently elevated in all blood samples collected and analysed (Mussack et al., 
2003). On the contrary, in this investigation relatively few samples demonstrated 
elevated levels of GFAP despite all animals being stunned prior to sample collection. 
The reason for this anomaly may relate to the reaction of astrocytes to trauma. 
Following head trauma, astrocytes are known to react by producing and releasing large 
quantities of GFAP into the circulation (Petzold et al., 2004). Although this process 
occurs quickly, it is not immediate and would not be a factor in these experiments of 
captive bolt gun stunning. In contrast, blood samples in human trials cannot be 
collected immediately after head trauma, allowing increased production of GFAP and 
explaining consistently elevated serum GFAP levels in all samples collected. 
Electrical stunning offers an alternative method of stunning, the use of which is well 
established for use in sheep in the UK, and which may see wider application for cattle 
stunning in the future. By combining a macroscopic study of cattle brains with analysis 
of blood samples taken after stunning, this experiment has confirmed predictions that 
electrical stunning is unlikely to cause brain tissue fragments to enter the circulation. 
The experiments in which aortic blood was sampled following injection of brain tissue 
suspensions into the jugular return were successful in confirming the potential of brain 
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tissue fragments and proteins to penetrate the pulmonary capillary filter. The findings 
of these investigations have given the first experimental evidence that brain tissue 
emboli created by captive bolt gun stunning are likely to enter the systemic circulation 
and be carried to edible parts of the carcass. Furthermore, the size of emboli detected in 
some ovine aortic samples indicates the size of brain tissue fragments that are capable of 
penetrating the pulmonary capillaries. The time with which such fragments entered the 
systemic circulation was well within the period that would occur between . stunning and 
sticking in a commercial abattoir. In further studies, the use of larger sampling 
populations might enable more accurate estimation of the proportion of stunned animals 
in which this is likely to occur. 
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3.2 ANATOMICAL INVETSIGATION OF VENOUS CEREBRAL DRAINAGE 
3.2.1 Introduction 
The technique used in these experiments follows that described by the University of 
Bristol anatomy department (Mr. Steve Gaze-personal communication) where the 
method has been used to produce a variety of casts of organ vasculature for 
demonstration purposes in the department. The technique however has not previously 
been applied to the cerebral venous sinuses and vessels of the vertebral plexus of cattle 
and sheep. 
These casts may be useful in identifying the vessels that are likely to be traumatised by 
the captive bolt at stunning and also for estimating the vessel diameters that may 
suggest the size of emboli, which may enter the circulation following application of 
stunning. 
3.2.2 Aims 
To investigate all venous drainage routes from the head that may contribute 
towards carriage of brain tissue emboli following the use of captive bolt gun 
stunning in sheep and cattle. 
3.2.3 Methodology 
3.2.3.1 Resin casting 
3.2.3.1.1 Bovine 4 weeks 
The specimen was obtained from a four-week old Holstein male calf of approximately 
60-kg live weight. Injection of resin was made into the left jugular vein only as the 
right jugular vein had retracted into the subcutaneous tissues and could not be located. 
A total quantity of 60- ml of resin was injected although resin was not observed at the 




3.2.3.1.2 Adult bovine 
This specimen was obtained from an OTMS abattoir. Injections of resin into both 
jugular veins was attempted although injection on the left side was stopped after 
injection of approximately 50-m1 of resin was injected due to increased back-pressure 
on the syringe. The remaining quantity of resin was injected into the right jugular vein 
only. In total 300-m1 of resin was injected before leakage of resin was observed from 
the cut-ends of the vertebral veins. 
3.2.3.1.3 Adult ovine 
Injections of approximately 30-ml of resin were made into each jugular vein before 
resin was observed at the cut-ends of the vertebral veins. 
3.2.3.2 Dissection of adult ovine head and neck 
A fresh adult sheep cadaver was obtained from the Langford site abattoir (University of 
Bristol) following the use of electrical stunning and slaughter by exsanguination. The 
head and neck were separated from the carcass at the level of the fourth cervical 
vertebrae. 
3.2.4 Results 
3.2.4.1 Resin casting 
3.2.4.1.1 Bovine 4 weeks 
The dorsal cerebral sinus system (dorsal sagittal sinus, transverse sagittal sinus, 
confluens sinuum, deep cerebral vein) of the specimen demonstrated good perfusion 
with resin on both sides despite having injected only through the left jugular vein. The 
basilar system of sinuses and the vertebral plexus demonstrated incomplete perfusion 
with resin with no part of the left basilar plexus visible and only a short length (30-cm) 
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of the vertebral plexus present on the left side of the specimen. The length of vertebral 
plexus visible demonstrates vessels of significant dimensions (Table 3.16) that continue 
as the basilar sinus plexus cranial to the foramen magnum. 
Figure 3.14 Resin cast of cerebral venous drainage of calf four weeks into the 
maceration process 





Dorsal sagittal sinus 7 
Transverse sagittal sinus 4-6 
Deep cerebral vein l 
Basilar sinuses 9 
Internal vertebral plexus 3-6 
Jugular vein 11 
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Figure 3.15 Resin cast of cerebral venous drainage of calf 
Internal vertebral plexus 
Transverse sagittal sinus 
Dorsal sagittal sinus 
Deep cerebral 
veins 
External jugular vein 
Linguofacial vein 
3.2.4.1.2 Adult bovine 
Maxilliary vein 
Resin injection resulted in excellent perfusion of the cerebral sinuses and the internal 
vertebral plexus although efficient perfusion appears to have occurred only from the 
right jugular vein. A constriction of the left jugular vein at the level of the angle of the 
jaw suggests that comparatively less resin was injected on this side. The left side of the 
cast is incomplete although the basilar plexus appears symmetrical. The internal 
vertebral plexus consists of a pair of longitudinal vessels interconnected by transverse 
interconnecting anastomoses. The longitudinal vessels are segmentally arranged with 
convexities interconnected with areas in which the vessels approach and appear to 
merge. The diameter of the vessels decreases slightly over the length of the cast 
corresponding to the edge of the fourth cervical vertebrae at which point the cast ends. 
Cranially the ventral vertebral plexus merges with the basilar sinus which itself gives 
off the orbital veins that are only visible on the right side of the cast. The vertebral vein 
is also visible running dorsal and lateral to the plexus on the right side of the cast. The 
diameter of the vertebral vein appears constant up to the level of C2 at which point the 
vein branches and forms a small plexus with branches off from the internal vertebral 
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plexus. The cerebral sinuses are demonstrated on the right side of the cast although 
some vessels including the greater part of the dorsal sagittal sinus was lost during 
preparation of the cast. The cast demonstrated the large size and complexity of the 
basilar plexus as well as the clear and extensive connection with the vertebral plexus. 
The intercavernous sinus as well as the cup-shaped vascular drainage of the hypophysis 
is demonstrated by the resin. The ratio of the diameter of the dorsal sagittal sinus to that 
of the basilar sinuses is 5.7%. 
129 
Chapter 3 
Table 3.19 Measured diameters of the cast of some veins draining the head of an 
adult bovine 
Vessel Diameter (mm) 
Dorsal sagittal sinus 2 (width) x8 (depth) 
Transverse sagittal sinus 8 
Confluence of sinuses 3 
Dorsal occipital plexus 3 
Deep cerebral vein 4 
Basilar sinuses 35 
Condylar sinus 9 
Temporal sinus 8 
Inter-cavernous sinus 2 
Cavernous sinus 12 
Emissary vein of foramen 
orbitorotundum 
10 
Dorsal cerebral vein 2 
Table 3.20 Measured diameters of the cast of some veins of the neck of the adult 
bovine specimen 
Vessel Diameter (mm) 






Basivertebral veins 2 
Transverse anastomoses 10 
Vertebral vein 8 
Spinous branch 2 
Jugular vein 21 
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Figure 3.17 Lateral view of resin cast of bovine cerebral sinuses and vertebral plexus 
Dorsal sagittal sinus Right transverse sinus 
Deep cerebral 
vein -- 






External jugular vein 
Figure 3.18 Lateral view of the resin cast of cerebral sinuses and vertebral plexus 
superimposed on an adult bovine head indicating the relative positions of vessels and of 
the bolt trajectory 
Bolt Trajectory 
Schematic representation of 
brain position showing 
continuation of 







3.2.4.1.3 Adult ovine 
A complete cast of the vasculature of the cerebral sinuses and the internal vertebral 
plexus was obtained in addition to an intact jugular vein demonstrating the inter- 
connections with the vertebral plexus. The dorsal sagittal sinus is a vessel of 50-mm in 
length by 2-mm at it is widest width that follows the curvature of the brain. The basilar 
sinus plexus is largely absent in the specimen although caudally it merges with the 
longitudinal vessels of the internal vertebral plexus. These longitudinally- directed 
vessels are intact until the level of C5 and demonstrate wide inter-connections at the 
level of each vertebra. Two veins connecting the plexus with the jugular vein are visible 
at the level of Cl and C4. The external vertebral plexus is not demonstrated by the cast 
perhaps reflecting a failure of the resin to perfuse this network of vessels. 
Table 3.21 Measured diameters of the cast of some veins of the head of the ovine 
specimen 
Vessel Diameter (mm) 
Dorsal sagittal sinus 2 
Transverse sagittal sinus 3 
Deep cerebral vein 1 
Cavernous sinus 10 
Inter-cavernous sinus 3 
Basilar sinus plexus 5 
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Figure 3.19 Lateral view of the resin cast of the ovine cerebral sinuses 
Dorsal Sagittal Sinus 
Jugular Vein 
Deep Cerebral Vein 
Cavernous Sinus 
intercavemous Sinus 
Figure 3.20 Lateral view of the cast of the ovine cerebral sinuses and cerebral 
drainage veins 
Jugular Vem MmM. ry Vein htarcr~aus Sinus 
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Table 3.22 Measured diameters of the cast of some veins of the neck of the ovine 
specimen 
Vessel Diameter (mm) 
Internal vertebral plexus 
C1=6 
C2 to C4=4 
Basivertebral veins <_ 1 
Transverse anastomoses 5-12 
Spinous branch 1 
Jugular veins 9 
3.2.4.2 Dissection of adult ovine head and neck 
An oblique section through the body of the third cervical vertebrae (C3) was made. A 
large (4-mm diameter), valve-less vessel was exposed running close to and lateral to the 
spinal cord within a canal. The vessel was in a ventrolateral position relative to the 
body of the vertebrae. The vein on the other side was not exposed. Due to the 
significant size and position, this vein was identified as the vertebral vein (V. 
vertebralis). Several pictures were taken of the exposed vessel. Removal of overlying 
bone exposed the dura mater of the spinal cord. The dura mater was cut longitudinally 
along a length of several centimetres and reflected to expose the underlying tissues. A 
fine network of superficial blood vessels was visible on the surface of the cord. Several 
photographs were taken. 
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Figure 3.21 Dissected sheep neck indicating the position of the vertebral vein 
3.2.5 Discussion 
The cerebral drainage pathways of humans and animals have been investigated by 
anatomical study since the 16th Century (Worthman, 1956). The descriptions of the 
vertebral venous plexus in the literature indicate an essentially similar system of spinal 
veins in humans and animals. Although the vertebral venous plexus is known to 
comprise a prominent network of blood vessels, the jugular veins are still considered as 
the major venous outflow despite evidence that this may not always be the case (Epstein 
et al., 1970; Zippel et at., 2001). The functional role of the vertebral plexus has been 
investigated in terms of its physiological significance as a collateral route of venous 
return to the heart and as a vascular bypass during transient increases in 
thoracoabdominal pressure (Zippel, 2001). A pathological role of the plexus in 
transporting bacteria and neoplastic cells from the head to other areas of the body has 
been suggested (Batson, 1940). 
Since the emergence of BSE and the realisation that brain tissue emboli created by 
mechanical stunning methods may cause contamination of the carcass with infected 
prions (Garland, Bauer & Bailey, 1996), all potential contributing routes of 
dissemination of emboli in the carcass should be investigated and evaluated. The 
anatomical features of the venous cerebral sinuses that permit entry of brain tissue 
fragments following stunning have not previously been considered. Furthermore, the 
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dimensions and extent of the vertebral plexus has not been investigated in relation to the 
size and potential for dissemination of brain tissue fragments in the carcass. 
The aim of these anatomical studies was to demonstrate the vulnerability of these 
cerebral veins to rupture by mechanical stunning methods and to examine the potential 
of the vertebral veins to transport brain tissue emboli throughout the carcass. An 
involved description of the anatomy of the venous systems draining the head was not 
undertaken, since such detailed anatomical accounts of the cerebral sinuses and 
vertebral plexuses of cattle and sheep are already available (Smuts, 1977; Rauhut, 
1967). 
The prepared casts were successful in demonstrating the cerebral sinuses that may be 
traumatised by the passage of the captive bolt, and in addition, demonstrated the 
emissary veins that connect these sinuses to the venous systems draining the head. 
Furthermore, the casts provided information on the relative size of vessels within the 
cranium that reflects on the size of brain tissue fragments that might enter such a 
ruptured sinus. The vertebral plexus was shown to be a pair of vessels of significant 
proportions in both cattle and sheep specimens that might carry emboli throughout the 
carcass. 
Consideration of the measured diameter of vessels of the calf venous cast suggests that 
emboli of up to 7-mm in diameter might enter the dorsal sagittal sinus while brain tissue 
fragments up to approximately 9-mm in diameter might enter the ventral sinuses. These 
estimates based upon measurement of vessels represented by the resin cast, are likely to 
be moderate exaggerations of the size of emboli that might enter a ruptured sinus. The 
thin walled veins may have been dilated by the pressure of resin injected under pressure 
through the system during the preparation of the casts. In addition, the pressure changes 
that occur within the cranium in the period immediately after stunning may cause very 
significant deviations in the size of the cerebral venous sinuses demonstrated by the cast 
models. 
The cast of the adult bovine cerebral veins demonstrates an extensive network of 
voluminous vessels on the ventral aspect of the brain. The presence of these sinuses 
correlates well with previous observations of extensive haemorrhage on the ventral 
surface of the brain after stunning as a result of vessel rupture by the passage of the bolt 
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(Farag, 2002). It seems likely, given the large size of these ventrally situated vessels in 
relation to the more modest proportions of the dorsal sagittal sinus, that the ventral 
vessels are more likely to pick up and transport brain tissue fragments displaced by the 
passage of the bolt after stunning (Figure 3.18). The prepared cast also demonstrates a 
clear and direct connection between the basilar veins (ventral veins of the cerebral 
cavity) and the vertebral plexus of the spine. This communication must increase the 
likelihood of transport of brain tissue fragments through the spinal system of veins from 
the head after stunning. Examination of the cast model suggests that dissemination of 
brain tissue emboli following the use of CBG stunning may indeed occur by routes 
other than the jugular return. 
Demonstration of a complete cast of the vertebral venous plexus and the cerebral 
sinuses is difficult, due in part, to in-complete perfusion of the venous system with 
resin. A second confounding factor relates to the fragility of the casts obtained after the 
maceration process is complete. The presence of blood clots in some veins of the head 
and neck specimen may have prevented full perfusion of the vertebral venous system 
with resin. In future studies, flushing of the system with saline and streptokinase prior to 
resin injection as described in other studies (Groen et al., 1997) may result in more 
complete casts. The delicate nature of the casts resulted in breakage and loss of delicate 
structures during and after the preparation process. The continuous monitoring and 
recording of the casts by photography through-out the maceration process may have 
helped to mitigate this problem and allowed reconstruction of damaged areas of the cast 
after the maceration process was complete. The maceration process of cast production 
might be improved by the use of maggot digestion of soft tissues following injection 
and drying of the resin (Smuts, 1977). Following removal of soft tissues by the use of 
maggots, the remaining bony structures could be removed by use of concentrated 
alkaline solutions. This modification of the cast preparation process might reduce 
damage of the more delicate vessels of the cast. 
In addition to the use of resin injection and maceration of soft tissues, an adult ovine 
head and neck specimen was preserved in formalin and dissected to allow visualisation 
of the vertebral veins. Further dissection of similar specimens was not attempted due to 
limitations in the method highlighted by this trial. 
138 
Chapter 3 
Dissection of the cervical section of the specimen allowed visualisation and 
measurement of the vertebral vein (Figure 3.21). The diameter of vessels obtained by 
this method of dissection may be more accurate than measurements made from resin 
casts. Transverse sections made through the vertebral column revealed the relation 
between the vessels of the spine and the surrounding soft and bony tissues. The vessels 
of the vertebral column were observed to be of significant dimensions and lacking in 
intra-luminal valves, a feature that should allow blood and perhaps also brain tissue 
emboli, to flow in either direction. 
Dissection of the vertebral venous system may be enhanced in future studies by the 
combined use of resin injection of venous structures and conventional dissection 
methods. This modified technique of dissection (Van der Kuip, Hoogland & Groen, 
1999) should permit easier identification and isolation of venous structures. 
These anatomical studies were successful in demonstrating the potential of the vertebral 
veins to carry brain tissue emboli from the head. Further investigation of the anatomical 
features and functional roles of the spinal venous systems may allow an improved 
estimation of the risk of emboli dissemination by this route. 
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3.3 RADIOGRAPHIC STUDY OF VENOUS CEREBRAL DRAINAGE 
3.3.1 Introduction 
In this experiment the functional characteristics of the cerebral venous system are 
examined. The potential of the vertebral system of veins to carry brain tissue fragments 
from the head after stunning has not previously been investigated. The effects of 
postural changes on the haemodynamics of cerebral venous outflow that might occur 
during stunning are investigated using routine radiographic methods on a small number 
of anaesthetised sheep. 
3.3.2 Aims 
" To investigate the effects of animal orientation at stunning and slaughter upon 
uptake and transport of brain tissue emboli by the venous circulation after 
application of captive bolt gun stunning in sheep. 
3.3.3 Methodology 
3.3.3.1 Injection routes of contrast media 
3.3.3.1.1 Intra-cranial injection via a pre-drilled hole 
A 20-m1 volume of contrast media (Omnipaque, Nycomed, UK) was injected through a 
hole in the cranium into the estimated area of the dorsal sagittal sinus. A series of four 
radiographs were then taken with the animal in dorsal ventral recumbency. 
3.3.3.1.2 Intra-cranial injection via a bolt-hole 
Following induction of anaesthesia the animal was placed in sternal recumbency on the 
table. The animal was then stunned by the use of a cartridge-activated CBG used with a 
1.25-grain cartridge (Cox MK 9, Accles & Shelvoke, UK). A 20-m1 volume of contrast 
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media was then injected as a bolus through the bolt- hole. A series of two radiographs 
were then taken. 
3.3.3.1.3 Bilateral angularis oculi injection 
Following induction of anaesthesia, the animal was placed in sternal recumbency on the 
table and 10-m1 of contrast media was injected into each angularis oculi vein. A 
radiograph was taken with 3-ml of media remaining in each syringe. A second 
radiograph was taken 30 seconds later, following injection of the remaining contrast 
media. The animal was inclined at approximately 40-degrees to the horizontal in a head 
down position by tilting the table and the injections of contrast media and radiographs 
were repeated. 
3.3.3.1.4 Dorsal sagittal sinus injection 
A hole was drilled on the mid-line of the cranium over the expected position of the 
vessel. Although too small to visualise the dorsal sagittal sinus this procedure did cause 
significant bleeding which suggested perforation of the sinus by the drill. A plastic 
cannula was then introduced into the hole and 10-m1 of contrast media was injected by 
way of the cannula after confirming placement in the vein by first withdrawing blood. 
Two radiographs were taken immediately of the head and neck. 
3.3.3.1.5 One sided angularis oculi injection 
With the sheep in dorsal ventral recumbency, 10-m1 of Omnipaque contrast media was 
injected rapidly into the angularis oculi vein and two successive dorsal ventral 
radiographs of the head and neck was taken. A tape around the neck was temporarily 
used to compress the external jugular veins during the injection of contrast solution. 
While still heavily anaesthetised the animal was hoisted in a specially constructed frame 




3.3.3.1.6 Bilateral angularis oculi injection 
With the animals in dorsal ventral recumbency 10-m1 of Omnipaque contrast media was 
injected rapidly into both veins and two successive dorsal ventral view x-rays of the 
head and neck were taken. A tape around the neck was temporarily used to compress 
the external jugular veins during the injection of contrast solution. 
While still heavily anaesthetised the animal was hoisted in a specially constructed frame 
to assume a head down position. The contrast media injections and radiographs were 
repeated. 
3.3.4 Results 
3.3.4.1 Intra-cranial injection via a pre-drilled hole 
The substance entered the epidural space and drained down the cervical spine. No 
vessels of the vertebral venous system are visible suggesting that all the media was 
present in the epidural space. 
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Figure 3.22 Dorsoventral radiograph of the head following injection of contrast 
media through a hole drilled in the cranium. 
IP=injection point, SPC=spinal cord 
3.3.4.2 Intra-cranial injection via a bolt-hole 
The substance entered the epidural space and drained down the cervical vertebrae within 
the epidural space. No vessels are visible suggesting that all the media was present in 
the epidural space. 
143 
Chapter 3 
Figure 3.23 Dorsoventral radiograph of the head following injection of contrast 
media through a bolt-hole in the cranium created by use of a penetrating captive bolt 
gun 
BH=bolt-bole, CM=contrast media, SPC=spinal cord 
3.3.4.3 Bilateral angularis oculi injection 
3.3.4.3.1 Prone 
The cerebral sinuses are visible as well as both jugular veins. A small volume of 
contrast media has refluxed into the internal vertebral plexus although the majority of 
the contrast medium drains from the head by way of the jugular veins. 
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Figure 3.24 Dorsoventral radiograph of the head and neck following injection of 
contrast media into both angularis oculi veins 
CS=cavernous sinus; IVP=internal vertebral plexus; JV=jugular vein; SC= sinuum 
confluens 
3.3.4.3.2 Inclined at 40°to the horizontal 




Figure 3.25 Dorsoventral radiograph of the skull following injection of contrast 
media into both angularis oculi veins with the animal tilted head-down at 40 degrees to 
the horizontal. ETT=endotracheal tube; JV jugular vein 
3.3.4.4 Dorsal sagittal sinus injection 
Contrast media is faintly visible along the midline of the cranium but no veins are 
visible either within the cranium or along the spine. 
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Figure 3.26 Dorsoventral radiograph of the skull following unsuccessful attempts to 
cannulate the dorsal sagittal sinus and inject the contrast media by this route 
CM=contrast media; ETT=endotracheal tube; IP=injection point; SPC=spinal cord 
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3.3.4.5 One sided angularis oculi injection 
3.3.4.5.1 Prone 
The cerebral sinuses are visible bilaterally while the internal vertebral plexus and 
jugular vein are visible only on the right side. 
Figure 3.27 Dorsoventral radiograph taken following injection of contrast media into 
the right angularis vein with the animal resting on the sternum 
CS=cavernous sinus; IC=intercavernous sinus; IVP= internal vertebral plexus; 
JV jugular vein; OP=orbital plexus; SC=sinuum confluens 
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3.3.4.5.2 Head down 
Both jugular veins are visible while the vertebral venous system is absent. 
Figure 3.28 Dorsoventral radiograph taken following injection of contrast media into 
the right angularis vein with animal inclined in a head-down position 
JV=jugular vein 
3.3.4.6 Bilateral angularis oculi injection in a prone position (Figure IA) and 
secondly in a head down position 
In the prone position the vertebral plexus is uniformly visible while the jugular veins are 
also visible although appears more faint in comparison. In the head down position the 
jugular veins are distended while the vertebral plexus is not visible. 
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Figure 3.29 Dorsoventral radiograph taken following injection of contrast media into 
both angularis oculi veins (Prone (1 a) and inclined (1 b)) 
CS=cavernous sinus; ETT=endotracheal tube; IS= intercavernous sinus; I VP= internal 
vertebral plexus; JV=jugular vein; PS= petrosal sinus; SV=sphenopalatine vein 
3.3.5 Discussion 
The vertebral venous plexus has been extensively investigated in human and animal 
studies using various investigative techniques including the use of radiography and 
ultrasound (Dilenge & Perey, 1973; Valdueza et al., 2000). Radiography using it 
commonly available contrast media provides adequate radiographic contrast to enable 
visualisation of the cerebral sinuses and the spinal veins against the background of the 
skull and vertebrae. Of the techniques available, radiography is particularly useful for 
investigations of blood flow, since the contrast media and blood are miscible and of 
similar viscosity. Furthermore the method requires no special equipment other than it 
standard x-ray unit and gives consistent results with few technical complications. 
The vertebral venous plexus has previously been implicated in the transport of bacterial 
and cancer cells between the head and other organs of the body (Batson, 1940), other 
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studies suggest that the plexus may be a source for entry of air embolism to the brain 
and heart during surgery to the spine or skull (Epstein et at., 1970). It seems reasonable 
to assume that the system might also transport brain tissue fragments from the head 
after the use of captive bolt gun stunning. 
The vertebral venous plexus deserves particular attention in relation to the 
dissemination of brain tissue emboli since the system is known to communicate directly 
with organs of the body providing a potential by-pass of blood flow around the 
pulmonary filter. This may mean that brain tissue fragments could lodge in organs of 
the carcass without passage through the lungs which filter blood returning from the head 
in the jugular veins. 
The effects of posture on venous outflow from the head have been demonstrated in 
humans and in a variety of animal species (Valdueza et at., 2000; Epstein et al., 1970). 
By injecting a radio-opaque dye into the surgically exposed sagittal sinus of monkeys, 
Epstein et at., demonstrated that the vertebral system is the main drainage route for 
blood from the head in the standing position, while the jugular veins carry the greater 
volume in the supine position. The effect of a `head-down' position on venous outflow 
was subsequently explored in monkeys and snakes (Dilenge & Perey, 1973; Zippel, 
2001), when it was observed that the flow of blood in the vertebral system is reversed in 
the `head-down'position 
The findings in this experiment on anaesthetised sheep support earlier descriptions of 
the postural dependency of blood flow. In studies conducted on monkeys and humans, 
the flow of blood through the vertebral plexus in the horizontal position was minor or 
absent (Epstein et al., 1970; Valdueza et al., 2000), while in our studies a significant 
blood flow was observed. An explanation for this discrepancy may relate to the 
different species in which the studies were conducted. Evidence of significant blood 
flow through the vertebral venous plexus of recumbent sheep is significant since sheep 
are in a recumbent position immediately following stunning by captive bolt gun. 
During this time there may be potential for brain tissue fragments to drain from the head 
by way of the vertebral plexus. 
In the perpendicular `head-down' position and at 45°to the horizontal with the head- 
down, blood flow was observed only in the jugular veins. This substantiates the findings 
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of earlier studies that confirm the jugular veins as the only significant outflow of blood 
in the `head-down' position (Zippel et al., 2001). It appears therefore that after 
shackling and hoisting of the animal after stunning all blood flow would occur through 
the jugular veins. 
A variety of methods for introducing the contrast media into the cerebral sinuses were 
investigated. Ideally the method employed would have mimicked the entry of brain 
tissue fragments into a ruptured sinus after captive bolt gun stunning. Injection of the 
contrast material into a hole created by drilling or by the use of penetrating captive bolt 
gun stunning was not successful in demonstrating any uptake of contrast media into the 
venous circulation. If further trials were conducted using this method on larger sample 
numbers of sheep, uptake of contrast media may have been demonstrated. 
The use of the dorsal sagittal sinus as an injection point for the contrast media was also 
not successful in introducing the media to the venous circulation. Considerable 
extravasation of the contrast medium occurred with significant volumes of media 
draining down the spinal cord in the epidural space. If the experiment were repeated, 
increasing the visualisation of the dorsal sagittal sinus by creating a larger cranial defect 
before attempting cannulation might increase the chances of success. Injection via the 
dorsal sagittal sinus has previously been described in anaesthetised dogs although the 
authors report, that the technique is difficult and associated with potentially serious 
complications (Oliver, 1969). 
Injection of contrast media via the angularis oculi veins has been described in previous 
work (Lee and Griffiths 1972; Chawla et al., 1985). This method was successful in 
achieving good perfusion of the cerebral sinuses with the contrast media. Cannulation 
of the angularis oculi veins was aided by using a cut-down technique over the vein and 
by using digital pressure to straighten the vein and maintain its position under the skin. 
Injection of a single angularis oculi vein produced the anomaly of bilateral filling of the 
cerebral sinuses but only unilateral drainage of media through the vertebral plexus. The 
reason for this observation must relate to the arrangement of vascular communications 
between the angularis oculi veins and the vertebral plexus. 
The prediction that the jugular veins are not the only vessels to transport blood and 
brain tissue emboli from the head after stunning is important for several reasons. 
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Firstly, estimates of the frequency of brain tissue embolism after stunning based on 
jugular venous samples might under-estimate the risk posed by use of these stunning 
methods. Secondly, transport of emboli by the vertebral venous system may cause 
contamination of unforeseen tissues of the carcass. Finally, control measures based on 
limiting carcass contamination via jugular venous drainage may not be adequate for 
preventing contamination of the carcass by alternative drainage routes. 
The results of this study have practical implications for the stunning and slaughter of 
livestock and the potential for carcass contamination with brain tissue material. In 
abattoirs with longer stunning to sticking intervals in which the animal is left in lateral 
recumbency on the ground before shackling, there may be an increased risk for 
dissemination of brain tissue emboli by the vertebral system of veins as compared to 
that of abattoirs that shackle and hoist relatively rapidly. 
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3.4 SEPARATION AND QUANTIFICATION OF BRAIN TISSUE EMBOLI BY 
FILTRATION 
3.4.1 Introduction 
In previous studies, stunning livestock by the use of captive bolt guns has been shown 
to sometimes cause embolism of brain tissue fragments into the jugular vein blood (Anil 
et al., 1999; 2001). Methods have been developed for detection of brain tissue 
fragments in minute aliquots of the blood samples collected. Although these methods 
are sensitive, the non-homogeneous nature of brain tissue fragments in blood does not 
allow measurement of the amount of brain tissue entering the venous circulation after 
stunning. The amount of brain tissue that may comprise an embolus is clearly a critical 
determinant of any risk assessment of CBG stunning and possible prion protein 
contamination of the carcass by way of infected brain tissue fragments carried in the 
blood. A method is needed where by the entire volume of blood that may potentially 
carry brain tissue fragments, is processed to allow separation of all suspended brain 
tissue fragments and blood. The isolated brain tissue may then be weighed to give a 
more accurate estimation of the total brain tissue mass that enters the circulation after 
use of captive bolt gun stunning methods. 
Initial bench studies on the potential of leukocyte filters to remove known amounts of 
brain tissue fragments from blood samples indicated that much of the brain tissue was 
retained in the pre-filter part of the filter system (Mr. A. Shand, Department of 
Neurosciences, Frenchay hospital, Bristol, UK-personal communication). Any material 
within the leukocyte filter itself was very difficult to recover although back flushing 
with buffers was attempted. Based on these studies, we have attempted to remove 
fragments of brain tissue that may be present in jugular blood after captive bolt gun 





" To investigate the use of a leukocyte filtration system for separation from blood 
of brain tissue emboli created by the application of captive bolt gun stunning in 
sheep. 
" To quantify the amount of brain tissue emboli released into the venous 
circulation after captive bolt gun stunning. 
3.4.3 Methodology 
Fifteen adult sheep were used in this study. The animals ranged in weight from 20 to 
60-kg. Animals were anaesthetised and catheters were placed in the jugular veins of 
each animal. Eight sheep were then stunned by cartridge-activated captive bolt gun and 
seven by pneumatically-activated captive bolt gun and jugular blood samples were 
taken. Blood samples were filtered and captured tissue in each pre-filter was weighed 
and sent for analysis using the combined techniques of microscopy and 
immunocytochemistry. The filtrate was analysed by ELISA for the brain protein GFAP. 
3.4.4 Results 
Visible quantities of tissue were recovered in the pre-filters from ten of the fifteen sheep 
sampled. Analysis of these samples using the combined techniques of microscopy and 
immunocytochemistry indicated that six of the ten samples contained some brain tissue 
suggesting that 40% of the animals sampled had brain tissue embolism after stunning 
(frequency of 0.4,95% confidence interval of 0.198 to 0.643). The weights of tissue 
recovered from these confirmed samples ranged from 0.22-g to 2.08-g. The mean 
weight of brain tissue obtained from these six samples was 0.97-g (SD=0.81). Although 
positive samples identified by microscopy were confirmed by staining with two 
antibody stains, only a proportion of the tissue sample recovered in each pre-filter was 
brain tissue (Prof. S. Love, Department of Neuropathology, Frenchay Hospital, Bristol, 
UK-personal communication). The remainder may have comprised fibrin and retained 
blood cells. The filtrate from a single animal sample confirmed the presence of elevated 
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levels of GFAP from a sample in which 1.75-g of tissue was captured in the pre-filter all 
other filtrate samples analysed by ELISA were negative for GFAP. 
Table 3.23 Weight of brain tissue recovered from each filter following filtration of 


















Confirmed positive by 
immunocytochemical 
analysis and ELISA 
Yes (J)/No (x) 
1 2 Cartridge - - - - 
2 6,7,8 Cartridge QSF2 1.49 2.63 1.14 
3 10,11,12 Pneumatic QSF3 1.50 1.65 0.15 x 










5 18,19,20 Cartridge QSF6 1.62 1.84 0.22 
6 22,23,24 Pneumatic QSF1 1.51 3.26 1.75 + GFAP ELISA 
7 26,27,28 Cartridge QSF8 - - - 
8 30,31,32 Pneumatic QSF9 1.64 1.84 0.20 x 
9 34,35,36 Cartridge QSF10 1.64 2.04 0.4 
10 38,39,40 Pneumatic QSF1I 1.49 1.58 0.09 x 
11 41,42,43 Cartridge QSF 12 1.60 1.89 0.29 x 
12 46 Pneumatic QSF 13 1.49 1.49 0.00 - 
13 49,50,51,52 Cartridge QSF 14 1.49 1.83 0.24 
14 53,54,55,56 Pneumatic QSF 15 1.61 1.61 0.00 - 
15 58 Cartridge QSF 16 1.63 1.63 0.00 - 
-no sample 
I=confirmed positive by microscopy and immunocytochemistry 
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Figure 3.30 Weights of tissue obtained in venous blood following captive bolt 
gun stunning of sheep 
  Cartridge-activated 
CBG 
  Pneumatically- 












13579 11 13 15 
Sheep designation 
The results of this experiment indicated that filtration of jugular blood samples after 
stunning may provide a more efficient and cost effective method of separating brain 
tissue from blood than the previously described techniques of buffy coat isolation by 
centrifugation (Anil et al., 1999; Love et al., 2000). The filtration of samples offers 
several advantages over this previously described method. Firstly, filtration of blood 
samples is faster allowing processing of greater volumes of blood from a single animal 
and consequently increasing the chances of identifying positive samples. The technique 
has the additional advantage of allowing quantification of the brain tissue captured in 
the filter. Furthermore, the capture of brain tissue emboli in filters and preservation in 
formalin reduces the labour intensiveness of the analytic methods since such samples 
can be stored indefinitely without adverse effects in quality until further processing. 
This is in contrast to the buffy coat samples that must be processed within twenty-four 
hours of separation. The results from this pilot study indicate a frequency of brain 
tissue in the jugular venous return of 6/15 (40%) that is considerably higher than found 
in the frequency study of brain tissue embolism after stunning. This raises the 
possibility that the method of centrifugation may have under-estimated the frequency of 
embolism in that sample population. The finding of up to 2-g of tissue in the jugular 
blood provides the first experimental estimates of the quantity of brain tissue that may 
enter the venous return at stunning. It is likely that only a fraction of the tissue 
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collected in the filter was of CNS origin (Prof. Seth Love, Department of 
Neurosciences, Frenchay hospital, Bristol, UK), nevertheless, the estimate does provide 
an upper limit of the weight of brain tissue in the captured blood. Unfortunately, the 
technique of microscopy and immunocytochemistry used to analyse the tissue captured 
in the filter, does not allow accurate estimates of the relative proportions of tissue 
present in the prepared wax sections. This additional facility may have yielded more 
accurate data on the weights of brain tissue captured in the pre-filters. 
Further investigation of the method should be conducted on jugular and aortic blood 
from cattle and sheep to enable more accurate estimation of the public health risk posed 
by the use of captive bolt gun stunning of livestock. 
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3.5 POLYMERASE CHAIN REACTION FOR DETECTION OF MALE DNA IN 
TISSUES OF FEMALE ORIGIN 
3.5.1 Introduction 
This series of experiments investigates the application to ovine tissue, a real-time PCR 
originally developed for use with bovine tissues. Secondly, this experiment attempts to 
use the assay to determine the extent of dissemination of brain tissue fragments within 
the ovine carcass after CBG stunning. Furthermore, the method offers potential for 
estimation of the amount of carcass contamination with brain tissue that occurs 
following release of brain tissue fragments into the circulation after the use of captive 
bolt gun stunning methods. 
3.5.2 Aims 
" To validate a real-time PCR assay previously developed for use with bovine 
DNA using ovine DNA. 
" To use the assay to investigate contamination of the ovine carcass with brain 
tissue emboli following the application of captive bolt gun stunning. 
3.5.3 Methodology 
3.5.3.1 Amplification of male and female bovine tissue samples 
Initial trials with the real-time PCR were conducted using bovine tissues supplied by 
Dr. C. Helps, (University of Bristol, UK) in order to gain familiarity with the technique. 
3.5.3.2 Amplification of male and female ovine tissue samples 
Although this real-time PCR was previously validated using bovine DNA, the 
amplification of ovine DNA using the same primers and probes has not previously been 
attempted. Comparison of the specific gene sequences obtained from Genbank 
indicated that the primer sequences in sheep and cattle were identical suggesting that the 
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assay should also work using ovine DNA. A difference of one base was observed in the 
probe sequence. The objective of this experiment was to examine the application of the 
real-time PCR assay to amplify ovine SRY chromosomal DNA and ovine 28S rDNA. 
3.5.3.3 Efficiency of amplification of male ovine DNA extracted from brain tissue 
The efficiency of amplification of this real-time PCR assay was determined from the 
slope of the regression lines generated after real-time amplification of ten-fold serial 
dilutions of the ovine male DNA. The computer software (Bio-rad) using the equation 
100 x 10 (-1/slope) -1 calculated the percentage efficiency of amplification. 
3.5.3.4 Dilutions of male ovine tissue in female ovine tissue 
Known amounts of brain tissue from a male animal were homogenised and combined 
with weighed quantities of homogenised tissue from a female animal. The first dilution 
contained 10-mg of male brain tissue in 2000-g of female brain tissue (0.5%) (U2) 
while the second contained 50-mg of male brain tissue in 2000-g of female brain tissue 
(2.5%) (U3). Samples of these prepared dilutions along with positive and negative 
controls were then analysed by real-time PCR following extraction of DNA from each 
sample. 
3.5.3.5 Detection of male ovine brain tissue in organs of a female ovine carcass 
In this study male brain tissue suspensions were injected into the jugular vein blood of a 
female animal while simultaneously stunning using a penetrating captive bolt gun. 
After exsanguination and slaughter, specified organs were removed from the carcass 





3.5.4.1 Amplification of male and female bovine tissue samples 
The Y chromosome DNA was detected at a threshold value similar to that obtained in 
previous trials of the assay (Dr. C. R. Helps, University of Bristol, personal 
communication). Both male and female DNA samples produced similar threshold 
values of 28S rDNA. 
Table 3.24 SRY probe threshold values for bovine male DNA 
Well Ct Value Template 
D4 23.5* SRY 
D5 23.7* SRY 
D6 0.00 Female 28S rDNA 
D7 0.00 Female 28S rDNA 
D8 0.00 Water (-control) 
D9 0.00 Water (-control) 
Figure 3.31 SRY probe threshold values of bovine DNA 
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D4 19.0* Male 28S rDNA 
D5 19.1 * Male 28S rDNA 
D6 19.0* Female 28S rDNA 
D7 18.9* Female 28S rDNA 
D8 35.6* Water (-control) 
D9 36.5* Water (-control) 
Figure 3.32 28S probe threshold values of bovine DNA and control 
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3.5.4.2 Amplification of male and female ovine tissue samples 
The amplification of the ovine SRY DNA and the 28S rDNA showed similar 
amplification to that of the bovine control sample DNA. 
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Table 3.26 SRY probe threshold values for ovine male DNA 
Well Ct Template 
C3 25.6* Male ovine 
C4 25.4* Male ovine 
C5 0.00 Female ovine 
C6 0.00 Female ovine 
C7 0.00 water 
C8 0.00 water 
C9 23.6* Male bovine 
C10 23.6* Male bovine 
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Table 3.27 28S probe threshold values for ovine male and female DNA 
Well Ct Template 
C3 21.5* Male ovine 
C4 21.6* Male ovine 
C5 24.6* Female ovine 
C6 24.4* Female ovine 
C7 37.1* water 
C8 35.8* water 
C9 19.6* Male bovine 
CIO 19.5* Male bovine 
Figure 3.34 28S probe threshold values of ovine DNA and control samples 
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3.5.4.3 Efficiency of amplification of male ovine DNA extracted from brain tissue 
Serial 10-fold dilutions of male sheep DNA using FAM-probe showed an efficiency of 
103.1% with a slope of -3.251 (Figure 3.34) and demonstrated linearity over a 10.3 















Serial 10-fold dilutions of male sheep DNA using the Texas-red probe showed an 
efficiency of 103.9% with a slope of -2.575 (Figure 3.36) and demonstrated linearity 
over a 10-4 range of starting templates. 
The detection limit of the assay for male brain tissue was 1001tg/ml [20mg (starting 
quantity of brain tissue)/40,000 (dilution factor)] or 0.05%. 
Table 3.28 SRY probe threshold values for dilutions of ovine male DNA 
Well Ct value template 
C3 24.4* Stock Male DNA 
C4 28.1 * 10'1 
C5 31.9* 10"2 
C6 34.2* 10-1 
C7 0.00 10-4 
C8 0.00 10'1 
C9 0.00 10-1 
D8 0.00 water 
D9 0.00 water 
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Figure 3.36 Standard curve of dilutions of ovine male DNA generated by plotting the 
Ct values of the SRY probe against the logarithm of the initial copy numbers 
Correlation Coefffdent: 0.993 Slope: -3.251 Intercept: 15.452 Y- -3.251 X+ 15.452 0 Unknowns 
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Table 3.29 28S probe threshold values for dilutions of ovine male DNA 
Well Ct value template 
C3 21.5* Stock Male DNA 
C4 25.6* 10"' 
C5 29.1 * 10"2 
C6 32.2* 10"3 
C7 35.3* 10"4 
C8 36* 10"5 
C9 36.5 10 6 
D8 36.1 * water 
D9 36.8* water 
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Figure 3.38 Standard curve of dilutions of ovine male DNA generated by plotting the 
Ct values of the 28S probe against the logarithm of the initial copy numbers 
Correlation Coefficient: 0.999 Slope: -3.232 intercept: 10.376 Y- -3.232 X+ 10.376 
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3.5.4.4 Dilutions of male ovine tissue in female ovine tissue 
SRY DNA was detected in both samples containing 0.5% and 2.5% male DNA 
equivalent to 5 mg and 25mg of male brain tissue per gram of female brain tissue. Both 
negative and positive control samples produced expected threshold results. 
Table 3.30 SRY probe threshold values for ovine male DNA contaminant 
Well Ct Template 
C3 0.00 28s DNA (U I) 
SRY +28s DNA 
C4 35.1* 
(U2) 
SRY +28s DNA 
C5 32.8* 
(U3) 
C6 26.7* SRY DNA 
C7 26.7* SRY DNA 
C8 0.00 water 
C9 0.00 water 
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Table 3.31 28S probe threshold values for ovine male DNA contaminant and female 
DNA 
Well Ct Template 
C3 22.9* 28s DNA (U I) 
SRY +28s DNA 
C4 21.9* 
(U2) 
SRY +28s DNA 
C5 22.2* 
(U3) 
C6 23.1 * SRY DNA 
C7 23.2* SRY DNA 
C8 35.6* water 
C9 33.4* water 
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3.5.4.5 Detection of male ovine brain tissue in organs of a female ovine carcass 
SRY-chromosome DNA was detected only in the positive control samples. The 28S 
rDNA was identified in all samples except for the negative controls. 
Table 3.32 SRY probe threshold values for the selected organ samples 
Well Ct Template 
D4 0.00 Spleen 
D5 0.00 Spleen 
D6 0.00 Liver 
D7 0.00 Liver 
D8 0.00 Kidney 
D9 0.00 Kidney 
E6 0.00 water 
E7 0.00 water 
E8 25.9* Male ovine 
E9 25.7* Male ovine 
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Figure 3.41 SRY probe threshold values of DNA extracted from organ samples 
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Table 3.33 28S probe threshold values for the selected organ samples 
Well Ct 
D4 14.2* 
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3.5.5 Discussion 
The real-time PCR assay was demonstrated to amplify ovine DNA at similar rates to 
that of bovine DNA in the samples analysed from each species. Furthermore, ovine 
SRY DNA from a male animal was demonstrated to be detectable in ovine tissues of 
female origin that were themselves identified by the use of the 28S rDNA present in 
both male and female tissues. The dilution of ovine male DNA demonstrated a 
detection limit of 0.05% or equivalent to 100-µg male brain tissue/ml of buffer. A 
subsequent experiment using artificially contaminated organs detected SRY DNA in 
samples containing the lowest prepared concentration of 0.5% male brain tissue in 
female tissues. The failure to detect the SRY DNA in the organ samples examined after 
captive bolt gun stunning and injection of brain tissue may indicate an absence of 
contamination above the limit of detection of the assay. 
In some cases, 28S DNA was detected at low levels in the negative control samples. 
The explanation for this anomaly arises from use of batches of Taq polymerase in which 
contamination with 28S DNA is present originating from the strain of yeast from which 
the enzyme was obtained. The low levels present have previously been observed at 
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3.6 INVESTIGATION OF PROTHROMBIN TIME ESTIMATION OF PLASMA AS AN 
INDIRECT TEST FOR BRAIN TISSUE EMBOLI IN BLOOD 
3.6.1 Introduction 
The development of coagulation abnormalities following severe head trauma has been 
extensively described (Kuo, Chou & Chio, 2004). Brain tissue contains the highest 
concentration of thromboplastin of any tissue in the body, and it is the release of this 
protein that activates the extrinsic pathway of the clotting cascade. Activation of the 
cascade results in the exhaustion of clotting factors present in the blood and would be 
expected to cause prolongation of prothrombin time measured in plasma obtained from 
such samples. 
In this study, clotting times have been determined for plasma samples obtained from 
cattle and sheep within one minute of stunning, using determination of prothrombin 
time (PT time) as an accepted measure of clotting time. 
While all animals suffered severe head trauma, only a small proportion were found to 
have brain tissue emboli in the venous circulation following analysis of samples by two 
methods of brain tissue detection (See 3.1.3). Prothrombin time values were 
investigated to determine the diagnostic value of this tool for predicting the presence of 
brain tissue emboli in blood from which plasma was obtained. 
Currently, brain tissue fragments in venous blood samples, are detected using an ELISA 
for GFAP or by a complementary technique of microscopy and immunocytochemistry. 
These techniques although sensitive and specific are labour intensive, and may over- 
look some positive samples since each test can only examine a small sample aliquot of 
the collected blood. The use of PT time analysis would offer a quick and cost effective 
method for separating possible positive samples. Such samples could then be further 




" To investigate the use of prothrombin time estimation as a tool for identifying 
samples from sheep and cattle in which embolism of brain tissue into the blood 
occurred following stunning by captive bolt gun. 
3.6.3 Methodology 
3.6.3.1 Estimation of prothrombin time of cattle plasma samples 
Plasma was selected from twenty four cattle that were negative for brain tissue emboli 
and from six cattle in which brain tissue fragments or proteins had previously been 
detected by the combined technique of microscopy and immunocytochemistry or by 
ELISA. Seven plasma samples including a pre-stun and six post-stunning samples were 
available for analysis from each animal selected for inclusion in the study. 
Table 3.34 Number of cattle selected in each group for analysis of plasma 
obtained pre and post-stunning 
Type of CBG and previous animal Penetrating Non-penetrating 
designation based on analysis for 
captive bolt gun captive bolt gun 
brain tissue emboli 
Positive 4 2 
Negative 13 11 
3.6.3.2 Estimation of prothrombin time of sheep plasma samples 
Plasma from eighty-two negative and from nineteen positive animals for brain tissue 
fragments or elevated levels of GFAP was included in the experiment. Seven plasma 
samples including a pre-stun and six post-stunning samples were available for analysis 
from each animal selected for inclusion in the study. 
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Table 3.35 Number of sheep selected in each group for analysis of plasma obtained 
pre and post-stunning 
Type of CBG and previous animal Cartridge- Pneumatically- 
designation based on analysis for activated captive activated captive bolt 
brain tissue emboli bolt gun gun 
Positive 9 10 
Negative 38 45 
3.6.4 Results 
3.6.4.1 Assay performance 
Intra assay and inter-assay coefficients of variation of :5 5% and <_ 10% were calculated. 
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3.6.4.2 Prothrombin time of cattle plasma samples 
Table 3.36 Prothrombin times of plasma from cattle after use of non-penetrating and 
penetrating captive bolt guns that were found to be negative for brain tissue emboli 
Plasma from cattle stunned by non-penetrating captive bolt gun 
sample Prothrombin times (s) 
Pre-Stun 1 2 3 4 5 6 Mean Post-stun 
120 26 23 23 29 24 24 23 24 
154 21 22 22 21 23 21 21 22 
178 25 20 16 19 18 18 16 18 
180 28 23 25 24 24 24 25 24 
182 27 27 29 27 28 28 31 28 
184 24 23 24 25 22 28 28 25 
187 34 25 27 26 26 32 28 27 
189 42 31 32 32 34 34 29 32 
191 28 39 70 70 70 70 14 56 
193 27 25 24 26 28 25 23 25 
194 25 23 23 24 23 24 23 23 
mean 27.9 27.6 
Variance 32 101.06 
Plasma from cattle stunned by penetrating captive bolt gun 
sample Prothrombin times (s) 
Pre Stun 1 2 3 4 5 6 Mean Post stun 
115 25.1 26 29 29 28 30 31 29 
157 25 23 24 23 23 24 24 24 
161 27 24 27 27 27 25 25 26 
173 28 27 27 27 28 27 27 27 
179 17 14 14 13 13 13 12 13 
181 14 13 12 14 12 12 24 15 
183 20 23 23 23 17 24 22 22 
185 38 30 34 35 29 32 28 31 
186 34 33 33 35 33 31 35 33 
177 
188 30 26 28 34 28 31 29 
190 28 24 23 24 28 25 24 25 
192 26 25 25 26 25 25 25 25 
199 22 21 24 23 24 24 22 23 
mean 25.7 24.7 
variance 42.5 33 
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Table 3.37 Prothrombin times of plasma from cattle after use of non-penetrating and 
penetrating captive bolt guns that were found to be positive for brain tissue emboli 
Plasma from cattle stunned by non-penetrating captive bolt gun 
88 23 36 35 28 30 26 26 30.1 
137 23 26 24 29 23 24 27 25.5 
mean 23 27.8 
Variance 0 10.8 
Plasma from cattle stunned by penetrating captive bolt gun 
65 25 33 34 32 43 35.5 
67 29 31 35 35 43 30 34 34.6 
129 30 30 39 20 32 30.25 
133 27 34 31 31 30 30 25 30.1 
mean 27.7 32.6 
variance 5 8 
3.6.4.2.1 Comparison ofprothrombin times in pre-stun and post-stun samples 
A significant difference was observed between the pre and post-stunning sample means 
from samples in which brain tissue emboli was previously identified (p=0.025). 
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Table 3.38 Pre and post-stun sample prothrombin time mean values from positive 
bovine samples 
Pre-stunning Post-stunning F value Significance 
samples samples 
Mean 25.38 33.03 7.62 p50.05 
prothrombin 
time 
For samples negative for brain tissue emboli no significant difference was observed 
between pre and post PT times (p=0.87) 
Table 3.39 Pre and post-stun sample prothrombin time mean values from negative 
samples 
Pre-stunning Post-stunning F Significance 
samples samples value 
Mean prothrombin 26.80 26.48 0.03 ns 
time 
ns-not signmcan 
3.6.4.2.2 Influence of captive bolt gun upon prothrombin time 
A general linear model with gun type and time as factors for samples from cattle 
positive or negative for brain tissue emboli indicated there was no significant difference 
between the type of captive bolt gun used (p=0.49 and 0.18 respectively). 
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Table 3.40 Prothrombin time of plasma from cattle positive for brain tissue emboli after 
captive bolt gun stunning 
Non-penetrating Penetrating. F Significance. 
CBG CBG value 
Mean prothrombin 28.21 30.20 0.52 ns 
time 
ns=not signitican 
Table 3.41 Prothrombin time of plasmas from cattle negative for brain tissue emboli 
after captive bolt gun stunning 
Non-penetrating Penetrating. F Significance. 
CBG CBG value 
Mean prothrombin 28.21 30.20 0.52 ns 
time 
ns=not signitican 
344.2.3 The presence of brain tissue emboli and prothrombin time 
No significant difference was found between the post-stunning prothrombin sample 
times from cattle positive or negative for brain tissue emboli. (t-test, p=0.068) 
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3.6.4.3 Prothrombin times of sheep plasma samples 
Table 3.42 Prothrombin times of plasma from sheep after use of captive bolt gun 
stunning that were found to be negative for brain tissue emboli 
Sample 




1st 2nd 3rd 4th 5th 6th 
Average post- 
stunning 
1 59 70 70 70 70 70 70 70 
8 30 35 58 70 60 70 70 60.5 
15 27 70 70 36 70 36 56.4 
22 26 63 37 26 65 37 39 44.5 
29 26 36 65 70 35 38 30 45.6 
36 28 70 70 70 70 70 70 70 
43 26 70 70 70 70 70 70 70 
50 28 32 56 31 70 70 70 54.8 
57 45 70 70 70 70 70 70 70 
64 22 12 70 70 70 70 70 60.3 
78 28 30 63 70 70 70 70 62.1 
85 26 70 70 70 70 70 
92 30 70 70 70 70 70 70 70 
99 30 13 70 70 70 70 70 60.5 
498 29 29 38 40 44 62 70 47.1 
505 30 21 36 56 28 63 41 40.8 
533 30 21 36 56 28 63 41 40.8 
547 27 70 43 33 30 25 28 38.1 
582 28 70 70 70 70 70 70 70 
589 70 33 39 70 70 70 70 58.6 
603 70 28 70 70 70 70 70 63 
610 28 70 70 70 70 70 70 70 
617 26 25 47 29 29 29 70 38.1 
631 26 70 70 70 35 36 41 53.6 
645 31 35 70 70 70 70 70 64.1 
659 33 70 70 70 70 70 70 70 
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673 26 70 70 70 70 70 70 70 
680 31 67 70 70 70 70 70 69.5 
694 31 70 70 70 70 70 70 70 
701 28 70 70 70 70 70 70 70 
708 33 31 37 30 29 34 36 32.8 
715 30 70 70 70 70 70 70 70 
729 26 49 53 70 70 70 70 63.6 
743 30 30 46 70 70 70 57.2 
750 29 53 70 70 70 70 70 67.1 
757 25 33 43 57 62 70 70 55.8 
764 70 70 70 70 70 70 70 70 
778 26 70 70 70 70 70 70 70 
785 29 70 70 70 70 70 70 70 
813 43 41 70 70 70 70 70 65.1 
827 32 70 70 70 70 70 34 64 
834 33 70 70 70 70 70 70 70 
848 32 63 70 70 70 70 68.6 
855 29 70 70 70 70 70 70 70 
862 34 36 70 70 70 70 70 64.3 
869 32 70 70 70 61 56 62 64.8 
876 29 70 70 70 70 70 
883 39 70 70 70 70 70 70 70 
967 37 70 70 70 70 70 70 70 
974 26 70 70 70 70 70 70 70 
1016 70 70 70 70 70 70 70 70 
1037 70 70 70 70 70 70 70 70 
1044 70 70 70 70 70 70 54 67.3 
1065 24 31 29 31 28 33 33 30.8 
1072 24 70 70 67 55 48 41 58.5 
1093 28 70 70 70 70 70 70 70 
1107 20 70 70 70 70 70 48 66.3 
1128 27 70 70 70 70 70 70 70 
1142 38 70 70 70 70 70 70 70 
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1149 31 70 70 70 70 70 70 70 
1156 25 70 70 70 70 70 70 70 
1184 31 70 70 70 70 70 70 
1191 29 70 70 70 70 70 70 70 
1205 70 70 70 70 70 70 70 70 
1219 44 70 70 70 70 70 70 70 
1226 32 70 70 70 70 70 70 70 
1289 24 70 70 70 70 70 70 70 
1296 10 70 70 70 70 70 70 70 
1303 20 70 70 70 70 54 41 70 
1310 15 70 24 26 30 28 37 62.5 
1317 23 70 29 43 70 70 70 35.8 
1324 19 41 70 43 29 70 26 58.6 
1331 28 70 70 26 33 70 28 46.5 
1338 28 70 70 70 70 70 70 49.5 
1352 27 70 70 70 70 70 70 70 
1359 26 70 70 70 70 70 70 70 
1366 25 70 70 70 70 70 70 70 
1373 26 70 70 70 70 70 70 70 
1387 23 70 70 70 70 70 70 70 
1394 24 70 70 70 70 
1401 26 70 70 70 70 70 70 70 
1408 24 70 70 70 70 70 70 70 
variance 174.6 110.3 
mean 32.1 63.2 
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Table 3.43 Prothrombin time of plasmas from sheep positive for brain tissue emboli 
after captive bolt gun stunning 







Post-stun prothrombin times (upper 
limit of 70-s) 
- - number time 1 T 2 3 4 4 6 Mean 
74 512 27 70 43 33 30 25 28 38.17 
75 519 28 70 70 70 70 70 70 70 
111 771 39 38 70 70 70 70 70 64.67 
114 792 30 70 70 70 70 70 70 70 
130 904 25 49 66 70 70 70 70 65.83 
132 918 27 70 70 70 70 70 70 70 
155 1079 31 70 70 70 70 70 70 70 
161 1121 29 70 70 70 70 70 70 70 
169 1177 31 70 70 70 70 70 70 70 
mean 29.66 65.41 
variance 16.25 108.7 







Post-stun prothrombin times (upper 
limit of 70-s) 
no. time 1 2 3 4 4 6 Mean 
115 799 36 70 70 70 70 50 70 66.67 
118 820 24 27 33 70 70 70 70 56.67 
121 841 30 70 70 70 70 70 70 70 
129 897 31 57 70 70 70 58 45 61.67 
137 953 29 37 70 70 70 70 70 64.5 
143 995 32 70 49 70 70 70 70 66.5 
163 1135 27 70 70 66 70 70 70 69.33 
174 1212 35 70 70 70 70 70 70 70 
178 1240 31 70 70 70 70 70 70 70 
203 1415 25 70 70 70 70 70 70 70 
mean 30 66.5337 
variance 15.33 20.12 
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3.6.4.3.1 Comparison ofprothrombin times in pre-stun and post-stun samples 
A significant difference was observed between the pre and post-stunning sample means 
from samples both in which brain tissue emboli was previously identified and from 
samples that were negative for brain tissue emboli (p<0.001). 
Table 3.44 Pre and post-stun sample prothrombin time mean values from positive 
ovine samples 
Pre-stunning Post-stunning F Significance 
samples samples value 
Mean prothrombin 29.83 65.97 319.04 p<0.001 
time 
Table 3.45 Pre and post-stun sample prothrombin time mean values from negative 
ovine samples 
Pre-stunning Post-stunning t value Significance 
samples samples 
Mean 32.2 63.3 18.17 p: 50.001 
prothrombin 
time 
3.6.4.3.2 Influence of captive bolt gun upon prothrombin time 
A general linear model with gun type and time as factors indicated there was no 
significant difference between type of captive bolt gun (p=0.721). 
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Table 3.46 Prothrombin time of plasmas from sheep positive for brain tissue emboli 
after captive bolt gun stunning 
Cartridge- Pneumatically- F Significance 
activated CBG activated CBG value 
Mean 47.54 48.27 0.13 ns 
prothrombin time 
IflllI4 
3.6.4.3.3 The presence of brain tissue emboli and prothrombin time 
No significant difference was observed between post-stunning prothrombin times from 
sheep samples positive or negative for the presence of brain tissue emboli (t=--1.17) 
3.6.5 Discussion 
In this study, our aim was to investigate the activation of the clotting cascade in the 
blood of cattle and sheep after the application of captive bolt gun stunning. By 
determination of clotting times in plasma samples taken before and after stunning, the 
possibility of identifying animals in which brain tissue embolisation into the circulation 
has occurred, was explored. The use of prothrombin time to estimate clotting time was 
found to be an economical and readily available screening test for coagulation that gave 
consistent and reliable results in the bench tests that were conducted. 
The results of the study indicate that in the sheep plasma assayed, PT times were 
generally prolonged in all post-stunning samples irrespective of whether brain tissue 
had been identified in the sample (See 3.1.3). However, in the cattle plasma assayed, a 
significant difference was observed between pre-stun and post-stun samples only from 
cattle previously designated as positive for brain tissue emboli. No significant 
difference was observed between the calculated means of pre and post-stun samples 
from cattle in which brain tissue material was not detected. These observations indicate 
that measurement of PT time in cattle plasma might be useful for identification of cattle 
in which brain tissue embolisation had occurred following stunning. In contrast, the 
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results from assay of sheep plasma suggest that determination of PT time would not be 
helpful in similar investigations. 
The uniformly prolonged PT times observed following assay of sheep plasma may be 
the result of tissue factor release from tissues traumatised by the passage of the bolt 
after stunning. While similar abnormalities in clotting time have been documented in 
human studies of clotting following head trauma (van der Sande, et al., 1978), the 
activation of the clotting cascade within ten seconds of head trauma demonstrated in 
these experiments has not been recorded. The prolonged period between injury and 
blood sampling in studies that rely on collection of plasma from victims of accidental 
head trauma, may account for the lack of data on this observation. It is possible that 
these findings of rapid activation of the clotting cascade may have application to 
research areas separate from stunning and slaughter of livestock. The activation of the 
clotting cascade is known to be an important factor in the prognosis of human victims of 
head trauma (Simpson, Speed & Blumbergs, 199 1). 
Previous estimates of coagulation abnormalities following head trauma of humans have 
ranged from 3% to 72 % (Kuo, Chou & Chio, 2004; Selladurai et al., 1997). In this 
study elevated coagulation scores beyond sixty seconds in length were observed in 80% 
of post-stunning samples taken from sheep. Only 3% of cattle samples taken post- 
stunning demonstrated PT times beyond sixty seconds. The wide range of PT times 
observed in these and other investigations, suggests the influence of several factors 
including, the method of sampling, processing and assay of plasma, the species studied 
and the type and severity of the head injury. 
While it is likely that brain tissue emboli in the blood may release large amounts of the 
clotting activator thromboplastin, the activation of the cascade in sheep appears to 
happen regardless of the presence or absence of brain tissue fragments in the blood. 
Any additional activation of the extrinsic clotting pathway by release of clotting 
activators from brain tissue fragments may be concealed by the larger effect of tissue 
factor release from injured tissues. A consistent effect of head trauma upon prolonged 
clotting time is less apparent in the cattle samples where a difference between pre and 
post PT times is detected only from the samples previously designated as positive for 
brain tissue embolism. This fording may be due to the additive effect on PT time of 
thromboplastin released from brain tissue fragments into the blood. Comparison of the 
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mean post-stunning PT times demonstrates a significant difference between bovine 
samples negative or positive for brain tissue embolism. This suggests that in cattle, 
measurement of PT time in plasma may be useful for identifying samples containing 
brain tissue fragments. 
The observed difference in PT time between sheep and cattle plasma samples may relate 
to the greater volume of blood in cattle into which thromboplastin is released from 
similar levels of tissue damage. This dilution effect may prevent PT times from being 
prolonged in cattle samples unless brain tissue fragments are also present to prolong PT 
times even further. The prolonged prothrombin times observed in this study were 
detected in a small sample population of animals that were identified as positive for 
brain tissue embolism. A larger population of positive animal samples would increase 
the confidence in these results. Furthermore, the analysis of plasma by other measures 
of clotting activity including D-dimer levels might reveal additional correlations 
between brain tissue emboli and coagulopathy. 
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CHAPTER 4 DISCUSSION AND CONCLUSIONS 
4.0 INTRODUCTION 
Since brain tissue fragments were first reported in the pulmonary arteries of a cow at 
post-mortem following the use of an air-injection pneumatically-activated CBG 
(Garland, Bauer & Bailey, 1996), a number of research projects have been undertaken 
to substantiate these findings. In addition, investigations have examined the risks 
associated with stunning and slaughter and carcass contamination with brain tissues 
(Anil et al., 1999,2001; 2002; Schmidt et al., 1999). These studies made significant 
contributions to the body of knowledge on this subject and led to recommendations and 
measures being taken on stunning and slaughter of livestock by a European Scientific 
Steering Committee (SSC) (EC, 2002). In a report, the SSC concluded that the practice 
of pithing after penetrating CBG stunning and the use of penetrating air-injection CBGs 
would carry unacceptably high risks of causing CNS tissue embolism (EC, 2002). The 
use of these stunning methods was later banned by revision of EU legislation (EC 
Regulation 999/2001). Based on the research data available at the time the Spongiform 
Encephalopathy Advisory Committee (SEAC) in the UK (SEAC, 1998) recommended 
that further research on stunning and carcass contamination with CNS tissues should be 
undertaken. 
In this series of experiments a number of important questions have been explored and in 
some cases answered. In addition, the work has indicated gaps that remain in research 
on this subject and potential directions and methods that might be employed in future 
experimental work. The main questions that this work has attempted to address include: 
" Which stunning methods currently in use/or available in the UK carry a risk of 
brain tissue embolism? 
" What is the frequency of brain tissue entry into the venous circulation after 
stunning by captive bolt gun in cattle and sheep? 
" Can brain tissue fragments and proteins disrupted by captive bolt gun stunning 
of cattle and sheep penetrate the pulmonary capillary filter and enter the arterial 
circulation within the time-frame of commercial stunning and slaughter? 




" What are the potential venous drainage routes of emboli from the head following 
the use of captive bolt gun stunning? 




4.1. DETECTION OF BRAIN TISSUE CONTAMINATION IN BLOOD AND OTHER TISSUES 
USING AN ELISA AND A COMBINATION OF MICROSCOPY AND 
IMMUNOCYTOCHEMISTRY 
4.1.1 JUGULAR VEIN BLOOD SAMPLING FOLLOWING STUNNING 
This study has confirmed the potential of captive bolt gun stunning devices currently in 
use in the UK to cause entry of brain tissue fragments into the venous circulation after 
stunning. The public health risk associated with small levels of brain tissue or brain 
protein contamination of the venous blood is still unknown. In the absence of reliable 
infectious dose data applicable to humans, it must be assumed that even minute 
quantities of BSE infected tissue in meat pose an unacceptable risk to the consumer. 
The results of experiments to determine the frequency of brain tissue embolism 
following stunning in both cattle and sheep allows more accurate estimation of the risk 
of carcass contamination and can be used to influence policies on the continued use of 
these mechanical stunning methods in countries in which a theoretical risk of BSE 
transmission to humans exists. 
Previous studies examining brain tissue embolisation after head trauma have suggested 
rupture of the dorsal sagittal sinus as the most likely point of entry of brain tissue 
(Miyaishi et al., 1994), while other reports indicate that the rupture of blood vessels in 
the cranium may not be necessary for brain tissue proteins to enter the circulation 
(Mussack et at., 2003). It seems likely that different factors are involved in the entry of 
brain tissue fragments to the circulation, in contrast to brain tissue proteins that may 
enter the venous circulation following relatively minor disruption to the blood brain 
barrier. It is possible that any stunning method will run the risk of causing entry of 
small brain proteins including the prion protein into the venous circulation, as minor 
head trauma including that which might happen as the stunned animal strikes its head 
on the stunning box floor, appears unavoidable. However, by limiting the potential for 
more significant levels of contamination by way of brain tissue fragments in the blood, 
the risk of dangerous levels of TSE infectivity reaching the consumer may be reduced. 
The presence of two mechanisms of entry of brain proteins and of brain tissue 
fragments into the venous return offers an explanation for the disparity in the findings 
of the two analytic methods employed in these studies. The ELISA results of some 
positive cases may detect GFAP that has leaked across a damaged blood brain barrier 
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but in which insufficient trauma has occurred to blood vessels to allow entry of 
fragments of brain tissue detectable by microscopy and immunocytochemistry. 
Although the latter technique uses a combination of analytic methods to identify 
positive samples, any brain tissue fragments in a sample must be large enough to first be 
tentatively identified by microscopy before being positively identified by antibody 
staining. 
A previous study of GFAP blood concentrations of brain proteins conducted using 
samples taken from human subjects soon after head trauma found lower levels of GFAP 
than S-100ß proteins. The authors suggested that enzymatic degradation of GFAP in 
blood might offer an explanation for this observation (Missler et al., 1999). If 
significant degradation of GFAP does occur in blood, it may offer an additional 
explanation for the absence of elevated levels of GFAP in some samples that were 
found to contain brain tissue fragments. 
Examination of the results of the frequency of brain tissue embolism study in cattle 
demonstrates a significant difference in the numbers of individual samples identified as 
positive by either CBG stunning method, although the overall numbers of positive 
animals found in each group is not significantly different. These results suggest that the 
penetrating CBG is likely to produce more positive samples than observed in samples 
obtained from cattle after use of the non-penetrating CBG. This fording is consistent 
with earlier predictions outlined in a report by the European Commission (EC, 2002) 
that the penetrating CBG would be more likely to cause brain tissue emboli to enter the 
circulation than the less invasive non-penetrating gun. However, the discovery that the 
non-penetrating captive bolt gun can also induce brain tissue embolism is an important 
deviation from the risks outlined in the report by the EC in which the risk of brain tissue 
embolism after non-penetrating CBG stunning is described as negligible (EC, 2002). 
The results of the parallel study in sheep produced significantly higher frequencies than 
those observed in the cattle study and seem to suggest a strong case for reviewing the 
use of these stunning methods in this species especially in light of the availability of an 
effective alternative method by way of electrical stunning. Comparison of the number 
of positive sheep identified in each CBG group did not indicate a significant difference 
between each group while examination of the individual samples identified as positive 
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in each group also did not suggest a difference between the numbers of positive samples 
and the type of CBG used. 
A comparison of the frequency of brain tissue embolism after stunning in cattle and in 
sheep suggests possible mechanisms of entry of brain tissue fragments into the venous 
circulation. The frequency of entry of brain tissue fragments into the venous circulation 
would appear to be between 5 and 10 times greater in sheep than in cattle despite 
reported findings of similar brain tissue and vessel damage in both species after captive 
bolt gun stunning (Farag, 2002; Biggins, 2003). These findings may indicate that brain 
tissue damage and haemorrhage are secondary factors to a more important determining 
variable that may be intra-cranial pressure. An investigation of the effect of reducing 
intra-cranial pressure at CBG stunning might provide solutions to effective stunning 
while reducing the risk of brain tissue emboli. 
The investigation of brain tissue emboli and electrical stunning although not 
conclusively excluding the possibility of entry of brain tissue fragments into the 
circulation suggests this would be a rare event if it occurred at all. Further 
investigations on a larger sample group of cattle in which both pre and post-stunning 
samples were taken and analysed might resolve the anomaly of the single positive 
sample detected in this study. It is probable that the elevated levels of GFAP detected 
in the single positive sample represented the outcome of gliosis with increased 
production and release of GFAP into the circulation, a fording that is previously 
recorded in the literature (Uyeda, Eng & Bignami, 1972; Eng, Ghirnikar & Lee, 2000). 
Although the absence of a pre-stun sample in this experiment prevents confirmation of 
this explanation for the result, some precedent is set by a previous sample tested as part 
of the brain tissue embolism study in sheep in which all seven samples including that of 
the pre-stun sample demonstrated elevated levels of GFAP. These samples were 
accordingly designated as negative for the presence of brain tissue emboli despite the 
relatively high concentrations of GFAP in the samples detected by ELISA. 
The results of the parallel studies in cattle and sheep indicate the need for revision of the 
ranking of stunning methods and potential for causing brain tissue emboli previously 
proposed by the EU Scientific Steering Committee (EC, 2002). Based on the combined 
results from both investigations a revised ranking of stunning methods in descending 
order of reducing risk is as follows. 
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" Air-injection pneumatically activated CBG 
" Cartridge-activated penetrating CBG 
" Pneumatically-activated penetrating CBG 
" Cartridge-activated non-penetrating CBG 
" Electrical stunning (absent or negligible risk) 
This ranking based solely on the frequency results obtained in each study ignores 
several relevant factors including, the species in which the stunning methods were used 
and evaluated, throughput and local method of application and expertise of 
slaughtermen. With the exception of electrical stunning all of the listed stunning 
methods have been demonstrated to potentially cause brain tissue emboli in some 
animals following the application of stunning. An accurate estimation of the relative 
safety of each method as regards brain tissue contamination of the carcass would require 
further study of each stunning method in each relevant species. 
The public health concerns of the use of each of these stunning methods were 
considered in a recent report by the European Food Safety Authority (EFSA, 2004). In 
this report, penetrating captive bolt stunning is described as carrying a risk of 
haematogenous contamination of tissues as well as the potential to cause air-borne 
contamination of the operator, environment and hide of the stunned animal. Non- 
penetrating CBG stunning was reported to carry a risk of embolism of brain tissue 
material while electrical stunning was described as having no public health concerns for 
the spread of BSE. 
Completely preventing entry of brain proteins and tissue fragments into the venous 
circulation after stunning is unlikely to be possible since minor head trauma such as 
might occur if the animal were to strike it's head on the floor after stunning might itself 
carry a small risk of embolism. Nevertheless, the results of this study indicate that a 
wide range of frequencies of brain tissue embolism are possible dependant upon 
variables that include the type of captive bolt gun used for stunning and the size and 
species of animal to be stunned. This suggests that it may be possible by modified or 
novel stunning methods to minimise the likelihood of embolism to very low levels 
which if combined with testing of animals for BSE might reduce the risk of BSE 
transmission to the consumer by this route to negligible levels. 
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4.1.2 AORTIC BLOOD SAMPLING 
The potential of fragments of brain tissue to disseminate in the carcass has been the 
subject of considerable debate. Previously brain tissue emboli have been detected in the 
right side of the heart or lodged in the pulmonary arteries, leading some to speculate 
that passage beyond the lungs was unlikely (Bradley, 2002). A study using marker 
bacteria has demonstrated wide dissemination of the bacteria in the carcass after captive 
bolt stunning (Prendergast et al., 2004). Although useful this study provided little 
information on the dynamics and potential for brain tissue fragments to disseminate in 
the carcass since the biological composition and size of brain tissue fragments and 
bacteria must be very different. 
In previous studies conducted by the author a prepared brain tissue suspension was 
stained with a blue dye and then introduced into the pulmonary arteries of abattoir 
specimens of bovine lungs. These simple experiments demonstrated that in these 
isolated organ specimens, passage through the lungs and into the pulmonary veins was 
possible (Coore, unpublished trials). These crude demonstrations however were not 
transferable to the live animal in which muscle and vessel tensions and permeability are 
likely to be very different. Nevertheless, these trials were useful in formulating the 
techniques that were fmally used in the aortic sampling experiments conducted in sheep 
and cattle. 
The sampling of the aortic blood following exogenous introduction of brain tissue 
fragments to the venous circulation has demonstrated in sheep that the passage of small 
brain tissue fragments through the pulmonary capillaries is possible and furthermore has 
suggested the size of particles small enough to pass through and enter the aortic 
circulation. 
In aortic blood samples obtained from cattle, elevated levels of GFAP were detected in 
samples from three animals by ELISA while all samples were found negative by 
microscopy and immunocytochemistry. It is possible that brain tissue fragments were 
also present but were not identified in the prepared Cytoblocks since less than one 
percent of each blood sample was actually examined for the presence of brain tissue 
fragments (Prof. S. Love, Department of Neurosciences, Frenchay Hospital, Bristol, 
UK-personal communication). An explanation for fording brain tissue fragments and 
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proteins in sheep samples as opposed to brain proteins alone, in cattle samples may be 
due to the proportionately greater volume of blood in the bovine and the consequent 
much greater opportunity for missing positive samples as a result of greater dilution 
effects in cattle than in sheep. In any event, it seems clear that the prion protein (PrPW) 
in a BSE infected animal would pass into the aortic blood after stunning whether 
associated with larger fragments of brain tissue or perhaps simply as a protein in 
suspension. Once present in the aortic blood, brain tissue fragments or proteins may 
potentially be carried to all areas of the carcass including to muscles. 
The timing of passage through the lungs was another important aspect of this study, 
since in order to present a risk to the consumer of beef, brain tissue would need to 
access the aortic circulation before the circulation was halted by cardiac arrest due to 
exsanguination. In samples positive for elevated levels of GFAP or in those samples 
containing visible fragments of brain tissue, positive blood samples were found within a 
minute of stunning and injection of brain tissue suspension. This time frame is well 
within that which would allow contamination of the carcass to occur in the real abattoir 
situation. During commercial stunning and slaughter of livestock there is an interval of 
between thirty and ninety seconds between stunning and exsanguination achieved by 
cutting of major blood vessels in the neck or thorax. During this interval the stunned 
animal may be shackled and hoisted prior to exsanguination (sticking) depending upon 
the slaughter practice followed (in some abattoirs the animal may be exsanguinated 
without hoisting). This stunning to sticking interval during which the heart is still 
beating and the circulation is intact allows a window of opportunity for dissemination of 
brain tissue emboli through the lungs and into other tissues of the carcass. Clearly in 
abattoirs with prolonged stunning to sticking intervals one would expect an increased 
risk of passage of brain tissue emboli through the lungs and subsequent contamination 
of the carcass with brain material. 
Lymphocytes have been implicated in the peripheral pathogenesis of prion diseases 
following experimental transmission of BSE in sheep using infected blood and buffy 
coat (Hunter et al., 2002) and also following a case of vCJD in an individual as a result 
of a blood transfusion from a sub-clinically infected donor (Ironside & Head, 2004). 
Plasma is also suspected to contain lower but still detectable levels of infectivity 
(Ironside & Head, 2004). If blood from a BSE infected animal may already carry 
sufficient infectivity to cause infection in some susceptible individuals, then brain tissue 
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emboli may create by an additive effect a greater level of risk to more people in whom 
the species barrier might otherwise have prevented infection. The study has been 
successful in going further towards demonstrating the potential for carcass 
contamination by CBG stunning but still leaves unanswered questions as to which 
organs are most likely to be contaminated and the quantity of brain tissue that might 
disseminate in the carcass. 
The vertebral venous plexus is a complex system of veins that assist in the drainage of 
blood from the head. By occluding the jugular veins of anaesthetised sheep, an 
investigation of alternative drainage routes from the head was made, using GFAP as a 
marker for brain tissue. It was hoped that occlusion of the jugular veins might force 
brain tissue fragments introduced into the cerebral sinuses to exit the head by way of the 
vertebral veins. Alternatively, such brain tissue fragments might be forced to drain 
from the head through the lymphatic system by the change in pressure gradient in the 
venous system produced by blocking jugular drainage. The negative results obtained 
from the aortic blood samples and from organ samples including the cervical lymph 
nodes were inconclusive. Although laboratory trials with lymph node specimens and 
injected brain tissue suspension suggested that the GFAP ELISA might be sensitive 
enough to detect the presence of brain tissue in organs (Refer to 3.1.3.9.2.2), the high 
concentration of injected brain tissue used in these bench tests probably accounted for 
the success in detection. In the experiments conducted on the live animal, if brain tissue 
contamination did occur, the levels of contamination would probably have been many 
orders of magnitude lower making detection by this method impossible. The sheep 
injected with brain tissue suspension in these experiments were lying in lateral 
recumbency on the table that should have caused some blood to drain by way of the 
vertebral plexus (Coore et al., 2004). However, it is possible that the time required for 
circulation of brain emboli down through the plexus and into the posterior vena cavae 
before return to the heart and lungs may be far in excess of that available between the 
act of stunning, sticking and exsanguination. It seems unlikely that the lymphatic 
system contributes a significant risk of brain tissue dissemination within the carcass. 
Nevertheless, particles injected into the cerebral sinuses of anaesthetised animals have 
been demonstrated to be transported from the cerebral sinuses by this route (Kida, 
Pantazis & Weller, 1993), although the time frame for this transport described in these 




4.1.3 ORGAN SAMPLING 
The sampling of organs and analysis by the methods of ELISA and the combined 
methods of microscopy and immunocytochemistry were inconclusive since the negative 
results obtained might indicate an absence of organ contamination or simply indicate 
levels of contamination below the detection limit of each method of analysis. These 
trials suggested the need for the application of more sensitive detection methods and 
also for methods that avoid the need to sample small areas of organs while leaving the 
greater volume of tissue un-tested. 
4.1.4 VALIDATION 
The sandwich ELISA for GFAP used in these experiments was previously validated in 
experiments examining spinal cord tissue contamination of carcasess (Helps et at., 
2002). Although the assay protocol was essentially unchanged in these experiments, the 
application of the assay to blood samples rather than to swabs required that the 
sensitivity and specificity of the assay was re-evaluated. The validation studies 
demonstrated that this assay based on commercially available antibodies is robust and 
produces consistent and reliable results. The sensitivity of the assay for GFAP was 
0.5ng/ml that compares favourably with previous estimates of the limit of detection of 
similar assays (Helps et al., 2002; Schmidt et al., 1999). However, it is acknowledged 
that the limit of detection of this assay is many orders of magnitude higher than other 
ELISAs for GFAP that quote sensitivities as low as 5pg/ml (Petzold et al., 2004). 
Although assays offering greater detection sensitivities might appear to offer improved 
methods of detecting brain tissue contamination of the carcass, such assays may only 
result in greater detection of background GFAP levels and lead to further confusion as 
to the validity of the results. 
The validation studies of the complementary technique of microscopy and 
immunocytochemistry confirmed the findings of previous trials that used this method 
and in fact demonstrated a greater degree of consistent sensitivity than previously 
reported (Love et al., 2000). 
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4.2 ANATOMICAL INVESTIGATION OF VENOUS CEREBRAL DRAINAGE 
4.2.1 VASCULAR CASTING 
The vascular structures demonstrated in each of the prepared casts indicate an 
essentially similar structure in both bovine and ovine specimens. The sinuses of the 
head communicate directly or indirectly with both the jugular veins and with the 
vertebral venous system. 
The internal vertebral plexus is the most prominent vascular structure of the vertebral 
venous system demonstrated by the resin casts. This system has clearly developed as an 
important drainage portal for blood from the head. This observation confirms that of 
previous workers who identified the vertebral venous plexus as a collateral venous 
pathway and a potential conveyer of infection and emboli to the vertebrae from the head 
(Batson, 1940; Smuts, 1977). 
An examination of the bovine specimens suggests that the vessels of the calf specimen 
are relatively larger than those of the adult, although the vascular systems appear to be 
of similar structure and complexity. The ovine specimen demonstrates a system of 
vessels of generally smaller bore than in the bovine specimens consistent with the 
relative size of the animals. 
The vertebral plexus represents an alternate route, paralleling the caval system in 
transporting blood back to the heart via various anastomoses with the systemic as well 
as the visceral veins. It provides a bypass for the caval, portal and pulmonary systems 
and in view of the continuity with the dural sinuses inside the cranial cavity and the 
absence of valves in both systems, it allows blood to flow in either direction dependant 
upon the pressure gradient within the system (Goschal, Koch & Popesko, 198 1). This 
by-pass facility may be an important factor in the potential dissemination of brain tissue 
emboli by this complex system of veins. It suggests that brain tissue emboli from the 
head might be transported to visceral organs without passage through the lungs, that 




4.2.2 DISSECTION OF THE OVINE HEAD AND NECK 
This study demonstrated that the use of dissection alone without the combined use of 
resin injection of the venous system is difficult, due to the surrounding bony and soft 
tissues that protect the cerebral sinuses and vertebral plexus. However, the method does 
offer the advantage of demonstrating the relationship of the drainage system to the 
surrounding soft tissues such the vertebral vein to the transverse canal of the cervical 
vertebrae. In contrast, the technique of resin casting and maceration of tissues does not 
allow easy observation of this relationship, since all tissues are dissolved in the cast 
preparation. 
In this dissected specimen the vertebral vein was visualised and measured accurately 
without the use of prior resin injection that may have otherwise exaggerated the 
diameter of the vessel. In future similar anatomical studies, the combined used of resin 
injection and dissection may allow a more detailed investigation of the vertebral venous 
system. 
4.3 RADIOGRAPHIC STUDY OF VENOUS CEREBRAL DRAINAGE 
The potential role of the vertebral venous system as an additional drainage route for 
brain tissue emboli in suspension in the venous blood was demonstrated 
radiographically in this series of experiments. 
In addition, the postural effect on cerebral venous drainage demonstrated in previous 
studies conducted in other species (Dilenge & Perey, 1973; Zippel, 2001) was 
confirmed in this study of sheep. In the horizontal recumbent position, blood flow 
appears to drain from the head by the vertebral venous plexus as well as by both jugular 
veins. In contrast, in the vertical `head down' position, blood flow returns to the body 
exclusively by the jugular route. Previous workers have suggested variations in 
pressure in the cerebrospinal fluid as the explanation behind this observation (Dilenge 
and Perey, 1973). This factor may have particular significance to captive bolt gun 
stunning since the act of stunning is likely to cause rapid and significant elevations in 
pressure that might result in the preferential use of unexpected drainage pathways 
including that of the vertebral plexus. 
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The practical implications of the effects of posture upon transport of brain tissue emboli 
may mean that in abattoirs with prolonged stunning to hoisting intervals there may be a 
greater risk of dissemination of emboli by way of the vertebral plexus. Blood draining 
through the vertebral plexus will avoid the filtration effects of the pulmonary capillaries 
and might carry brain tissue fragments to peripheral tissues of the carcass. The longer 
that an animal remains on the stun box floor and the holding cradle before hoisting, will 
allow a greater volume of blood to drain from the head through the vertebral venous 
system. This will effectively increase the risk of brain tissue emboli dissemination by 
this route. This factor may create a further imperative for reducing stunning to hoisting 
intervals since slow shackling and hoisting will also increase stunning to sticking 
intervals with concomitant adverse effects upon welfare. Abattoirs with rapid stunning 
to sticking intervals that also hoist animals before exsanguination will substantially 
reduce risks of brain tissue dissemination in the carcass by the vertebral venous system. 
4.4 SEPARATION AND QUANTIFICATION OF EMBOLI BY FILTRATION 
This small pilot study has demonstrated a new and practical method of recovering brain 
tissue fragments in blood samples, with the added advantage of providing additional 
data on the weight of brain tissue that may enter the circulation after stunning. 
Although leukocyte filters have been proposed and used for this purpose in an earlier 
study (Anil, Krailadsiri & Seghatsian, 2002), the use of the pre-filter to capture brain 
tissue fragments, as opposed to the leukocyte filtration component is an innovation that 
has several advantages over this use of the filtration apparatus. The main such 
advantage lies with the ease of recovery of the captured tissue, since the leukocyte 
filters themselves are difficult to open, and back-flushing with saline to recover the 
tissue is likely to recover only fractions of the brain tissue material. The use of the pre- 
filter however, is cost and time effective allowing the processing and analysis of large 
volumes of collected blood. It avoids the necessity for sampling small volumes of the 
blood collected, as was the case with the method of separation by centrifugation (Refer 
to 2.1.8.1). Secondly, the method avoids confusion over the nature of the captured 
material since the tissue captured in the filters can be visualised and positively identified 
by microscopic and immunocytochemical analysis. Brain tissue proteins including 
GFAP and Syntaxin 1B will pass through the filter into the filtrate and can be detected 
by application of a suitable ELISA. 
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The study has provided the first experimental evidence of the weight of brain issue that 
enters the circulation after captive bolt gun stunning. This information is a critical 
determinant of any risk analysis of captive bolt gun stunning, and the potential for 
carcass contamination with infective prions. The finding of an average weight of 1-g of 
brain tissue in the jugular venous blood compares favourably with the weights of loose 
brain material collected from the bolt hole of bovine and ovine skulls after captive bolt 
gun stunning (Farag, 2002, Biggins, 2003). The infective oral dose of BSE infected 
brain tissue to humans is unknown, however, studies in animals estimate a minimum 
oral dose of 50-µg to 500-mg of infected brain tissue (Love et al., 2000). Using these 
estimates of brain tissue infectivity, one-gram of BSE infected brain tissue would 
contain between 2 and 20,000 times the amount necessary for transmission of infection 
by the oral route. 
Previous methods of analysis have been unable to provide an accurate estimate of the 
amount of brain tissue that may enter the venous circulation due to reliance on sampling 
of small volumes of collected blood samples. Estimates of up to 10-g of brain tissue 
have been made based upon the amount of brain material that can be dislodged by the 
penetrating captive bolt gun (Anil et al., 2002). However direct measurement of the 
amount of brain material present in the circulation after stunning has not previously 
been described. The European Food Safety Authority (EFSA) recently published a 
report on BSE risk from dissemination of brain particles in blood and carcasses (EFSA, 
2004), in which new research findings in the field are discussed and described, 
including many of the findings from this study. In this report by EFSA, the need for 
further research on quantification of the contamination of organs with brain tissues is 
reiterated. 
In future studies, refinements to the use of the filtration method might include the use of 
filters with smaller pore sizes as well as improvements in the analysis of the captured 
tissue. Such new analytic methods might allow an accurate estimation of the 
proportionate weight of brain tissue, as opposed fibrin and debris captured in the filter. 
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4.5 POLYMERASE CHAIN REACTION FOR DETECTION OF BRAIN TISSUE CONTAMINATION 
OF THE CARCASS 
The aim of this study was to determine the extent of organ contamination with brain 
tissue that may occur following the use of captive bolt gun stunning of sheep. By 
injecting quantities of brain tissue into the jugular blood while sampling the aortic 
blood, we have demonstrated in a previous study that small fragments of brain tissue are 
capable of passing through the fine lung capillaries (Coore et al., 2004b). The 
subsequent considerable dilution in the blood of this brain material necessitates the use 
of a highly sensitive detection method to identify any contamination with this material 
in visceral organs. The PCR assay applied in this experiment proved to be highly 
sensitive with a detection limit of 0.05%, determined by analysis of dilutions of known 
amounts of male DNA in buffer, a figure that compares favourably with PCR assays 
used in related studies (Bottero et al., 2003). This detection limit is equivalent to 0.5-µg 
of brain material per 5-µl of buffer (100-µg/ml). This detection limit compares with the 
detection limits determined during the validation of the ELISA and analysis by 
microscopy and immunocytochemistry. 
Although the detection limit of the PCR is not substantially better than that achieved by 
the GFAP ELISA (refer to 3.1.3.9.1.1 & 3.1.3.9.2.1), it does offer advantages for the 
detection of brain tissues in organs. High background, levels of GFAP in organs 
prevented detection of low levels of contamination by ELISA leading to a reduction in 
the specificity of the assay (refer to 3.1.3.8.1). Since the SRY (sex-determining region 
of the Y-chromosome) DNA is present only in the Y- chromosome there is no 
possibility for cross-reaction from other sources, giving the potential for high specificity 
of the PCR. An explanation for the level of sensitivity achieved by the PCR may be 
that the SRY chromosomal DNA is a single copy gene present only once in each cell. 
This would mean that at low concentrations of male brain tissue contamination in 
organs there may be insufficient DNA present to be amplified enough for detection to 
be possible. 
The detection of the SRY DNA in lymphatic tissues from a female sheep conducted as 
part of the validation of the PCR assay indicated that the assay could detect small 
quantities of tissue contamination. The failure to detect any SRY DNA in the organs of 
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a sheep following injection with brain suspension into the jugular venous blood, 
suggests that if any contamination occurred, it was below the limit of detection of this 
sensitive assay. An alternative explanation may rest with a draw-back of the assay 
which still relies on sampling of minute quantities of the organ for analysis. Incomplete 
homogenisation and mixing of the organ specimens may have resulted in pockets of 
male brain tissue in organs that were simply not taken for DNA extraction and analysis. 
To reduce the risk of this in future experiments using this method, complete digestion of 
an entire organ with large volumes of the enzyme Proteinase K followed by DNA 
extraction of the tissue digest may ensure that any male tissue contamination was not 
over-looked. 
Previous studies investigating organ contamination using a bacterial marker found 
extensive contamination of muscles and of organs with the marker (Buncic et at., 2002; 
Prendergast et at., 2004). The application of such studies to investigations of the 
dissemination of brain tissue in the carcass is open to question since the morphology 
and dynamics of bacteria and brain tissue fragments in blood may be very different. In 
addition, the use of a replicating marker while useful for demonstrating potential 
contamination does not allow quantification of the brain tissue contamination that could 
occur. 
It is possible that low levels of organ contamination may be detected using this 
technique of male brain tissue injection and subsequent DNA extraction from tissues 
and PCR analysis if further studies are conducted, using larger sample populations of 
animals. 
4.6 INVESTIGATION OF PROTHROMBIN TIME ESTIMATION OF OVINE PLASMA AS AN 
INDIRECT TEST FOR BRAIN TISSUE EMBOLI IN BLOOD 
This experiment attempts to identify the presence of brain tissue fragments in jugular 
blood samples taken after CBG stunning by measurement of prothrombin time in the 
plasma. By estimation of the amount of thromboplastin released into the blood samples 
it may be possible to separate samples in which brain tissue fragments are present. The 
more thromboplastin present in a sample the more clotting should occur with the 
accompanying exhaustion of more clotting factors. This should cause prothrombin 
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times to be prolonged in these samples when compared to samples in which less 
thromboplastin was present and in fact this is what was observed in the series of sheep 
plasma samples examined. Comparison of the mean pre-stun plasma PT times with that 
of the mean post-stun plasma PT times after use of both types of captive bolt gun shows 
a very significant difference in the time for clotting to occur. The post-stun sample PT 
times were considerably longer than those observed from the pre-stun plasma samples. 
The explanation for this observed difference lies with the release of thromboplastin 
from damaged tissue as a result of CBG stunning. Although thromboplastin is found in 
high concentrations in brain tissue it is also found in all other tissues albeit in smaller 
quantities. The ubiquitous nature of this potent activator of the extrinsic clotting 
pathway suggests that it may not be ideal as a marker solely for brain tissue. 
Nevertheless, while it was expected that all post-stun samples might demonstrate 
prolonged PT times over the pre-stun samples it was hoped that samples containing 
brain tissue fragments might show PT times prolonged even beyond these times. This 
may in fact have occurred in samples containing brain tissue but may be 
indistinguishable from other post-stun samples since most post-stun samples 
demonstrate PT times beyond 70-seconds which are the limit of recordable PT times on 
the coagulation analyser used in the study. Consequently, no separation is possible 
among samples in which PT times are beyond 70-seconds. In future studies on this 
subject it may be worthwhile either manually timing PT times to get an accurate reading 
from all samples including those with prolonged PT times or by using an alternative 
automated system that allows a greater range of PT time recording. 
The sheep plasma samples produced consistent elevation of PT times within sixty 
seconds of stunning and in fact comparison of mean pre-stun PT times with the PT time 
of samples taken within ten seconds of stunning also produces a significant difference 
(P<0.05). The rapidity of the clotting process after severe head trauma is not previously 
described although prolonged PT times have been observed after analysis of plasma 
obtained from victims of head trauma at various intervals post injury (Kuo, Chou & 
Chio, 2003). The advantage offered by this study is that sampling began almost 
immediately post-stunning and continued over one minute. 
Investigation of PT times within the first minute of head trauma may provide useful 
information for research on the activation of the clotting cascade after head trauma or 
even upon that which might occur during surgery on the brain. The results of this study 
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indicate that the clotting cascade is activated almost simultaneously with the application 
of head trauma. 
4.7 INVESTIGATION OF PROTHROMBIN TIME ESTIMATION OF BOVINE PLASMA AS 
AN INDIRECT TEST FOR BRAIN TISSUE EMBOLI IN BLOOD 
Analysis of the prothrombin times obtained from assay of bovine plasma indicated a 
significant difference between the pre and post-stunning samples from animals in which 
brain tissue embolism had occurred. No significant difference was demonstrated 
between pre-and post stun samples prothrombin times from negative samples. This 
suggests that estimation of prothrombin time in bovine plasma may offer a method of 
distinguishing samples taken from animals with brain tissue emboli after stunning. 
While statistical analysis did establish significance of this result, the small sample size 
of the positive group of animals must reduce the confidence in this association. A 
larger sample group of cattle with brain tissue emboli after stunning would be necessary 
to confirm these results. 
An explanation of the success of the assay as a tool for identifying bovine samples 
containing emboli although not from ovine samples may stem from the much larger 
volume of blood in cattle as compared sheep. After captive bolt gun stunning similar 
levels of head and brain trauma occur in both species and it might be expected that 
comparable amounts of thromboplastin would be released into the circulation. In cattle, 
the dilution effects of the large blood volume on the thromboplastin may lead to a 
failure of activation of the clotting cascade in most cases. Only in instances in which 
brain tissue emboli are also present is a sufficiently high concentration achieved to 
activate the clotting cascade. 
In sheep, with a much smaller blood volume as compared to cattle, the comparatively 
low concentrations of thromboplastin released from head and brain tissue trauma may 
be sufficient to activate the clotting cascade in all cases. This may explain the 




Further studies upon the effects of brain tissue emboli on coagulation might examine a 
range of parameters of coagulation including D-dimer concentrations, activated partial 
thromboplastin time (APT'I'), thrombin clotting time, fibrinogen assay, and fibrinogen 
degradation products. The use of these additional measures of coagulation may increase 
the sensitivity of the method for brain tissue emboli detection. 
4.8 IMPROVED DESIGNS OF CAPTIVE BOLT GUN 
While this study has involved the investigation of a range of issues and factors relating 
to the use of captive bolt guns and the occurrence of brain tissue emboli, the desired 
outcome of these studies must be a reduction of the risk posed by the use of these 
stunning methods. 
Captive bolt guns have been used in the humane stunning and slaughter of livestock for 
over one hundred years with only minor evolution in design. An ideal stunning 
technique should fulfil these requirements: 
1) Produce an immediate and reproducible stun for maintenance of good welfare 
standards 
2) Must be economic and widely accessible and acceptable (religious slaughter) 
through-out the world 
3) Ease of operation and safety for the operator 
4) Does not encourage embolism of brain tissue into the venous return 
The last of these requirements is recent and has only become important since the BSE 
outbreak in cattle and the discovery that captive bolt gun stunning can sometimes cause 
brain tissue emboli to enter the circulation (Anil et al. 1999; 2001; 2002). The results of 
this study suggest the need for the development of a humane stunning method that 
avoids the risk of brain tissue embolism. The economic realities of the beef industry 
combined with the recorded problems with the currently available use of electrical 
stunning on cattle indicate that electrical stunning may not be the only answer. Many of 
the current problems associated with electrical stunning methods used on cattle relate to 
welfare and to meat quality issues. Application of the electrodes may be associated 
with a brief period of pain before unconsciousness is induced, particularly if poor 
contact occurs between the electrodes and the skin. Furthermore, electrical stunning 
207 
Chapter 4 
may in some cases lead to signs of returning consciousness before sticking, or to failure 
to initiate cardiac arrest leading to the necessity of repeat stunning by re-application of 
the electrodes or by captive bolt gun stunning. Meat quality may be adversely affected 
after use of electrical stunning by way of muscle haemorrhages and by the occurrence of 
bone fractures. The high cost of electrical stunning equipment for cattle is a further 
obstacle for the use of this method especially in smaller abattoirs with modest through- 
put of livestock. 
Modifications of current bolt designs have previously been suggested many of which 
have relied upon reducing the damage inflicted on the brain by the bolt. At a recent 
meeting initiated by the European Commission and attended by academics and 
representatives from the industry, a variety of novel and modified stunning methods 
were discussed. Novel stunning methods discussed at the meeting included, the 
potential use of trans-cranial magnetic stimulation (TMS) and improvements to 
electrical stunning methods currently in use. The main outputs from this seminar were 
later included in a report to the European Commission (Safestun, accompanying 
measures QLK2-2002-3 051). 
The wide breath of this study encompassing both trials with CBGs and anatomical 
studies has provided in-sights into possible mechanisms by which embolism occurs and 
also has led to theoretical suggestions for CBG modifications. The necessity for 
modifications to current CBG designs has been suggested for other reasons besides that 
of brain tissue embolisation. During the recent Foot and Mouth disease epidemic in the 
UK the unprecedented call for wide-scale slaughter of livestock as a method of 
controlling the spread of disease led to a welfare disaster. The need to slaughter a large 
number of animals rapidly resulted in the use of captive bolt guns as a method of 
slaughter causing some animals to exhibit signs of recovery in the cull. In the period 
since the cull there has been a call by the UK government for a new design of CBG gun 
that will kill as well as induce a stun. 
Recent studies have revealed information on the drainage of emboli from the head 
(Coore et at. 2004) and also on the dissemination of emboli within the carcass 
including entry into the aortic blood supply (Coore et al. 2004a). The mechanism of 
entry of brain tissue emboli into the venous circulation after stunning remains unclear. 
The dorsal sagittal sinus has been suggested as an entry point for emboli following gun 
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shot to head and raised intra-cranial pressure has been sited as a major pre-disposing 
factor (Miyaishi et al., 1994). 
Anatomical studies that we have completed using a technique of resin corrosion casts of 
the cerebral venous drainage in sheep and cattle suggests an alternative entry point for 
brain tissue fragments after CBG stunning. The casts demonstrate that while the dorsal 
sagittal sinus will undoubtedly be ruptured by the passage of the bolt, the vessel itself is 
of modest proportions, even in an adult cow. Measurements of the vessel obtained from 
the prepared cast of the adult bovine, suggest a diameter of only 8-mm at its widest 
point and only 2-mm in diameter for much of its length. On the other hand, the basilar 
system of veins located on the ventral surface of the brain is much more extensive and 
of greater proportions of up to 35-mm in diameter. Estimations based on the average 
length of the bolt and the depth of the cranial cavity indicates that the basilar vessels 
will also be ruptured by the passage of the bolt in many instances. This statement is 
supported by examination of cattle and sheep brains following CBG stunning (Farag, 
2002; Biggins, 2003). It appears much more likely that it is this ventrally situated 
plexus of vessels that is the entry point for brain tissue emboli, rather than the dorsal 
sagittal sinus. 
Based on this hypothesis it would seem sensible to modify current designs of captive 
bolt gun to reduce the risk of rupture of these ventrally situated vessels. Although 
vessels may be ruptured by concussive force alone, the length of the bolt of a 
penetrating gun ensures that these vessels will always be traumatised, at least in sheep, 
where the bolt strikes the base of the cranial cavity. 
Entry of projectiles including captive bolts into the skull is known to result in raised 
intra-cranial pressure, as a result of several contributing factors (Blackmore, 1985). 
Such factors may include the following: 
1) Entry of gas into the cranium generated by the explosive discharge of the 
projectile 
2) Formation of a temporary cavity (cavitation effect) 
3) Displacement of tissue by the volume of the bolt (-12.5cm) [2 h where 
r=0.5cm and h=8cm] 
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Cavitation refers to the temporary cavity created by radial forces imparted to the brain 
parenchyma by the passage of the bolt. It persists for 5 to 30-microseconds and may 
have a diameter of 30 to 40 times that of the projectile and generate local internal 
pressures greater than 10-mPa within the expanding walls of the cavity (Finnie, 2000). 
Displacement of tissues by the space-occupying bolt will further raise this pressure 
presumably only for the microseconds that the bolt remains in the skull before it returns 
to the barrel. Evidence for this rapid increase in intra-cranial pressure has been 
demonstrated by experiments in which de-capitated heads were shot with the captive 
bolt gun and was followed by an explosive discharge of brain material from the foramen 
magnum (Finnie, 2000). 
The increased intra-cranial pressure produced by the entry of the bolt into the skull 
provides the best explanation for why brain tissue fragments sometimes enter the 
venous sinuses after stunning. While the venous system is a low-pressure environment, 
one would expect that it should still be higher than that present in the surrounding 
tissues under normal circumstances. Emboli are very unlikely to passively drift into an 
area of positive pressure from the surrounding brain tissue, if the pressures within the 
cranial cavity were lower than those in the venous system. It seems probable that 
emboli are forced into the venous sinuses by a brief but significant rise in intra-cranial 
pressure. Following extraction of the bolt, the system is no longer a closed one and 
intra-cranial pressures should fall. The extrusion of brain material from the bolt-hole is 
a result of the equalising pressures between the external environment and within the 
skull. This explanation of the pressure as the main factor rather than brain 
fragmentation and haemorrhage is born out by the recent prevalence studies of brain 
tissue embolism in cattle and sheep subjects (Coore et al., 2004; 2005- in press). The 
significantly higher prevalence obtained in the sheep study over that of the cattle study 
can be explained by the higher intra-cranial pressures expected within the smaller sheep 
cranium than in the bovine cranial cavity. Recent studies involving the macroscopic 
examination of both sheep and cattle brains after captive bolt stunning have failed to 
produce evidence of either greater haemorrhage or generally greater quantities of loose 
brain in sheep than in cattle (Farag, 2002; Biggins, 2003). It is likely that in sheep, the 
high infra-cranial pressures force emboli into the venous sinuses more frequently than in 
the bovine. The bolts used in both cases are of similar volumes, albeit discharged with 
greater force in cattle. 
210 
Chapter 4 
Based on the findings from previous work and from the proceeding explanation a 
modification of captive bolt design is suggested that may reduce the problem of brain 
tissue embolism while maintaining the other requirements of a good mechanical 
stunning device. The basis for this suggestion is the provision for an alternative outlet 
for the brain tissue that might otherwise become an embolus in the venous return. To be 
effective this other exit would need to be created simultaneously with the bolts 
penetration of the skull and be sufficiently large to reduce internal cranial pressure. The 
downside of this approach might be to reduce the effectiveness of the stun, since raised 
intra-cranial pressure is known to cause tearing and stretching of axons that contribute 
to the effectiveness of the stun and reduce the chances of a return to consciousness. 
4.8.1 Modifications to a penetrating captive bolt gun 
In this modification to the gun, a hollow bolt is created through which brain tissue under 
pressure might exit. Connecting this system to a suction device might increase the 
efficiency and reduce blockage of the outlet with loose tissue. It might also, serve to 
collect the brain tissue obtained and prevent contamination of the abattoir environment. 
In addition, the bolt is shortened to approximately 6-cm while the diameter of the bolt is 
increased to maintain the durability of the hollow bolt. 
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Figure 4.1 Modified penetrating captive bolt gun providing an outlet for brain material 
to exit the cranium while the shorter bolt length should reduce trauma to the cerebral 
sinuses lying on the ventral aspect of the bovine brain 
through wbwh the 
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The use of captive bolt gun stunning of cattle and sheep has been demonstrated to cause 
brain tissue emboli to enter the venous return at frequencies of from 2 to 23% 
depending upon the species of stunned animal and the type of captive bolt gun 
employed. The amount of brain tissue that may be found in the jugular vein blood of 
sheep after captive bolt gun stunning was found in a small pilot study to have a mean 
weight of 0.97-g (range 0.22 to 2.08). 
The potential of small fragments of brain tissue up to a diameter of 20-µm to pass 
through the lung capillaries of sheep to enter the arterial circulation has been 
demonstrated and in cattle for brain tissue proteins to enter the arterial circulation by the 
same route. 
Venous cerebral drainage was demonstrated to occur by the vertebral system of veins in 
addition to the jugular veins and the potential for dissemination of brain tissue emboli at 
stunning and slaughter by the vertebral venous system was examined. 
The use of the polymerase chain reaction to detect small amounts of marker DNA in a 
carcass was demonstrated to be a sensitive and practical technique of investigating the 
potential for brain tissue contamination of carcass organs as a result of stunning. 
The use of a coagulation test was shown to be a potential method of identifying plasma 
samples from cattle in which brain tissue had entered the circulation after stunning. 
Analysis of sheep plasma samples, indicated that the coagulation test was a sensitive 
method of detecting brain trauma within 10-s of the injury including that which resulted 
in brain tissue emboli. 
The information gained from these studies has been applied towards possible 
modifications to current captive bolt gun design aimed at reducing the risk of brain 




" Research on novel stunning methods as well as modified versions of current 
methods 
" Further studies on the potential for dissemination of brain tissue emboli in the 
carcass conducted under commercial conditions 
" Development of improved analytic methods for the detection and quantification 
of stunning induced brain tissue contamination of the carcass 
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APPENDIX 1 RAW DATA FROM THE VALIDATION OF THE GFAP ELISA ON CATTLE 
AND SHEEP SAMPLES 
Data obtained using bovine tissue samples 
Table 1A OD values for the dilution curve of bovine brain tissue in blood 
Concentration Dose dilution curve (OD Value) 
(mg/ml) 1 2 3 4 5 Mean SD 
10.00 3.07 2.95 2.86 3.15 2.90 2.99 0.12 
5.00 3.04 3.04 2.92 3.08 2.85 2.99 0.10 
2.50 3.14 2.79 2.86 3.11 2.88 2.96 0.16 
1.25 2.40 2.56 2.85 3.04 2.85 2.74 0.26 
0.6250 1.43 2.88 2.89 1.18 2.17 2.11 0.80 
0.3125 0.87 0.78 2.03 0.90 1.51 1.22 0.54 
0.1560 0.47 0.89 1.51 0.37 0.46 0.74 0.48 
0.0780 0.28 0.34 0.77 0.25 0.21 0.37 0.23 
0.0390 0.17 0.14 0.41 0.14 0.16 0.20 0.11 
0.0195 0.11 0.09 0.16 0.16 0.15 0.13 0.03 
0.0098 0.09 0.08 0.11 0.07 0.11 0.09 0.02 
0.0049 0.06 0.05 0.06 0.06 0.05 0.06 0.01 
0.0024 0.07 0.07 0.06 0.06 0.06 0.06 0.01 
0.0012 0.04 0.06 0.05 0.05 0.05 0.05 0.01 
0.0006 0.07 0.04 0.04 0.04 0.09 0.06 0.02 







OD Value GFAP ng/ml 
1 10.0000 3.070 S 
2 5.0000 3.041 S 
3 2.5000 3.140 S 
4 1.2500 2.400 13.78 
5 0.6250 1.430 6.34 
6 0.3125 0.866 3.05 
7 0.1560 0.466 1.64 
8 0.0780 0.281 0.775 
9 0.0390 0.169 nd 
10 0.0195 0.105 nd 
11 0.0098 0.087 nd 
12 0.0049 0.056 nd 
13 0.0024 0.069 nd 
14 0.0012 0.043 nd 
15 0.0006 0.065 nd 
S- Saturated levels 
nd-Not detectable 







OD Value GFAP ng/ml 
16 10.0000 2.950 S 
17 5.0000 3.040 S 
18 2.5000 2.790 S 
19 1.2500 2.560 S 
20 0.6250 2.880 S 
21 0.3125 0.780 S 
22 0.1560 0.891 3.3 
23 0.0780 0.342 1.05 
24 0.0390 0.144 nd 
25 0.0195 0.091 nd 
26 0.0098 0.079 nd 
Appendix 
27 0.0049 0.054 nd 
28 0.0024 0.073 nd 
29 0.0012 0.059 nd 
30 0.0006 0.043 nd 
S- Saturated levels 
nd-Not detectable 







OD Value GFAP ng/ml 
46 10.0000 2.860 S 
47 5.0000 2.920 S 
48 2.5000 2.860 S 
49 1.2500 2.850 S 
50 0.6250 2.890 S 
51 0.3125 2.030 11.08 
52 0.1560 1.510 7.42 
53 0.0780 0.772 3.01 
54 0.0390 0.405 1.53 
55 0.0195 0.161 nd 
56 0.0098 0.114 nd 
57 0.0049 0.064 nd 
58 0.0024 0.062 nd 
59 0.0012 0.046 nd 
60 0.0006 0.040 nd 
S- Saturated levels 
Appendix 
nd-Not detectable 







OD Value GFAP ng/ml 
61 10.0000 3.150 S 
62 5.0000 3.080 S 
63 2.5000 3.112 S 
64 1.2500 3.040 S 
65 0.6250 1.180 5.24 
66 0.3125 0.895 2.432 
67 0.1560 0.374 0.877 
68 0.0780 0.247 0.58 
69 0.0390 0.137 nd 
70 0.0195 0.159 nd 
71 0.0098 0.073 nd 
72 0.0049 0.059 nd 
73 0.0024 0.057 nd 
74 0.0012 0.045 nd 
75 0.0006 0.044 nd 
S- Saturated levels 
nd-Not detectable 







OD Value GFAP ng/ml 
76 10.0000 2.900 S 
77 5.0000 2.850 S 
78 2.5000 2.880 S 
79 1.2500 2.850 S 
80 0.6250 2.170 9.75 
81 0.3125 1.510 5.21 
82 0.1560 0.456 1.06 
83 0.0780 0.208 0.497 
84 0.0390 0.162 nd 
85 
-- - 
0.0195 0.150 nd [ t6 
0.0098 0.112 nd 
Appendix 
87 0.0049 0.045 nd 
88 0.0024 0.062 nd 
89 0.0012 0.048 nd 
90 0.0006 0.086 nd 
S- Saturated levels 
nd-Not detectable 
Table 7A OD values for the standard curve of the GFAP ELISA 
Appendix 
Concentration GFAP standard curve (OD Value) 
(ng/ml) 1 2 3 4 5 Mean SD 
2000 3.00 3.00 3.15 2.81 3.01 3.00 0.121 
1000 2.88 2.93 2.97 2.72 2.74 2.85 0.110 
500 2.95 2.95 2.95 2.71 2.87 2.89 0.101 
250 2.98 2.81 2.87 2.80 2.81 2.86 0.076 
125 3.19 2.94 2.93 2.80 2.71 2.91 0.183 
62.5 2.99 2.96 2.97 2.81 2.77 2.90 0.101 
31.25 2.99 3.08 3.04 2.73 2.74 2.92 0.167 
15.625 3.26 3.32 3.28 2.74 2.94 3.11 0.258 
7.812 2.69 2.67 2.91 1.26 2.38 2.38 0.652 
3.906 1.66 1.57 1.97 0.56 0.86 1.32 0.592 
1.976 1.03 1.02 1.35 0.36 0.60 0.87 0.390 
0.976 0.52 0.49 0.75 0.20 0.31 0.45 0.210 
0.488 0.34 0.30 0.43 0.11 0.18 0.27 0.127 
0.288 0.20 0.17 0.20 0.08 0.13 0.16 0.051 
0.122 0.09 0.10 0.11 0.06 0.08 0.09 0.021 
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Data obtained using ovine tissue samples 
Table 8A OD values for the dilution curve of ovine brain tissue in blood 
Concentratio 
n 
Dose dilution curve (OD Value) 
(mg/ml) 1 2 3 4 5 Mean SD 
10.0000 2.83 2.98 3.10 3.10 2.97 3.00 0.11 
5.0000 2.85 2.81 3.08 3.06 2.80 2.92 0.14 
2.5000 2.97 2.35 1.26 2.34 2.23 0.71 
1.2500 3.06 1.85 2.13 1.30 0.82 1.83 0.85 
0.6250 1.42 0.78 0.98 0.93 0.43 0.91 0.36 
0.3130 1.13 0.58 0.39 0.36 0.29 0.55 0.34 
0.1560 0.96 0.21 0.24 0.18 0.24 0.36 0.33 
0.0780 0.70 0.11 0.32 0.14 0.23 0.30 0.24 
0.0390 0.08 0.09 0.12 0.13 0.15 0.11 0.03 
0.0195 0.09 0.06 0.08 0.12 0.54 0.18 0.20 
0.0098 0.08 0.06 0.09 0.12 0.11 0.09 0.02 
0.0049 0.13 0.04 0.10 0.12 0.12 0.10 0.04 
0.0024 0.05 0.04 0.10 0.12 0.25 0.11 0.08 
0.0012 0.07 0.05 0.08 0.04 0.25 0.10 0.09 
0.0006 0.04 0.04 0.09 0.03 0.21 0.08 0.08 






OD value GFAP ng/ml 
16 10.000 2.7 S 
17 5.000 2.4 S 
18 2.500 2.6 S 
19 1.25 1.5 7.8 
20 0.6250 1.5 7.7 
21 0.3125 0.32 1.46 
22 0.1560 0.787 4.2 
23 0.078 0.093 nd 
24 0.0390 0.014 nd 
25 0.0195 0.007 nd 
26 0.0098 0.003 nd 
27 0.0049 0.205 nd 
28 0.0024 0.005 nd 
29 0.0012 0.018 nd 










OD value GFAP ng/ml 
31 10.000 3.058 S 
32 5.000 2.143 S 
33 2.500 1.57 7.6 
34 1.25 0.873 4.4 
35 0.6250 0.185 0.83 
36 0.3125 0.14 nd 
37 0.1560 0.05 nd 
38 0.078 0.06 nd 
39 0.0390 0.007 nd 
40 0.0195 0.042 nd 
41 0.0098 0.003 nd 
42 0.0049 0.007 nd 
43 0.0024 0.006 nd 
44 0.0012 0.085 nd 
45 0.0006 0.004 nd 
S-Saturated levels 
nd-Not detectable 






OD value GFAP ng/ml 
46 10.000 2.79 S 
47 5.000 2.74 S 
48 2.500 2.84 S 
49 1.25 1.78 9.6 
50 0.6250 0.88 4.6 
51 0.3125 0.64 3.3 
52 0.1560 0.32 1.4 
53 0.078 0.18 0.8 
54 0.0390 0.091 nd 
55 0.0195 0.053 nd 
56 0.0098 0.078 nd 
57 0.0049 0.02 nd 
58 0.0024 0.05 nd 
59 0.0012 0.08 nd 
60 0.0006 0.03 nd 
nd-Not detectable 
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OD value GFAP ng/ml 
61 10.000 3.01 S 
62 5.000 1.74 7.5 
63 2.500 0.69 5 
64 1.25 0.72 5.2 
65 0.6250 0.27 1.8 
66 0.3125 0.20 1.4 
67 0.1560 0.39 2.9 
68 0.078 0.058 nd 
69 0.0390 0.31 2.0 
70 0.0195 0.31 2.0 
71 0.0098 0.02 nd 
72 0.0049 0.07 nd 
73 0.0024 0.16 nd 
74 0.0012 0.08 nd 
75 0.0006 0.086 nd 
S-Saturated levels 
nd-Not detectable 






OD value GFAP ng/ml 
76 10.000 2.8 S 
77 5.000 2.723 S 
78 2.500 2.735 S 
79 1.25 2.0 16.9 
80 0.6250 2.27 21.3 
81 0.3125 1.08 7.5 
82 0.1560 0.084 nd 
83 0.078 0.086 nd 
84 0.0390 0.06 nd 
85 0.0195 0.135 nd 
86 0.0098 0.13 nd 
87 0.0049 0.093 nd 
88 0.0024 0.124 nd 
89 0.0012 N/A N/A 
90 0.0006 N/A N/A 
nd-Not detectable 
N/A -Not available 
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Table 14A OD values obtained from the dilutions of the GFAP standard 
Concentratio 
n 
GFAP standard curve (OD Value) 
(ng/ml) 1 2 3 4 5 Mean SD 
2000 3.02 3.12 3.27 2.99 3.18 3.12 0.12 
1000 2.62 2.97 2.89 2.81 2.94 2.85 0.14 
500 2.98 3.13 2.98 2.91 2.97 2.99 0.08 
250 2.95 2.99 
. 
2.98 2.81 2.88 2.92 0.08 
125 3.14 3.07 3.03 2.83 2.96 3.01 0.12 
62.5 2.67 3.05 3.03 2.96 2.88 2.92 0.16 
31.25 2.95 3.29 3.02 3.08 2.57 2.98 0.26 
15.625 2.91 3.17 3.04 2.55 1.36 2.60 0.73 
7.812 1.09 1.94 1.76 1.39 0.60 1.36 0.54 
3.906 0.38 0.93 1.26 0.39 0.37 0.66 0.41 
1.953 0.27 0.67 0.68 0.34 0.16 0.42 0.24 
0.976 0.14 0.37 0.40 0.29 0.11 0.26 0.13 
0.488 0.11 0.18 0.16 0.14 0.08 0.13 0.04 
0.244 0.07 0.11 0.12 0.08 0.06 0.09 0.03 
0.122 0.04 0.06 0.07 0.06 0.05 0.06 0.01 
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SHORT COMMUNICATIONS 
Neural embolism and 
cerebral venous 
drainage at stunning 
and slaughter 
R. R. COORE, F. J. BARR, J. L. MCKINSTRY, 
M. H. ANIL 
THE establishment of a link between bovine spongiform 
encephalopathy (BSE) in cattle and variant Creutzfeldt-Jakob 
disease in human beings (Will and others 1996) initiated a 
review of stunning and slaughter practices to prevent the con- 
tamination of carcases by tissues designated as specified risk 
material (sMt). In the UK, over 30 per cent of sheep are 
stunned before slaughter by a captive bolt gun (Anon 1997). 
Due to the continuing uncertainty over whether the UK sheep 
flock may harbour the BSE agent, equally stringent stint 
controls are applied to sheep as to bovine carcases. 
The continued use of captive bolt guns for stunning sheep 
and cattle in the UK has been questioned as investigations have 
demonstrated the risk of neural tissue embolism and carcase 
contamination after stunning (Anil and others 2001). Neural 
tissue emboli were detected in the jugular return of four of 15 
sheep after the use of two types of captive bolt guns (Anil and 
others 2001). The presence of alternative cerebral drainage 
vessels in this species suggests that neural tissue emboli might 
also be detectable in other veins draining blood from the 
head. 
The internal vertebral plexus (tvp) has been well described 
in both human beings (Groen and others 1997) and in a vari- 
ety of animal species (Smuts 1977, Ghoshal and others 1981) 
including sheep (Rauhut 1962). The plexus originates at the 
foramen magnum from the cerebral venous sinuses and 
forms paired, ventrally situated interconnecting vessels, which 
extend posteriorly within and along the length of the verte- 
bral canal. The ivp offers an alternative outflow for venous 
blood from the head that may, under certain conditions, 
exceed that of the jugular veins (Valdueza and others 2000, 
Zippel and others 2001). 
During stunning and slaughter, an animal will undergo 
various postural changes starting with a normal standing 
position and changing to one of recumbency after stunning. 
Finally, the animal maybe hoisted into a head-down position 
for slaughter by exsanguination or, alternatively, may be 
exsanguinated while recumbent. This short communication 
describes the effect of posture upon the venous outflow from 
the head in the context of stunning and slaughter, and the 
potential for the carriage of neural emboli. 
Radiographic studies were performed on four adult cull 
sheep. The animals were anaesthetised with an intramuscu- 
lar induction mixture (12 mg/kg bodyweight ketamine and 
0.4 mg/kg bodyweight xylazine), and then intubated and 
maintained on halothane, oxygen and nitrous oxide. The 
angularis oculi vein, which runs medial and ventral to the 
eyes, was raised by digital pressure and cannulated with a 
22 G1 inch catheter (Otiva, Johnson and Johnson). A simi- 
lar catheter was also placed in the contralateral vein. With the 
animals in a recumbent position, 10 ml of contrast medium 
(Omnipaque; Nycomed) was injected simultaneously into 
both veins via the catheters. At the same time, a dorsoventral 
radiograph was taken of the head and neck. A second dorso- 
ventral radiograph was taken within 30 seconds of the first. 
While maintaining anaesthesia, each animal was hoisted 
to assume a head-down position to mimic the effect of hoist- 
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ing following stunning. The injections of contrast medium 
and the radiographs of the head and neck were then repeated. 
All four animals were euthanased humanely without recov- 
ery from anaesthesia. 
The radiographic images obtained show the veins by 
which the contrast medium drained from the cerebral sinuses (Fig 1). In the recumbent position, the ivp is clearly visible, indicating a significant carriage of blood from the head, while 
the jugular veins are only faintly apparent, suggesting a 
reduced blood flow in these vessels (Fig 1 a). The radiographs 
taken following hoisting of the sheep into a head-down posi- tion show distension of the jugular veins, while the ivp is not 
visible (Fig 1b). 
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FIG 1: Dorsoventral venogram of the head and neck of a sheep with the animal (a) in a 
recumbent position, and (b) hoisted into a head-down position, following the injection 
of 10 ml of contrast medium into both angularis oculi veins. 5V Sphenopalatine vein, 
CS Cavernous sinus, PS Petrosal sinus, IVP Internal vertebral plexus, JV Jugular vein, 
ETT Endotracheal tube, SC Sinuum confluens, IS Intercavernous sinus 
The findings suggest that, following stunning using a cap- 
tive bolt gun, the Ivr may be capable of transporting neural 
emboli while the animal is in a recumbent position. This ini- 
tial period following stunning lasts at least 15 seconds, which 
is within the time that neural emboli may be detectable in 
blood after captive bolt gun stunning (Anil and others 2001). 
After hoisting, it appears that the jugular veins will drain all 
the blood from the head, making it unlikely that, at this stage 
of the slaughter process, the ivp could contribute towards the 
carriage of neural emboli. As the jugular veins are themselves 
severed at exsanguination, any risk of carcase contamination 
by this route should be minimised. 
Possible changes to cerebral venous drainage routes from 
the head as a direct consequence of captive bolt gun stunning 
may need to be examined in future studies. If further inves- 
tigations indicate that the IvP may offer an additional route 
for the dissemination of neural tissue emboli after captive bolt 
gun stunning, a review of current stunning and slaughter 
practices may be required. 
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=ABSTRACTS 
Treatment of anal furunculosis 
with cyclosporin A and 
ketoconazole 
NINETEEN dogs with anal furunculosis were treated with a 
combination of cyclosporin A and ketoconazole, and the signs 
resolved completely within three to 10 weeks. However, in 
seven of the dogs the signs recurred after remission periods 
ranging from one to six months. In some of the dogs the treat- 
ment had adverse effects, including hair loss, lethargy, vom- 
iting and poor appetite, but none of them was considered 
serious. The results were as good as or better than the surgi- 
cal alternatives, and there was an approximately 70 per cent 
saving in cost compared with using cyclosporin A alone. 
O'NEILL, T., EDWARDS, G. A. & HOLLOWAY, S. (2004) Efficacy of combined 
cyclosporine A and ketoconazole treatment of anal furunculosis. Journal of 
SmallAnimal Practice 45,238-243 
Transient hydrops fetalis in 
pregnant dogs diagnosed by 
ultrasound 
BETWEEN November 1999 and May 2002 a total of 161 
bitches were diagnosed pregnant by ultrasound. Seventeen of 
them developed signs of hydrops fetalis during the pregnancy, 
but no pups were born with clinical signs of hydrops fetalis. 
One of the litters was aborted after the bitch developed sys- 
temic mastocytosis. Of the 95 pups in the other 16 litters seven 
were resorbed, eight were aborted and seven were stillborn. 
Eleven of the 73 pups born alive died within a few days and 
seven were born with congenital abnormalities. Pugs were 
significantly more likely to be affected than other breeds. 
HOPPER, B. J., RICHARDSON, J. L. & LESTER, N. V. (2004) Spontaneous 
antenatal resolution of canine hydrops fetalis diagnosed by ultrasound. 
Journal of Small Animal Practice 45,2-8 
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Dissemination of Brain Emboli following Captive Bolt Stunning 
of Sheep: Capacity for Entry into the Systemic 
Arterial Circulation 
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ABSTRACT 
The epidemic of bovine spongiform encephalopathy in the United Kingdom and the recognition of a variant of Creutzfeldt- 
Jakob disease prompted revision of the guidelines for slaughter of cattle and sheep to prevent contamination of the edible 
parts of the carcass with central nervous system tissue. We previously showed that captive bolt gun stunning, which is routinely 
used for the slaughter of cattle and sheep, causes entry of fragments of central nervous system tissue into the jugular vein. 
To determine whether such tissue can traverse pulmonary capillaries to enter the systemic circulation, we introduced small 
volumes of brain tissue that had been disrupted by stunning with a captive bolt gun into the jugular vein of sheep sent for 
slaughter We examined aortic blood samples by immunocytochemistry for neurofilament and S100 proteins and by enzyme- 
linked immunosorbent assay for glial fibrillary acidic protein and found fragments of neurofilament- and S 100-immunopositive 
central nervous system tissue in samples from 2 of 11 sheep and elevated glial fibrillary acidic protein in 6 sheep. Our findings 
suggest that central nervous system tissue that is dislodged during routine captive bolt gun stunning and slaughter of sheep 
can enter the systemic arterial circulation and that, in some cases, this method of slaughter of an animal infected with bovine 
spongiform encephalopathy would be likely to contaminate edible parts of the carcass with infective material. 
Bovine spongiform encephalopathy (BSE) was first 
recognized in the United Kingdom in the mid-1980s (14). 
There is now compelling evidence that the BSE agent is 
responsible for a variant of Creutzfeldt-Jakob disease first 
reported in 1996 (15). The recognition of BSE and subse- 
quently of its link to the variant Creutzfeldt-Jakob disease 
(8) led to the introduction of stringent measures to prevent 
the contamination of meat products by brain and spinal 
cord, the tissues with the highest potential for infectivity 
(10). Although the controls reduce the risk of entry of BSE- 
infected material into the food chain, it remains unclear 
how effective they are in preventing contamination of ed- 
ible parts of the carcass. This concern is relevant to sheep 
as well as cattle because it is still uncertain whether sheep in the United Kingdom might also be affected by the BSE 
agent (12). 
In the United Kingdom, most cattle and many sheep 
are stunned by captive bolt guns (CBGs). In 1996, U. S. 
researchers noted neural tissue in the pulmonary arteries of 
cattle stunned with an air-injection pneumatic gun (6). Sub- 
sequently, Bauer et at. (4) identified neural emboli within 
the pulmonary arteries of 7 of 220 cattle carcasses. At the 
time, this finding was refuted in the United Kingdom (13), 
Author for correspondence. Tel: +44-117-928-9646; Fax: +44-117-928- 
9324; E-mail: trcoore@bristol. ac. uk. 
but the occurrence of neural emboli after stunning with 
some types of CBG was subsequently confirmed (3). 
In previous studies of cattle and sheep subjected to 
conventional captive bolt stunning, we found neural emboli 
in jugular venous blood (1-3) but not in single samples of 
blood taken from the aorta in a small number of animals 
M. We have now further explored the possibility that entry 
into the jugular venous return of central nervous system 
(CNS) tissue carries a risk of dissemination within the sys- 
temic arterial circulation, risking the contamination of ed- 
ible parts of the carcass. 
MATERIALS AND METHODS 
Animals. Twelve adult sheep were used: 11 experimental 
animals and 1 control. The 11 experimental animals were anes- 
thetized with a mixture of ketamine (12 mg/kg, Fort Dodge, 
Southampton, UK), and xylazine (0.4 mg/kg, Bayer, Bury St. Ed- 
munds, UK) given intravenously. Once the animals were deeply 
anesthetized, the jugular vein was exposed and a catheter intro- 
duced. Anesthesia was maintained by intravenous infusion of a 
100: 3: 10 mixture of 10% guaiphenesin (Chassot [UK] Ltd., Pres- 
wick, UK), 2% xylazine, and 10% ketamine. An arterial catheter 
was advanced through one of the carotid arteries into the proximal 
aorta. A previously prepared 10-m1 suspension of brain tissue 
fragments in normal saline (see below) was then injected through 
the jugular catheter At the same time that the suspension was 
injected, the animal was stunned with a pneumatically activated 
J. Food Prot., Vol. 67, No. 5 
penetrating CBG (Cash Ramrod, Accles and Shelvoke, Birming- 
ham, UK), and blood collection was initiated through the aortic 
catheter. The collection of blood was continued until all flow had 
ceased 3 to 11 min later The volume collected over each succes- 
sive 1-min period was divided into aliquots with 20 ml of citrate 
anticoagulant in 250-ml bottles. Postmortem examination con- 
firmed correct placement of the aortic catheter in every case. 
Preparation of brain tissue suspensions. Loose brain tissue 
created by previous stunning of an animal with a penetrating CBG 
was collected through the bolthole of a fresh carcass by flushing 
with normal saline followed by aspiration with a 10-m1 syringe. 
The tissue was suspended by vigorous agitation in normal saline 
at a ratio of 1g tissue to 9 ml saline. A 10-ml sample of suspen- 
sion therefore contained approximately 1g of brain tissue. Our 
previous studies suggest that this is a conservative estimate of the 
amount of brain tissue that can be dislodged from the cranial 
cavity by a CBG (1). Our aim in obtaining and suspending the 
brain tissue in the manner described was to achieve a volume of 
CNS tissue and range of particle sizes comparable to the embolic 
showers produced by a CBG. 
Positive controls. One sheep was stunned by CBG and five 
100-ml aliquots of blood were collected without prior injection of 
brain tissue into the jugular vein. A suspension of brain tissue was 
prepared as described above. Dilutions of brain volumes of 0.1, 
0.5,1.0,5, and 10 ml of suspension were added to the blood 
aliquots. 
Negative controls. Negative controls comprised jugular ve- 
nous blood samples taken from sheep before stunning and injec- 
tion of brain suspension. 
Preparation of aortic blood samples for assays. Buffy coat 
fractions were prepared as described (3,9). For enzyme-linked 
immunosorbent assays (ELISAs), 3 ml of each aliquot was frozen 
rapidly in liquid nitrogen and stored at -70°C until just before 
assay. The remaining volume was fixed in an equal volume of 
20% formalin for immunocytochemistry. 
ELISA. A capture ELISA for glial fibrillary acidic protein 
(GFAP), a specific marker of CNS tissue (11), was used. The 
method followed that of an earlier study (7), except that 75 eu of 
buffy coat from each aliquot was mixed with 75 µl of phosphate- 
buffered saline and 03% Triton X-100 for the assays. Duplicate 
50-µl samples of this mixture were assayed. 
Immunocytochemistry. The immunocytochemical methods 
were as previously described (9). Samples of formalin-fixed huffy 
coat were pelleted and embedded in paraffin wax Cytoblocks 
(Shandon, Runcome, UK). Sections (5 µm) were cut in triplicate 
at three levels through the blocks. The adjacent sections were 
stained with hematoxylin and eosin or immunostained by a stan- 
dard strepatavidin-bictin-peroxidase method for neurofilament 
protein (Dako M0762, Dako, Ely, UK) or S100 protein (Dako 
Z031 1). In addition to the controls described above, each immu- 
nocytochemical run included positive samples from previous stud- 
ies (9) and sections immunostained with omission of primary an- 
tibody. 
RESULTS AND DISCUSSION 
GFAP ELISA. The results of the ELISA showed that 
GFAP was absent from all blood samples taken before in- 
jection of brain tissue and was detected in all of the positive 
control samples. Levels were elevated in aortic blood from 
6 of 11 animals tested (Table 1). In five animals, GFAP 
BRAIN EMBOLI IN THE ARTERIAL CIRCULATION 1051 
TABLE 1. Analysis of samples by glial fibrillary acidic protein 
(GFAP) ELISA 
Results by sheep' 
Time 
(min' abcdefhijkI 
I++ ND + ND ++ ND ND ND ND 
2++ ND + ND ++ ND ND ND ND 
3++ ND + ND ++ ND ND + ND 
4 ND + ND ++ ND ND ND 
5 ND + ND ++ ND ND ND 
6 ND + ND + ND ND ND 
7 ND + ND ND ND ND 
8 ND + ND ND ND ND 
9+ ND ND ND 
10 + ND 
11 + 
6Time following injection of brain homogenate and stunning by 
CBG. 
b Each animal was designated a letter from a through 1. The absent 
sheep (g) was the positive control sample. +, positive for GFAP; 
ND, not detectable. 
was detectable within 60 s of injection of brain suspension 
and in all subsequent samples until blood flow ceased. In 
the sixth animal, GFAP was detected in only the third, final 
sample. 
Microscopy and immunocytochemistry. Immunocy- 
tochemical analysis demonstrated that CNS tissue was ab- 
sent from all blood samples taken before injection of brain 
tissue and was detectable by immunocytochemistry for both 
S100 protein and neurofilament protein in all of the positive 
control samples. Multiple buffy coat samples from two an- 
imals-S(h), S(k)-yielded Cytoblock sections that con- 
tained tissue immunopositive for S100 and neurofilament 
proteins (Fig. 1). 
The lungs are effective filters of cellular embolie ma- 
terial, such as metastatic tumors (5). Although CNS emboli 
are known to enter the jugular veins (2,3) and pulmonary 
arteries (6) after stunning with a CBG, it has not previously 
been shown that such emboli can pass through the pul- 
monary vasculature to enter the aorta. This is clearly a crit- 
ical determinant of the risk that stunning by CBG might 
disseminate PrPsc within the edible tissues of a BSE-in- 
fected animal. In previous studies, we suggested that some 
of the fragments of CNS tissue in the jugular venous blood 
of cattle stunned with a CBG were small enough to traverse 
the pulmonary capillary bed (2,3,9). The present findings 
indicate that this might indeed occur and, in addition, dem- 
onstrated that emboli as large as 20 µm in diameter can 
pass through the ovine pulmonary capillary bed to enter the 
arterial circulation. 
The reliability and specificity of the methods used in 
this study have been evaluated and validated extensively 
(2,3,9). The discrepancies between the results of immu- 
nocytochemistry and ELISA in some animals probably re- 
late to the limited sampling of buffy coat in these assays. 
In total, less than 1% of the buffy coat in any aliquot was 
sampled for immunocytochemistry or ELISA, and although 
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FIGURE 1. Cvtoblock sections of huffy coat from a sheep with CNS tissue in aortic blood samples. The sections have been labeled Jnr 
neurofilament protein (NF) and S100 protein. Both sections contain fragments of immunopositive CNS tissue. Bars = 20 µm. 
immunocytochemistry was performed on sections cut at 
several levels, the intervening material was not examined. 
It is therefore inevitable that the immunocytochemical find- 
ings will have tended to underestimate the number of pos- 
itive samples. Furthermore, because the neural emboli are 
particulate in nature, the blood samples cannot be consid- 
ered to be homogeneous solutions of GFAP, and ELISA 
might also underestimate the number of positive samples. 
ELISAs on sequential aliquots of blood in the six an- 
imals with positive assays indicated that neural tissue con- 
tinued to be released from the pulmonary vasculature into 
the aorta for as long as the heart continued to beat, although 
the initial bolus had been administered over a period of 
only a few seconds. The delayed passage of some of the 
embolic tissue through the lungs probably reflected partial 
obstruction by the pulmonary capillaries. In contrast, some 
embolic tissue passed through the lungs into the systemic 
circulation within a minute of its introduction into the jug- 
ular vein. Neural emboli can enter jugular veins within 30 
s of stunning with a CBG (3), and in the context of stunning 
and slaughter of livestock in abattoirs, our results suggest 
that there would be sufficient time for emboli to pass 
through the lungs and into the systemic circulation before 
exsanguination and cardiac arrest. 
The present study has confirmed the potential for sys- 
temic embolization of CNS tissue. Further work is necessary 
to improve the sensitivity of the assays, to determine the 
incidence of neural embolism in larger cohorts, and to assess 
the risk in cattle as well as sheep. Although BSE is declining 
in the United Kingdom, at least in cattle, it is increasing in 
incidence in other countries, and it is important to continue 
to try to minimize the risk that stunning and slaughter of 
subclinically infected animals will cause prions to enter the 
human food chain. To this end, it is necessary to explore 
alternative methods of stunning, existing or novel, that do 
not carry the risk of neural embolism. 
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Captive Bolt Gun Stunning of Sheep 
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ABSTRACT 
In accordance with controls instituted to protect the consumer from meat potentially infected with bovine spongi- 
form encephalopathy (USE), brain tissue emboli caused by the use of captive bolt gun (CBG) stunning have been. 
identified as a potential public health risk that requires further investigation. As the natural occurrence of BSE 
in sheep remains uncertain we have investigated the frequency of brain tissue embolism associated with stun- 
ning by two types of CBG that are in commercial use in the United Kingdom. Blood samples collected from sheep 
following stunning were analysed by ELISA as well as by a combination of microscopy and Immunocytochem- 
istry. The combined positive results from each method of sample analysis were used to determine the frequency 
of brain tissue embolism in the sample population. The frequency of brain tissue embolism was found to be 23% 
in sheep stunned with a cartridge-activated CBG (95% confidence interval of 15.8-32.2%) and 14% in those stunned 
with a pneumatically activated CBG (95% confidence interval of 8.5-22%). The frequency of brain tissue embolism 
associated with the use of CBG stunning may represent a significant source of carcass contamination with brain 
tissue. 1 
INTRODUCTION 
ALTHOUGH EXTENSIVE INVESTIGATIONS 
have 
not revealed naturally acquired bovine 
spongiform encephalopathy (BSE) in sheep 
(Baylis et al., 2002), the UK government has im- 
plemented controls to reduce any potential risk 
to the human population should BSE be de- 
tected in the sheep population in the future. 
Brain tissue has previously been detected in 
jugular blood samples from two of 15 sheep 
(13.3%) that had been stunned with a conven- 
tional penetrating captive bolt gun (CBG) and 
in a further two of 15 animals that had been 
stunned with a pneumatically-activated pene- 
trating CBG (Anil et al., 2001,2002). CBGs are 
used to stun around 38% of sheep in the UK 
and brain tissue embolism may present a sig- 
nificant risk factor for carcass contamination 
with tissues of potential high infectivity (Anil 
et al., 2001). In this paper, we present the re- 
sults of work undertaken to examine the fre- 
quency, of brain tissue emboli present in jugu- 
lar venous blood obtained from 200 sheep 
stunned-using either a cartridge or pneumati- 
cally activated penetrating CBG. 
Sample collection 
Two hundred adult sheep of varying age 
were sampled for brain tissue embolism fol- 
lowing stunning by one of two types of CBG. 
All sheep were stunned by an experienced 
slaughter-man according to standard commer- 
'Department of Clinical Veterinary Science, University of Bristol, Langford, United Kingdom. 2Department of Neuropathology, Institute of Clinical Neuroscience, Frenchay Hospital, Bristol, United Kingdom. 
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each jugular vein and firmly secured in place 
by ligatures. A 10-mL pre-stun sample of blood 
was taken from the jugular cannulas into a col- 
lection tube containing citrate anti-coagulant 
0 
FIG. I. The anatomical landmarks used for identifying 
the correct stunning position followed that for polled 
sheep. The muzzle of the CBG was placed on the highest 
point of the head on the midline aiming straight down before activation of the CBG. 
0 
cial practice in the UK (Fig. 1). The animals 
were first anaesthetized by intra-muscular ad- 
ministration of a ketamine (12 mg/kg; Fort 
Dodge, Southampton, UK) and xylazine (0.4 
mg/kg; Bayer, Bury St. Edmunds, UK) mix- 
ture. Anaesthetic depth was maintained by in- 
travenous infusion of a 100: 3: 6 mixture of 10% 
guaiphenesin (Chassot Ltd, Preswick, UK), 2% 
xylazine, and 10% ketamine. After sufficient 
anaesthetic depth was achieved, a plastic can- 
nula was advanced in a cranial direction into 
TABLE 1. ANIMALS POSITIVE FOR BRAIN TISSUE EMBOLISM BY ANALYSIS OF BLOOD SAMPLES 
GFAP ELISA 
Microscopy and immunocytochemistry 
Total positive animals 
Processing of blood samples 
The samples were placed in a pre-cooled cen- 
trifuge (Hi-spin 21, MSE, UK; 5°C) and cen- 
trifuged at 800 Xg for 30 min. The buffy coat 
from all samples was isolated by suction of the, 
greater quantity of red bloods cells and plasma, 
and then three 1-mL aliquots of the isolated 
buffy coat fraction were frozen at -30°C and 
retained for assay by ELISA. Samples of buffy 
coat were also retained for analysis by mi- 
croscopy and immunocytochemistry. 
Positive controls 
., For positive controls, a series of five two-fold dilutions of macerated brain tissue in blood 
was prepared and sent for analysis by EUSA 
and by microscopy and immunocytochemistry. 
COORE ET AL. 
No. of positive animals 
stunned by pneumatically- 




'Nine animals were confirmed positive for brain tissue embolism by both assays. f 
(3.8% citrate, pH 5.2). 1 
Half of the sheep were stunned-with a car---- 
tridge-activated penetrating CBG (Temple Cox 
Mark X, Accles & Shelvoke, Birmingham, UK), 
and half were stunned with a pneumatically- 
activated penetrating CBG without air-injec- 
tion facility (Cash Ramrod, Accles & Shelvoke, 
Birmingham, UK). Simultaneously with stun- 
ning, blood collection was initiated from the 
pre-placed jugular cannulas and continued 
over one minute. Samples were taken at 10-sec 
intervals into six separate plastic 250-mL bot- 
tles containing citrate anticoagulant (3.8% cit- 
rate, pH 5.2). Following sample collection, the 
animals were slaughtered by exsanguination 
according to normal commercial practice. 
No. of positive animals 
stunned by cartridge- 
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ätive controls included jugular blood sam- 
iken prior to stunning from all animals. 
to ELISA for GFAP 
x1 fibrillary acidic protein (GFAP) has pre- 
ly been used as a sensitive marker of cen- rvous system tissue (l-Ielps et al., 2002). reviously described ELISA for GFAP 
et al., 2002) with minor modifications 
ed to analyse all samples. Modifications 
assay included the initial addition of 75 
huffy coat from each aliquot to 75 µL of 
. 5% Triton-X 100 to break down any em- 
aterial and achieve a homogeneous so- 
Duplicate 50-µL samples of this mixture 
then assayed according to the described 
ol. 
copy and immunocytochemistry 
method for sample processing and analy- 
been previously described (Love et al., 
Briefly, samples of buffy coat were fixed 
lin, pelleted, and embedded in paraffin 
ytoblocks. 5-µm-thick sections were then 
: multiple levels through the block. Adja- 
ections were stained with haematoxylin 
sin or immunostained by a standard lavidin-biotin-peroxidase method for neu- 
ent protein (Dako, Ely, UK) or S100 pro- 
ako, Ely, UK). SarnDles were reearded as 
ve if the Cytoblock sections included frag- 
or tissue that were immunpositive for 
ILeuroruarnent protein and S100 protein. 
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obtained from each CBG group (p = 0.174, Chi- 
squared analysis). 
The detection limit of the ELISA and the mi- 
croscopy and immunocytochemical analysis 
was found to be 156 µg/mL (wet weight brain 
per ml blood) and 312 µg/mL (wet weight brain 
per ml blood), respectively. All negative control 
samples were correctly identified by both meth- 
ods of sample analysis. The intra-assay and in- 
ter-assay coefficient of variation of the GFAP 
EUSA was 13% and 17%, respectively. 
Comparison of the positive results obtained 
by EUSA and by microscopy and immunocy- 
tochemistry demonstrates a greater disparity 
than previously found in similar studies (Anil 
et al., 2001,2002). This discrepancy may relate 
to the small volumes of venous blood analyzed 
by each test. For practical reasons, <1% of each 
aliquot obtained over a 10-sec period could 
be analyzed, and it is therefore likely that 
both methods underestimated the number of 
weakly positive aliquots. However, by com- 
bining the two methods, we have tried to min- 
imize the number of false negative results. The 
frequency of brain tissue embolism found in 
this study suggests that a significant propor- 
tion of sheep carcasses entering the food chain 
after CBG stunning risk contamination with 
brain tissues. If BSE were to be identified in 
farmed sheep, the use of CBG stunning in this 
species might pose a risk to the consumer. 
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RESULTS AND DISCUSSION 
e frequency of brain tissue embolism in p stunned by the cartridge-activated, pene- 8 ý-uV WdS L. 3%n 
--w. tuaucitle uttervai 
The frequency of brain tissue e ii usm iouowing the use of the nnenmah_ Y activated CBG was 14% (95% confidence 
Lvai of ts. 5"/o-22%). These results represent 
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AP ELISA and analysis by microscopy and 
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ý .,; aiý: s " Although the incidence of bovine spongiform encephalopathy in cattle continues to decline in the United Kingdom; , It ýJt;, remains important to maintain vigilance of all potential routes of transmission of infection to humans. Initial studies have,, '; 
demonstrated a potential riskof carcass contamination with brain tissue following the use of captive bolt gun stunning""in'., ii 
cattle. The objective of this study was to further explore these initial findings particularly in regard to captive bolt -guns,, 
'; ' 
currently in use in the United Kingdom. Brain tissue fragments or elevated levels of a marker protein for brain tissue were ;<' 
detected in venous blood samples from 4% (95% confidence interval. 1.6 to 9.8%) of cattle stunned by penetrating captiv4 i, c4 
bolt gun and from 2% (95% confidence interval. 0.6 to 7%) of those stunned by nonpenetrating captive bolt gun. ; äisxýf 
The controls instituted to eliminate bovine spongiform 
encephalopathy from United Kingdom cattle have been suc- 
cessful in causing a steady decline in reported cases of the 
disease (S), and a range of further measures has been taken 
to reduce the possibility of transmission from the remaining 
bovine spongiform encephalopathy cases to, humans (3). 
Nevertheless, it remains important to maintain vigilance 
and to explore and properly assess all potential routes by 
which consumers might be exposed to the bovine spongi- 
form encephalopathy agent. 
To maintain welfare standards, most cattle in the Unit- 
ed Kingdom are stunned with a captive bolt gun (CBG) 
before slaughter (4). The use of CBGs for stunning cattle 
has previously been shown to introduce fragments of brain 
tissue into the venous circulation in some cases, raising 
questions as to the risk of contamination of the carcass with 
potentially bovine spongiform encephalopathy-infected tis- 
sues (1,2). Investigations demonstrated brain tissue frag- 
ments in the jugular blood of 4 of 15 cattle sampled fol- 
lowing the use of a pneumatically operated air-injection 
penetrating CBG and in a single cow stunned with a con- 
ventional cartridge-activated penetrative CBG followed by 
pithing (1,, 2). As a consequence of these and other findings, 
the practice of pithing is now banned in the United King---' 
dom and European Union, and air-injection type CBGs are 
no longer used. Based on analysis of this earlier work (1, 
2), the United Kingdom Food Standards Agency recom- 
mended further investigation of the potential of stunning 
methods to introduce brain tissue into the venous circula- 
tion. 
" Author for correspondence. Tel: +44-117-928-9265; Fax: +44-117-928- 
9324; E-mail: Ilaluk. Anil@bristol. ac. uk. 
MATERUILS AND METHODS 
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Sample-collection; Two hundred cattle were sampled 'at a 
designated abattoir used for culling cattle over 30 months of äg01, 
with the permission of the United Kingdom Home Office. and 
Intervention Board, in batches of 6 to 10 animals over a 1-year 
period. Anesthesia was induced in each animal by administering 
an intravenous bolus of xylaiine (0.4 mg/kg; Bayer, Bury 
St. Ed- 
munds, UK) and ketamine (12 mg/kg; Fort Dodge, Southampton, 
UK). Anesthetic depth was maintained with further doses bf a 
100: 3: 6 anesthetic mixture of 10% guaiphenesin (Chassot [UK] 
Ltd, Preswick, UK), 2% xylazine, and 10% ketamine. Under'deep 
anesthesia an incision was made over and into each jugular vein, 
and 14-gauge Foley catheters were advanced in a cranial direction 
into each jugular vein lumen and secured in place with ligatures. 
The catheter balloon cuffs were then inflated to ensure collection 
of all blood returning in the jugular`veins. A 10-ml prestun sample 
was collected at this point into a test tube containing citrate an- 
ticoagulant (3.8% citrate, pH 5.2). 
One hundred animals were stunned with a penetrating car- 
tridge-operated CBG (Cash 8000 Cowpuncher, Ac Iles &' Shel- 
voke, Birmingham, UK) using a three-grain cartridge. A nonpen- 
etrating cartridge-operated CBG (Cash 9000 Magnum Knocker, 
Accles & Shelvoke) with a six-grain cartridge was used on the 
second group of 100 animals. Immediately after stunning, blood 
collection wäs initiated from the preplaced jugular catheters. -' 
. Blood sampling continued at 10-s intervals over 1 min into six 
250-ml collection bottles containing citrate anticoagulant (3.8% 
citrate, pH 5.2). This collection period was chosen to include the 
average time that may elapse between stunning and exsanguina- 
tion. Following sample collection the animals were shackled and 
exsanguinated according to normal commercial practice. 
. Positive controls. A quantity of macerated fresh bovine brain 
tissue was used to prepare a twofold serial dilution in blood over 
concentrations ranging from 10 mg/ml to 0.6 µg/ml. The dilution 
.r:: 
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cries was mpmted on five-=-W: resulting 
patrol samples wem processödüidanalyud by methods identical 
j ulOSC used bn the : tudi4airiQles 
b ý,.: ; ýý "-'.,. Negative controls. A dilution series without added brain tis- 
ue was sent for processing and analysis along with all samples 
iken prior to stunning each animal. 
Processing of samples. The samples were placed in a pre- 
'oled centrifuge (iii-spin2l, MSE, Crawley, Sussex, UK) at 5°C 
Ad spun at 800 xg for 30 min. The huffy coat was removed 
ud 3 ml retained for assay by glial fibrillary acidic protein en- 
rme-linked immunosocbent assay (GFAP ELISA); the remaining 
)luune was fixed in an equal volume of 20% formalin to be 
talyzed by microscopy and immunocytochemistry. 
Capture ELISA for GFAP. GFAP is the principle 8- to 9- 
intermediate length filament found in astrocytes of the central 
crvous system and has previously been used as a sensitive mark- 
r of central nervous system tissue (7.10). A previously described 
LISA for GFAP (7) with minor modifications was used to ana- 
rze all samples. Modifications to the assay included the initial 
ddition of 75 µl of bully coat from each aliquot to 75 µ1 of 
hosphate-buffered saline. 0.5% Triton X-100 to break down any 
ragments of brain tissue and achieve a homogeneous solution. 
)uplicate 50-µl samples of this mixture were then assayed ac- 
ording to the described protocol (7). 
Plates were incubated overnight at 4°C and read at wave- 
engths of 405 and 492 um. A curve was generated from a serially 
Muted standard that allowed quantification of the results. 
Microscopy and immunocytochemistry. A previously de- 
cribed method (8) was used to analyze samples taken between 
10 and 40 s after stunning from each anima], since previous stud. 
ies indicated that during-this interval most of the dislodged brain 
tissue fragments enter the jugular venous return (1.2). Buffy coat 
samples were fixed in formalin, pelleted by centrifugation, and 
finally embedded in paraffin wax cytoblocks. Sectiöns 5-µm thick 
were then cut at multiple levels through the block. Adjacent sec- 
tions were stained with hematoxylin and eosin or were immuno- 
stained by a standard streptavidin-biotin-peroxidase method for 
neurofilament proteins (Dako M0762, Ely, Cambridgeshire, UK) 
and S100 protein (Dako Z0311, Ely). .A 
positive result was de- 
fined by the presence of tissue fragments in the Cytoblock sections 
that reacted with both antibodies. 
RESULTS AND DISCUSSION 
Analysis by microscopy and immunocytochemistry 
demonstrated small fragments of brain tissue in blood sam- 
ples taken from three cattle stunned by penetrating CBG 
and in blood samples from a further two cattle stunned by 
nonpenetrating CBG. In addition, blood samples from two 
cattle stunned by penetrating CBG showed elevated levels 
of GFAP. -The-combined results from ELISA and from mi- 
croscopy and immunocytochemical analysis indicate that 
4% (95% CI, 1.6 to 9.8%) of cattle stunned by penetrating 
C13G and 2% (95% CI, 0.6 to 7%) stunned by nonpene- 
trating CBG were found to have brain tissue fragments and 
or elevated levels of GFAP in jugular blood samples. The 
agreement between the results of the complementary detec- 
tion methods used in this study was not as consistent as 
that seen in previous work (1,2). Explanations for this dis- 
crepancy may relate to the small sample volumes analyzed 
by each method in combination with the nonhomogeneous 
;;; -t- a--.. 0 0q 
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FIGURE 1. Standard curve for the GFAP EL1SA (M) and a par- 
allel curve of dilutions of brain tissue in blood ("). Each point 
represents the mean ± standard deviation (SD) of 
f ve replicate 
samples that were assayed in duplicate. 
The positive and negative 
threshold (-) was calculated by the addition of the mean of 30 
prestun optical density (OD) values and 5 SD. 
nature of the samples in which brain tissue 
fragments were. 
present. An aliquot of blood without particulate 
brain tissue 
may be taken from an ELISA-positive sample, and con- 
versely the presence of an occasional 
fragment of brain tis- 
sue in the buffy coat may not always be associated with 
elevated levels of GFAP in the liquid fraction of the sample. 
The EUSA of the twofold serial dilutions of brain tis- 
sue in blood undertak@n as part of the assay validation gen- 
erated a curve that was parallel to that of the 
GFAP stan- 
dard (American Research Products, Belmont, Mass. ) (Fig. 
1). The minimum detection limit of brain tissue 
in blood 
was found to be 156 p g/ml (wet weight brain per milliliter 
of blood) by ELISA and 312 µg/ml (wet weight brain per 
milliliter blood) by the complementary method of micros- 
copy and immunocytochemistry. 
The presence of brain tissue in blood samples taken 
after the use of the penetrating. CBG without subsequent 
pithing has not previously been demonstrated and is partic- 
ularly significant as this type of CBG is presently used by 
the majority of abattoirs in the United Kingdom and Eu- 
ropean Union. The finding of a 4% frequency in the sample 
population may equate to as many as 80,000 animals when 
extrapolated to the total number of cattle slaughtered an- 
nually in the United Kingdom (6). The demonstration of 
brain tissue fragments in venous blood associated with the 
use of nonpenetrating CBG stunning casts doubt on the 
advisability of using these CBGs as a safer alternative to 
the use of penetrating CBGs. Recently, the European Com- 
mission initiated a review and consultation process with 
stakeholders on stunning methods for cattle as part of a 
recent project called SAFESTUN (accompanying measures 
QLK2-CT 2002-30531). A technical seminar held in 2003 
considered alternative methods to CBG stunning that in- 
cluded modifications to the current designs of CBGs, as 
well as the use of novel methods such as transcranial mag- 
netic stimulation. A final report of this project was sub- 
mitted to the European Commission in 2004 (9). Further 
studies of current stunning methods for cattle'are needed to 
assess the quantity and potential for dissemination of brain 
884 (, `OORH ET AL 
tissue fragments and proteins in the peripheral circulation, 
organs, and muscles of the carcass. 
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